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CHAPTER 1 
General introduction. 
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Lung 
Morphology 
The primary function of the lung is to take care of a proper gas exchange, 
to supply the blood with ©2 and to remove CO2. The lungs anatomy is constructed 
in such a way as to serve this function. Starting with the primary bronchi 
(originating from the trachea) there is a continuous branching of airways 
according to a pattern of irregular dichotomy, ultimately ending blindly. In 
total, an average of 23 generations of branching are present in a human lung 
(Weibel, 1980). The first 16 generations, ending with the terminal bronchioli, 
belong to the conducting zone; their function is to channal air into the 
terminal airway units. The terminal bronchioli split up into the respiratory 
brochioli, which already contain alveoli in their walls and they on their turn 
break up into the alveolar ducts from which the alveolar sacs and alveoli arise 
(Fig. 1). The 17th upto the 23rd generation comprise the transition and 
respiratory zone. All together these branches form the brochial tree. The 
pulmonary arteries are located adjacent to the air vessels and have a more or 
less similar branching pattern; pulmonary veins, however, follow a different 
pattern. 
Lung parenchyma comprises, strictly speaking, only alveoli, alveolar sacs 
and alveolar ducts (Weibel, 1963). In general, however, with parenchyma is meant 
the tissue comprising the transition and the respiratory zone. 
The actual gas exchange takes place in the alveoli (Fig. 2). On average 
there are 300 million alveoli in a human lung. Their form has been described as 
saucers, cups, brandy snifters and polyhedra. Literally alveolus is the Greek 
word for little cup. At high inflation levels their form can be compared with 
polydedra. The main part of an alveolus consists of the airspace, while the gas 
exchange process itself is located in the alveolar walls (alveolar septa). It 
should be noted that two alveoli have one septum in common. 
Air transport in the lung is largely by flow; in the most peripheral air-
ways, however, transport by diffusion becomes increasingly important, while the 
transport of alveolar air to the blood is basically a diffusional process. This 
implies that, in order to obtain an effective gas exchange, the barrier between 
the alveolar air and the blood must be extremely thin (Fig. 3). To facilitate 
gas exchange, alveolar cells are adapted. The most important cells of an 
alveolar septum are: 
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Fig, І . Port ion of the lung of a young man, showing branching from 
bronchus to alveoli. Bar: 0.3 mm. From Bloom, W, λ Fawcett , D.W. 
1975 m Ά Textbook of Histology, W.B. Saunders Co. , Philidelphia-
London-Toronto; with permission. 
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a) Type I epithelial cell (Fig. 3); this squamous alveolar cell contains a 
very thin layer of cytoplasm which can extend over a distance of about 50 μπι 
from the nucleus. About 93% of the alveolar epithelial surface is formed by 
these cells (Crapo et al., 1982). 
b) Capillary endothelial cells; these cells form the capillary surface and 
exist of a nucleus surrounded by a thin layer of cytoplasm which extends to thin 
sheets, similar to the type I epithelial cells. Numerous vesicles are frequently 
encountered in the endothelial cytoplasm taking care of transendothelial 
transport of macromolecules by the process of endo- and exocytosis. 
The blood-air barrier is formed by the thin cytoplasmatic extensions of the 
epithelium and the endothelium and by a thin interstitium separating the two 
cell layers. In general this interstitium consists of the alveolar and the 
capillary basement membrane, which are in close apposition to each other. 
Basement membranes are continuous sheet-like structures found at the boundary 
between cells (endothelium, epithelium, muscle cells etc.) and connective tissue 
stroma. They form an extracellular scaffold and provide, amongst others, 
physical support. 
c) Type II epithelial cell; this cuboidal cell has numerous short microvilli 
and is characterized by osmophilic, multilamellar bodies which contain phospho­
lipids of which dipalmitoyl-phosphatidylcholine is a major component. The 
content of these bodies is secreted into the alveolar airspace, where it lines 
the tissue surface. This surfactant plays an important role in stabilizing the 
alveolus by reducing the surface tension, thereby preventing the alveolus from a 
collapse. Although the type II epithelial cells outnumber the type I epithelial 
cells, they constitute only about 7% of the epithelial surface (Crapo et al., 
1982) . 
d) Fibroblast; this spindle-shaped cell is characteristic for the connective 
tissue. It contains large cytoplasmatic processes and synthesizes most compo­
nents of the extracellular matrix (e.g. elastin, collagen, proteoglycans). 
e) Alveolar macrophage (Fig. 4); this cell moves about on the alveolar 
surface. One of its functions is to phagocytose airborne particles (dust, 
bacteria) and to remove them from an alveolus. Alveolar macrophages are not 
permanently present. 
There are other cell types less frequently encountered in an alveolar 
septum. Amongst them are the type III epithelial cell, of which the function is 
unknown (Dormans, 1985), the pericyte (a contractile cell, lining capillaries) 
and wandering blood cells (e.g. neutrophils). Cells making up lyirçphatic 
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Fig. 2. Human lung alveoli. An alveolus consists 
of an alveolar airspace (a), limited by an 
alveolar wall (aw), in which the actual gas 
exchange takes place. Bar: 0.1 mm. 
Fig. 3. Alveolar septa (mouse). The thin lager 
of tissue separating the blood from the alveolar 
airspace (a), is called the blood-air barrier 
(bab). It is formed by an epithelial cell layer 
a thin interstitium, and an endothelial cell 
layer. Furthermore, a type I epithelial cell 
(ect I) with a cytoplasmatic extension (arrow) 
can be seen, e: erythrocyte. Bar: 5 \im. 
Fig. 4. Alveolus (mouse), containing an alveolar 
macrophage (m), attached to the alveolar surface. 
Capillaries form a major constituent of an 
alveolar wall, e: erythrocyte. Bar: 2.5 \im. 
capillaries do not penetrate alveolar septa. Nerve fibres are small and scarce 
(Weibel, 1973). 
Connective tissue 
Since gas exchange is the basic function of the lung, there has to be a 
ventilatory system in order to supply fresh air and to remove "used" air. Upon 
inhalation the inspiratory muscles contract, the chest expands and the lungs are 
filled with air. In order to follow chest movements, the lung is attached to the 
chest wall by virtue of two sheets. One sheet, the visceral pleura, is fixed to 
the lung, while the other, the parietal pleura, is attached to the chest wall. 
Only a thin film of fluid is intercalated between the two pleuras and there 
exists a subatmospheric pressure between them. Upon expiration, when the 
inspiratory muscles relax, the lung retracts and air flows out of the lung. 
During quiet breathing this is a passive process and occurs as a result of the 
elastic recoil of the lung which is an intrinsic feature of the lung itself. 
The total surface available in a human lung for the actual gas exchange process 
is about 100-200 m2. At the end of a deep breath only 20% of the total lung 
volume is tissue, including blood; 80% is air. Taking into account that the lung 
tissue has to follow volume changes during breathing, it is obvious that a 
flexible but stable framework should be on hand, especially to ensure the 
structural integrity of such delicate structures as alveoli. 
The structural integrity of the lung depends on two major systems. One 
system is formed by the surfactant (see above) and will not be discussed 
further. The other is formed by the connective tissue framework, which main 
function is a supporting one. Connective tissue is characterized by its 
relatively limited number of cells (in lung the fibroblasts) and a large amount 
of extracellular matrix. Classically, the extracellular matrix is divided into 
two components: the fibrillar component (elastin fibers, collagen fibrils) and 
the ground substance, including proteoglycans. In lung, there exists a fibrous 
continuum of connective tissue elements extending from the airways all the way 
to the alveolar septa, as well as from the visceral pleura into the lung. The 
connective tissue in the alveolar walls is very delicate: capillaries constitute 
the largest part of an alveolar septum (Fig. 3 and 4). In the following, the 
three major components of the extracellular matrix, collagen, elastin and 
proteoglycans, will be discussed. 
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Collagen 
In lung parenchyma about 20% of the dry weight is collagen (Clark et al., 
1983). Collagene are glycoproteins composed of three α-chains/ coiled into a 
triple helix conformation, making the molecule appear as a rod-like structure. 
Collagen has a typical amino acid composition: about 1/3 is glycine, about 10% 
is hydroxyproline, while also hydroxylysine is present. There are many types of 
collagen (types I-XI, Miller, 1985; Martin et al., 1985; Laurent, 1986) and in 
the light of recent reports (e.g. Yamauchi et al., 1986), other types are to be 
expected. The types I, II and III are the most abundant types; they are 
organized into fibrils which can be easily detected by electron microscopy. They 
show a characteristic banding pattern due to the distribution of collagen mole­
cules in a fibril (quarter-staggered array). Of the other types of collagen, 
types IV and V are the best described. Type IV contains interruptions in the 
triple helix and seems to be restricted to basement membranes where it forms a 
fine network; type V collagen has a wider distribution. The other types of 
collagen are present in small quantities and most of them seem to have a 
restricted distribution (Mayne, 1984); they are at present poorly characterized. 
Biochemical and/or iiranunocytochemical studies have shown that in lung the 
types I, II, III, IV, V and X are present (McLees et al., 1977; Madri & 
Furthmayr, 1979; Konomi et al., 1981; Sano et al., 1981; Dixit et al., 1981; 
Fujiwara & Nagai, 1981; Kelley, 1984; Raghu et al., 1985; Bearman et al., 1986). 
Collagen type I is the most abundant and constitutes about 65% of the total. 
Type II collagen is confined to the cartilagenous structures of the major 
airvessels; type X collagen has been demonstrated in smooth muscles lining 
alveolar ducts. The other types of collagen have been demonstrated in the 
parenchymal tissue, including alveoli. The major function of collagen in the 
lung is a supporting one. Collagen fibrils have a great tensile strength and may 
prevent the alveolus from overstretching. In general, however, the biological 
function of the different types of collagen is poorly understood. 
Elastin 
In lung parenchyma about 30% of the dry weight is elastin (Clark et al., 
1983). Elastic fibers are composed of microfibrils and amorphous elastin. Micro­
fibrils are believed to act as nucleation sites for elastin depostion. The 
elastin component is very hydrophobic in nature due to an abundance of nonpolar 
amino acids; it also contains unique amino acids such as desmosine and isodes-
mosine. In elastin the molecules are highly cross-linked. Elastin has the 
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remarkable property of being able to stretch to large extensions with little 
force and to return again to its original dimensions when the tension is 
released. 
Proteoglycans and glycosaminoglycans 
Structure 
Proteoglycans are macromolecules which consist of a protein backbone to 
which glycosaminoglycan chains (s) and N-and/or O-linked oligosaccharides are 
covalently attached (Fig. 5). According to the IUPAC-IUB Joint Commission on 
Biochemical Nomenclature (1986), they should be considered as a subclass of 
glycoproteins. 
Glycosaminoglycans are linear polymers of repeating disaccharide units 
consisting of a hexosamine component and an uronic acid component; in keratan 
sulphate, the uronic acid is replaced by a galactose unit (Fig. 6). Due to 
variation in degree and place of sulphation, acetylation or sulphation of the 
amino group, type of glycosidic linkage, and geometry of the carboxylic and C-4 
hydroxyl group, there exists an enormous potential of different glycosamino-
glycans (and hence proteoglycans). Glycosaminoglycans can be grouped into 5 
types: hyaluronic acid, chondroitin sulphate, dermatan sulphate, heparan 
sulphate/heparin and keratan sulphate (Fig. 6). 
With the exception of hyaluronic acid, all these glycosaminoglycans are 
present in the tissue as proteoglycans. The attachment of glycosaminoglycans to 
the protein core involves a special linkage region generally consisting of 
serine-xylose-galactose-galactose-glucuronic acid; only keratan sulphate has an 
aberrant linkage region (Poole, 1986). There also exists a considerable 
variation in protein cores including such features as amino acid composition, 
molecular weight of the protein core and number of glycosaminoglycans attached 
(Hassell et al., 1986). On basis of their immunological properties and their 
sensitivity to trypsin protein cores can be grouped into different classes 
(Heingàrd et al., 1985). Proteoglycans and glycosaminoglycans are not rigid 
structures; NMR studies have shown that the protein core as well as the 
glycosaminoglycan side-chains are flexible structures (Brewer & Keiser, 1975; 
Torchia et al., 1977, 1981). 
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Fig. 5. Diagrammatic representation drawn to scale of 
some of the main proteoglycans (PGs), showing different 
types and diversity of structure. Oligosaccharides are 
not shown. The protein cores are drawn thicker than the 
attached glycosaminoglycans. CS: chondroitin sulphate; 
KS: keratan sulphate; DS: dermatan sulphate; HS: 
heparan sulphate; HABR: hyaluronic acid binding region. 
From Poole, A.R., 1986 in Biochemical Journal 236, p. 2, 
The Biochemical Society, London; with permission. 
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Location and function 
Proteoglycans are found in nearly all mammalian tissues. Their main location 
is the extracellular matrix. Proteoglycans are not separated molecules. A number 
of interactions with other macromolecules such as collagen, fibronectin, laminin 
and elastin have been reported and are likely to be of importance in the 
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Fig. 6. Structure of glycosaminoglyeans. The glycosaminoglycans 
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Gal: galactose. From Hook et al., 1984 in Annual Review of 
Biochemistry 53, p. 849. Annual Reviews Inc.; with permission. 
functioning Of proteoglycans (Ts'ao S Eisenstein, 1981; Woodley et al., 1983; 
Stamatoglou & Keller, 1983; Contri et al., 1985). 
Dermatan sulphate proteoglycans are frequently encountered associated with 
collagen fibrils (Scott et al., 1981; Poole et al., 1986) and may play a role in 
such phenomena as the structural coherence of collagen fibrils and fibrillo-
genesis. 
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The main proteoglycan in the extracellular matrix of cartilage is a huge 
chondroitin sulphate/keratan sulphate proteoglycan (Handley et al., 1985). These 
proteoglycans complexe with hyaluronic acid, making up large aggregates (up to 8 
μπι, Buckwalter et al., 1985). Due to their very high charge density, proteo­
glycans can bind much water and the aggregates can be regarded as a hydrated gel 
trapped in a network of collagen fibrils. This organization of the extracellular 
matrix in cartilage is responsible for its load absorbing properties. When 
cartilage is compressed, water is forced out of the system, thereby 
concentrating the proteoglycans and increasing their osmotic acitivity. Upon 
releasing the force, water flows back into the system. 
In the glomerular basement membrane, which separates the circulating blood 
from the urinary spaces, heparan sulphate proteoglycans act as filter barriers 
due to their organization as well as their negative charges. Selection of 
macromolecules depends on their charge as well as their size (Kanwar & Farquhar, 
1979) . 
There are several other functions ascribed to proteoglycans located in the 
extracellular matrix such as playing a role in mineralization processes (Hascall 
& Lowther, 1982), and maintenance of the optical transparency in cornea (Hassel 
et al., 1983). Furthermore, proteoglycans are involved in processes such as cell 
migration and differentiation (Toole, 1981). It should be noted that although 
many different functions havs been suggested for proteoglycans, hard 
experimental proof in vivo is difficult to obtain and therefore scarce. 
Apart from their presence in the extracellular matrix, proteoglycans can be 
found at other locations. Heparin proteoglycans are stored inside mast cells; 
after degranulation and cleavage by an endoglycosidase, the depolymerized 
products can exert their anticoagulant properties. Heparan sulphate proteo­
glycans are present as integrated molecules m the cell membrane and are 
involved in cell recognition and cell attachment phenomena (Hook, 1984). 
Furthermore, chondroitin sulphate proteoglycans have been found in human 
platelets (Okayama et al., 1986) and heparan sulphate proteoglycans appear to be 
present inside nuclei (Gallagher et al., 1986). 
The examples of the location and function of proteoglycans given above, are 
only a grap out of many. Our purpose was merely to indicate that proteoglycans 
(glycosaminoglycans) are universally present and may play a role in many basic 
functions of cells and tissues. 
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Proteoglycans and glycosaminoglycans in the lung 
Glycosaininoglycans constitute only 0.25-0.5% of the dry weight of the lung 
parenchyma (Laros et al., 1972; Horwitz & Crystal, 1976; Schmid et al., 1982). 
All types of glycosaminoglycans are present in the lung, keratan sulphate being 
restricted to the tracheobronchial cartilage (Mason & Wusteman, 1970) . In lung 
parenchyma, hyaluronic acid, chondroitin sulphate, dermatan sulphate, heparan 
sulphate and heparin have been demonstrated; chondroitin has not been shown 
(Schmid et al., 1982). Lung heparan sulphate is known for its variable degree in 
sulphation (Linker & Hovingh, 1975) and it shows self-associating properties in 
vitro (Fransson, 1981; Fransson et al., 1981). In human lung, heparin could not 
be detected biochemically (Schmid et al., 1982). However, because of the 
presence of mast cells in the lung it is likely that at least some heparin is 
present. On the contrary, bovine lung is a source of commercial heparin. In 
bovine and porcine lung, there is a dramatic increase in heparin content during 
development (Nader et al., 1982). 
The different types of glycosaminoglycans are not equally distributed over 
the various lung components. For instance, in the pleura, dermatan sulphate is 
the most abundant glycosaminoglycan, while in bronchi it is chondroitin sulphate 
(Schmid et al., 1982). The amount of glycosaminoglycans also differs from 
structure to structure. During development there is a change in glycosajnino-
glycan composition. In general, hyaluronic acid and chondroitin-4-sulphate 
decrease, while heparan sulphate increases (Horwitz & Crystal, 1975; 
Radhakrisnamurthy & Berenson, 1980; Schmid et al., 1982). 
Human embryonic lung fibroblasts in culture have been shown to synthesize 
heparan sulphate, dermatan sulphate and chondroitin sulphate proteoglycans; the 
heparan sulphate proteoglycan was found in the extracellular matrix as well as 
associated with the cell surface (Vogel & Peterson, 1981; Lories et al., 1986). 
Human foetal type II epilithelial cells produce hyaluronic acid (Sahu et al., 
1980); rat endothelial cells are capable of synthesizing chondroitin sulphate, 
dermatan sulphate and heparan sulphate/heparin (Cantor et al., 1977). 
Ultrastructural studies on proteoglycans (glycosaminoglycans) in lung 
parenchyma are scarce. Using Ruthenium Red/Triton X-100, heparan sulphate 
proteoglycans were found in basement membranes, while chondroitin and/or 
dermatan sulphate proteoglycans were associated with collagen fibrils (Vaccaro & 
Brody, 1979, 1981) . Anionic sites were detected in basement membranes of rat and 
rabbit lung alveoli using the high iron diamine technique (Sannes, 1984, 1986); 
using polyethylenimine, Ferrara and coworkers (1985) did the same for human lung 
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alveoli. 
Little is known about the roles proteoglycan and glycosaminoglycans play in 
the lung. However, their distribution over various lung components, their 
strategic ultrastructural location and their changes during development suggest 
they are of crucial importance for the architecture and functioning of the lung. 
Emphysema 
Emphysema is defined as a condition of the lung characterized by abnormal 
permanent enlargement of airspaces distal to the terminal brochiole, accompanied 
by the destruction of their walls, and without obvious fibrosis (National Heart, 
Lung, and Blood Institute; Workshop on the definition of emphysema, 1985). This 
definition is an anatomical one, and of limited use for clinical diagnosis. Lung 
function parameters, related to emphysema, are a decreased forced expiratory 
volume for one second in the presence of a normal inspiratory volume for one 
second, an increase in total lung capacity and residual volume, an increase in 
compliance relative to lung volume and a diminution of diffusing capacity. Chest 
radiographs are also of importance for diagnosis. 
There are two basic approaches in the biochemical and morphological study of 
emphysema: 1) studyibng pathological human lungs and 2) studying lungs of 
laboratory animals in which emphysema-like conditions have been artificially 
induced. Obviously, both approaches have their advantages and disadvantages. The 
main drawback in animal studies is that one is not sure if the events, occuring 
in induced emphysema, are the same as in naturally occuring human emphysema. A 
main advantage is that induced ençihysema can be followed from the very beginning 
in carefully selected animals. Studies on human emphysema, on the other hand, 
have the main disadvantages that the disease manifests itself clinically when 
the process is already in an advanced stage. Other complicating factors are the 
availability of material, coexistence with other diseases, clinical background 
of the patient, different types of emphysema, etc. 
Pathogenesis 
The main physiological determinant of emphysema is the loss of elasticity in 
the lung. The classic discovery of Laurell and Ericksson (1963), that there 
exists an association between homozygous alpha^antitrypsine deficiency and 
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pulmonary emphysema, led to the protease-antiprotease hypothesis. Alphaj-anti-
trypsine is the principal serum protease inhibitor and a major inhibitor of 
neutrophil elastase in the human lower respiratory track (Gadek & Crystal, 
1982). In short, this theory states that there exists and imbalance between the 
amount of proteases and antiproteases. Either by an increase of the amount of 
proteases or a decrease in the amount of antiproteases, the proteases 
(elastases) would attack and degrade extracellular matrix components (collagen 
fibrils, elastin, proteoglycans). This would ultimately lead to emphysematous 
conditions. The use of elastases to provoke panacinar emphysema in animals 
supports this model (Snider, 19Θ6). 
An extension of the protease-antiprotease theory is that there exists and 
imbalance between oxidants (e.g. hydroxyl radical, H2O2, ΝΟτ) and antioxidants 
(e.g. catalase) resulting in an oxidant burden (Cantin & Crystal, 1985). 
Oxidants are the result of normal biochemical processes, but may also rise from 
imflairanatory cells (alveolar macrophage, polymorphonuclear leucocytes) and 
inhaled toxic gasses (cigarette smoke). The antiprotease screen in the lung 
could be affected by the oxidants, and proteases (e.g. neutrophilic elastase) 
could attack the connective tissue matrix and lead to alveolar wall destruction. 
The protease-antiprotease theory, however, does not readily explain 
different anatomical types of emphysema (e.g. centriacinar, panacinar) or the 
male prevalence of the disease in men (Laros & Kuyper, 1978) . Furthermore, 
alpha^-antiproteinase deficiency accounts for less than 1% of all patients 
(Snider, 1981) . 
Involvement of proteoglycans and glycosaminoglycans in emphysema 
whatever basic mechanism is responsible for the onset of emphysema, little 
doubt exists that it is a disturbance in the connective tissue skeleton which 
ultimately leads to emphysematous conditions. Laros and Kuyper pointed out that 
proteoglycans may be primary targets in this respect, particularly because of 
their vulnerability towards proteinases (Laros, 1972; Laros & Kuyper, 1978, 
1982). Elastase, used to provoke emphysematous-like conditions, not only 
degrades elastin but also proteoglycans, collagen and fibronectin (Gadek et al., 
1984; Vaccaro et al., 1985). Other enzymes used for inducing emphysema (pronase, 
papaine), attack the protein core of proteoglycans as well. Since proteoglycans 
(glycosaminoglycans) determine to large extent the viscosity and cementing 
properties of the non-fibrillar ground substance, defects in these substances 
could well lead to a malfunctioning of connective tissue. Overstretching of the 
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connective tissue framework may be the result which may ultimately lead to 
emphysematous lesions. Laros et al. (1972) found experimental evidence for their 
hypothesis. In fresh human lung parenchyma the glucosamine/galactosamine ratio 
was increased from 0.7 in normal tissue to 3.3 in emphysematous tissue. Because 
the total amount of glycosaminoglycans, determined as uronic acid, did not 
change, these data pointed out to a shift in their composition. 
Several studies on the involvement of proteoglycans (glycosaminoglycans) in 
emphysema have been published, the results being contradictionary. An increase 
of [C]glucosamine incorporation in hyaluronic acid and heparan sulphate was 
noted in elastase-induced emphysema (Moczar et al., 1980; Lafuma et al., 1985). 
The lungs of rats treated with endotoxin, which leads to emphysematous-like 
conditions, showed an increase of incorporation of [S]sulphate into total 
glycosaminoglycans, due to an increase into dermatan sulphate and chondroitin-
4-sulphate and a concomitant decrease in heparan sulphate/heparin (Blackwood et 
al., 1983, 1984). An increase in dermatan sulphate and in total glycosamino-
glycan content was found in elastase-treated emphysematous hamster lungs 
(Karlinsky, 1982), but could not be corroborated (Karlinsky et al., 1983). In 
human emphysematous lungs, an increase in hyaluronic acid was found (Pecora, 
1967), where as Konno and coworkers noted just the opposite (1982). Saltzman et 
al. (1961) did not find a significant alteration in the glucosamine/galactos-
amine ratio in human emphysematous lung in contrast to Laros et al. (1972). 
Differences in experimental setup (time of sampling, organism, inducing agens, 
analytical methods etc.) probably mainly account for these conflicting results. 
Aim of the study 
The lung is a highly dynamic organ and undergoes considerable volume changes 
during the respiratory cycle. The extracellular matrix plays an important role 
in the maintenance of the structural integrity of the lung. Quantitatively, 
collagen and elastin are the major elements in the extracellular matrix of the 
lung. Proteoglycans and glycosaminoglycans are only minor components, but by 
their strategic location, they may play a keyrole in the functioning of the 
extracellular matrix. 
The research on proteoglycans and glycosaminoglycans of the lung is still in 
its infancy. Because of the limited amount of these substances in the lung, 
biochemical studies are difficult. Another complicating factor is the structural 
complexity of the lung. Many types of tissue structures (small bloodvessels, 
bronchioli, alveoli etc.) have been completely integrated. Biochemical studies 
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of these structures proper is not possible. In this respect, ultrastructural 
studies, in which proteoglycans can be localized and characterized, are of 
importance. A precise localization may also give a clue as to which roles 
proteoglycans play in the functioning of normal and pathological lung. The 
principal aim of this study was to obtain more general knowledge on proteo-
glycans and glycosaminoglycans of lung parenchyma, histochemically as well as 
biochemically. Furthermore, the possible involvement of these macromolecules in 
lung development and emphysema has been investigated. 
In Chapter 2, a staining procedure for the ultrastructural localization of 
proteoglycans in lung alveoli will be described. Using this technique and 
degradative procedures, the proteoglycans of mouse lung alveoli were character-
ized (Chapter 3). An attempt to correlate the ultrastructural appearance of 
proteoglycans of various connective tissues with biochemical data is made in 
Chapter 4. Using the elaborated staining technique, the proteoglycans of human 
lung alveoli have been investigated (Chapter 5). One type of the ultra-
structurally detected proteoglycans is a dermatan sulphate proteoglycan, which 
is associated with collagen fibrils. This proteoglycan has been isolated from 
bovine lung and biochemically analysed (Chapter 6). During the study on 
proteoglycans from human alveoli, an unusual proteoglycan, characterized by an 
irregular presence, was detected. The characterization of this proteoglycan is 
described in Chapter 7. In order to obtain a clue for the function of this 
proteoglycan, its presence was studied in developing mouse lung (Chapter 8). In 
Chapter 9, a biochemical and ultrastructural study is presented in which 
glycosaminoglycans, glycosaminoglycan-degrading enzymes and proteoglycans were 
investigated in normal and emphysematous human lung parenchyma. 
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CHAPTER 2 
Staining of proteoglycans in mouse lung alveoli. 
I. Ultrastructural localization of anionic sites. 
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Summary 
In order to contrast anionic sites in mouse lung alveoli, two staining procedures were applied: (a) 
staining with Ruthenium Red and Alcian Blue and (b) staining with Cuprolinic Blue in a critical 
electrolyte concentration method. The Ruthenium Red-Alcian Blue staining procedure revealed 
electron-dense granules in the alveolar basement membrane. The granules were closely associated 
with the epithelial cell membrane and conhnued to stain even when the procedure was carried out 
at a low pH, indicating the presence of sulphate groups in the granules. 
After staining with Cuprolinic Blue, electron-dense filaments, also closely associated with the 
cell membrane, became visible in the basement membrane of type I epithelial cells. Their length 
depended on the MgC^ concentration used during staining. At 0.4 M MgC^, the length was 
mostly within the range 100-180 nm. Using a modified Cuprolinic Blue method, the appearance of 
the filaments closely resembled that of spread proteoglycan monomers with their side-chains 
condensed. The basement membrane of type II epithelial cells also contained filaments positive 
towards Cuprolinic Blue; their length, however, was smaller in comparison with those of type I 
epithelial cells. The filaments lay in one plane and provided the whole alveolus with an almost 
continuous sheet of anionic sites. Cuprolinic Blue staining also revealed filaments in the basement 
membrane of the capillary endothelial cells. Furthermore, Cuprolinic Blue-positive filaments 
(average length about 40 nm) became apparent in close contact with collagen fibrils and separated 
from each other according to the main banding period of the collagen fibrils (about 60 nm), 
indicating a specific ultrastructural interaction between these two components. Filaments 
connecting collagen fibrils with each other were also detected. 
Introduction 
Proteoglycans are macromolecules consisting of a protein component and a poly­
saccharide component, the latter represented by the so-called glycosaminoglycans. The 
glycosaminoglycans (except keratan sulphate) are long chains of repeating di-
saccharides, consisting of a hexosamine and an uronic add residue. The current model 
for proteoglycans is a protein core to which the glycosaminoglycans are covalently 
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attached. Using isolated proteoglycans, such a model can be visualized in the electron 
microscope (Rosenberg et al., 1974; Thyberg et al., 1975). However, in tissues, such a 
structure has not yet been demonstrated. 
Proteoglycans are thought to have important functions in tissues, although their con-
tribution to the tissue dry weight is mostly quite small; for example, in lung, the proteo-
glycans constitute only 1% of the dry weight, about half of that being occupied by 
glycosaminoglycans (Horwitz et al., 1976). The principal functions of proteoglycans are 
the following: acting as a filter barrier (Kanwar et al., 1980), influencing morphogenesis 
(Silberstein & Daniel, 1982; Lash & Vasan, 1978), playing a role in cell recognition 
(Fransson et al., 1981), and absorbing compressive load (Hascall & Hascall, 1981). 
Because of this participation of proteoglycans in a variety of tissue functions, it follows 
that they may also be involved in several diseases. For instance, it has been shown from 
biochemical studies that in pulmonary emphysema (Laros et al., 1972; Moczar et al, 
1980) and pulmonary fibrosis (Nagaief al., 1977; Motomiya et al., 1975), changes occur in 
the glycosaminoglycan composition öf the lung. 
However, it is difficult to interpret which structural element is responsible for the 
biochemical data from lung blocks. This is due to the structural complexity of the lung, in 
which many types of tissue components (blood vessels, bronchioli, alveoli, etc.) are 
completely integrated, making it impossible to analyse biochemically the proteoglycan 
(glycosaminoglycan) content of lung alveoli proper. In contrast, histochemical staining 
procedures provide useful information regarding the localization and composition of 
proteoglycans and hence, they can supplement biochemical investigations. Several dyes 
have been used for demonstrating proteoglycans at the ultrastructural level, for ex-
ample, Alcian Blue (Goldberg et al., 1978), Ruthenium Red (Myers et al., 1973; Gordon & 
Bernfield, 1980), Toluidine Blue (Shepard & Mitchell, 1976), Acridine Orange (Lapis & 
Timar, 1980) and cationized ferritin (Kanwar & Farquhar, 1979). This staining of proteo-
glycans is presumably based on the electrostatic attraction between the positive dye and 
the polyanionic glycosaminoglycans (Scott, 1973). However, due to their collapse during 
the preparation of tissue, the proteoglycans appear as electron-dense granules rather 
than extended, open structures. In order to contrast proteoglycans, Scott (1980) 
introduced the phthalocyanin-like dye, Cuprolinic Blue, using it according to the critical 
electrolyte concentration method. 
In this paper, we report the application of this staining procedure, as well as a combi-
nation of Alcian Blue and Ruthenium Red, for identifying anionic sites in lung alveoli. 
Materials and methods 
Three-month-old mice (K-strain, inbred) were sacrificed and the lungs removed. Small lung 
blocks (1 mm χ 1 mm χ 1 mm) were placed in fixative and, in order to obtain thorough penetration 
of the fixative, degassed. 
Ruthenium Red-Alcian Blue staining 
Lung blocks were fixed (4 h, room temperature) in 0.1 M sodium cacodylate buffer (pH 7.2), 
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containing 2.5% glutaraldehyde, 0.2 or 2.0% Ruthenium Red (Luft, 1971, Aldnch-Europe, Beerse, 
Belgium) and 0.2 or 2.0% Alcian Blue (8GX, Serva, Heidelberg, West Germany). In this study, only 
a combination of Ruthenium Red and Alcian Blue resulted in a good and reproducible contrast of 
anionic structures. After washing in 0.1 M cacodylate buffer the tissue blocks were left overnight 
(4° C) in the same solution as the fixative, but without glutaraldehyde. Posthxation (4 h, room 
temperature) took place in 0.05 м cacodylate butter (pH 7.2) containing 1% Os04, 0.2 or 2.0% 
Ruthenium Red and 0.2 or 2.0% Alcian Blue, followed by dehydration in ascending concentrations 
of ethanol. 
In one case the cacodylate buffer was replaced by veronal-acetate-HCl butter (pH 2.6) using the 
same molarities. 
Cuprolinic Blue staining 
Lung blocks were fixed in 0.025 м sodium acetate buffer (pH 5.6) containing 2.5% glutaraldehyde, 
0.2% Cuprolinic Blue (BDH Ltd, Poole, U K.) and 0.1-0.4 M MgCl2. After fixation overnight (room 
temperature) the specimens were washed three times (for a total time of 30 mm) in the same 
solution, but without Cuprolinic Blue. After washing three times in 1% aqueous NajVVO^ the 
specimens were dehydrated in ascending concentrations of ethanol, the 30 and 50% 
concentrations containing 1% sodium tungstate unless otherwise stated. 
In addition, a modified Cuprolinic Blue staining procedure was applied; the specimen was 
allowed to stand for 1 h in the sodium acetate buffer containing 2.5% glutaraldehyde, 0.2% 
Cuprolinic Blue and 0.2 M MgCI2, then washed twice, each for 10 min, in the same solution without 
Cuprolinic Blue. Next the lung blocks were placed for 2 h in buffer containing 2.5% 
glutaraldehyde, 0.5% sodium tungstate and 0.2 M MgClj, washed twice for 10 min periods in the 
same solution without tungstate and allowed to stand for 2 h in buffer containing 2.5% 
glutaraldehyde, 0.2% Cuprolinic Blue, 0 5% sodium sulphate and 0 2м MgCl2, followed by 
dehydration. 
After dehydration, the specimens were embedded in Epon (Luft, 1961) following standard 
procedures. Ultrathin sections were collected on tormvar-coated grids. Occasional sections were 
poststained with uranyl acetate and lead citrate (Reynolds, 1963), or with 0.5% sodium tungstate 
in a 50% (v/v) ethanol-water mixture. Sections were examined in a Philips 201 electron 
microscope at 60 kV. 
Results 
Ruthenium Red-Alaan Blue staining 
The tissue layer which separates the blood from the alveolar airspace is called the 
blood-air barrier (Fig. 1) and is formed by an epithelial cell layer, an alveolar basement 
membrane and an endothelial cell layer. The epithelium and its alveolar basement 
membrane enclose the whole alveolus. 
After stainmg with Ruthenium Red-Alcian Blue, electron-dense granules appear in 
the alveolar basement membrane (Fig. 2a). They are closely associated with the 
epithelial cell membrane and mostly separated from each other by a distance of about 
60 nm (Fig. 2a, arrows). When the basement membrane is cut tangentially a field of 
electron-dense granules becomes visible (Fig. 2a), the granules lying in a quasi-regular 
pattern, similar to that observed previously for the renal glomerular basement 
membrane (Kanwar & Farquhar, 1979). When the pH of the fixative is lowered (pH 2.6), 
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the granules are still present (Fig 2b), indicating the presence of sulphate groups, since 
carboxylic groups are hardly ionized at such a pH No electron-dense granules were 
seen associated with collagen fibrils. 
When only Alcian Blue is present during glutaraldehyde fixation and only Ruthenium 
Red is present during postfixation with O s 0 4 , no electron-dense granules become 
apparent Without Ruthenium Red-Alcian Blue no granules are visible. 
Cuprolinic Blue staining 
Staining with Cuprolinic Blue reveals electron-dense filaments (Fig 3), located in the 
alveolar basement membrane of type I epithelial cells and closely associated with their 
Fig. 1. Blood-air bamer, which separates the blood from the alveolar airspace It consists of an 
epithelial cell layer (ep), an alveolar basement membrane (abm) and an endothelial cell layer (en) 
e, erythrocyte, a, alveolus, cap, capillary Glutaraldehyde-Os04 fixation, uranyl acetate + lead 
citrate 
Fig. 2. Blood-air bamer after staining with Ruthenium Red-Alcian Blue, uranyl acetate + lead 
citrate (a) Ruthenium Red-Alcian Blue staining reveals electron-dense granules, lying in the 
alveolar basement membrane and closely associated with the epithelium Most are separated from 
each other by a distance of 60 nm (arrows), when the alveolar basement membrane is cut 
tangentially a held of granules becomes apparent (b) Ruthenium Red-Alcian Blue staining at low 
pH The alveolar basement membrane granules continue to stain 
Fig 3 Blood-air barrier after Cuprolinic Blue staining (0 3 м MgCl2) In the basement membrane 
of type I epithelial cells, electron-dense filaments (bmf I) become visible When the alveolar 
basement membrane is cut perpendicularly the filaments can be seen linearly aligned Sodium 
tungstate was used only in the poststaining step 
Fig. 4. Tangentially sectioned alveolar basement after Cuprolinic Blue staining (0 4 м 
MgCl2) Sodium tungstate was used dunng the wash and dehydration steps the bmf I are stained 
more heavily compared with those in Fig 3 The transition of the perpendicularly sectioned 
alveolar basement membrane to the tangentially sectioned membrane is indicated In the 
tangentially cut alveolar basement membrane, fields of basement membrane hlaments become 
apparent, the length of the basement membrane filaments is mostly within the range of 100-180 nm 
Fig. 5. Alveolar basement membrane after Cuprolinic Blue staining at 0 15 M MgClj The average 
length of the basement membrane hlaments I is approximately 50 nm 
Fig. 6. Tangentially sectioned alveolar basement membrane after applying the modified 
Cuprolinic Blue staining procedure (see Matenals and methods) The basement membrane 
filaments I appear to be thicker and contain electron-dense dots (arrows^ Inset occasional 
projection arising from the filaments are visible (arrows) 
Fig. 7. Alveolar basement membrane of type II epithelial cells (ect II) after Cuprolinic Blue staining 
(0 3 M MgCy Electron-dense epithelium-associated filaments (bmf II) become apparent in the 
alveolar basement filament The appearance of multilamellar bodies (mb) indicates that 
phospholipids are washed out, as a result of the procedure used Because of the specific 
interaction ot Cuprolinic Blue with nucleic acids nbosomes (nb) also stain 
Fig. 8. Capillary basement membrane (cbm) after Cuprolinic Blue staining (0 2 м MgCl2) Electron 
dense hlaments (bmf III), more scattered in comparison with those located in the alveolar 
basement membrane, become visible in the capillary basement membrane 
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cell membrane. These Cuprolinic Blue-positive filaments appear to lie in one plane, thus 
providing the alveolus with an almost continuous sheet of anionic sites. When a filament 
is cut perpendicularly, it becomes visible as an electron-dense dot (Fig. 3). In grazing 
sections of the alveolar basement membrane, fields of these filaments become apparent 
(Fig. 4). Staining with sodium tungstate whilst being washed and dehydrated (Fig. 4) 
results in filaments of greater electron density becoming evident than when sodium 
tungstate is applied only in the poststaining step proper (Fig. 3). The length of these 
basement membrane filaments (bmf I) depends on the MgCl2 concentration used during 
staining; for instance, at 0.15 M MgC^ their average length is about 50 nm (Fig. 5), while 
at 0.4 M MgCl2 their length is mostly within the range of 100-180 nm (Fig. 4). Very large 
filaments (Fig. 4) are considered to be fusions of filaments. The filaments at a lower 
MgCl2 concentration appear to be thicker and are more intensely stained. When 
applying the modified Cuprolinic Blue staining procedure (see Materials and methods) 
the filaments appear to be thicker (Fig. 6); furthermore, rounded electron-dense dots can 
be detected on the filaments and sometimes projections arising from the filaments are 
visible (Fig. 6, inset). 
The filaments thus far described are located in the alveolar basement membrane 
associated with type I epithelial cells. Type II epithelial cells, which produce phospho-
lipids of the surfactant system, are also associated with an alveolar basement 
membrane which provides only a minor contribution to the total amount of alveolar 
basement membrane. Filaments, which are smaller than those associated with type I 
cells, can be detected in this basement membrane (Fig. 7, bmf II). Furthermore, the 
capillary basement membrane, associated with the endothelium, also contains 
Cuprolinic Blue-positive structures (Fig. 8, bmf III) but they are more scattered in 
comparison with those located in the alveolar basement membrane. This is independent 
of the MgCl2 concentration used. 
In addition to the basement membrane associated filaments, collagen-associated 
filaments can also be detected in the alveolar wall after Cuprolinic Blue staining (Fig. 9). 
These filaments are about 40 nm long, their length being much less dependent on the 
MgCl2 concentration used, and are separated from each other according to the main 
banding period of fibrils (±60 nm). In some cases these filaments connect collagen fibrils 
Fig. 9. Collagen fibrils after Cuprolinic Blue staining (0.2 M MgCl2), uranyl acetate + lead citrate. 
Collagen associated filaments (caf) become apparent; their distance from each other follows the 
main banding period of the collagen fibrils (about 60 nm). c, collagen fibril; el, elastin. 
Fig. 10. Collagen fibrils after Cuprolinic Blue staining (0.2 M MgCl2), uranyl acetate + lead citrate. 
The collagen fibrils are connected to each other by Cuprolinic Blue-positive filaments (arrows). 
Fig. 11. Collagen associated filaments (0.1 M MgCl2). When poststaining with uranyl acetate and 
lead citrate is omitted, the collagen fibrils cannot be detected; the collagen associated filaments 
(caf), however, are still present and reflect the position of the collagen fibrils; besides numerous 
collagen associated filaments which lie perpendicular to the fibril axis, some can be detected lying 
in a parallel fashion (arrows). 
34 
Staining of proteoglycans in lung alveoli 
35 
VAN KUPPEVELT, DOMEN, CREMERS and KUYPER 
with each other (Fig. 10). Although most filaments are lying perpendicular to the fibril 
axis, some of them lie parallel (Fig. 11). When poststaining with uranyl acetate and lead 
citrate is omitted, the collagen fibrils can no longer be detected; the collagen-associated 
filaments, however, remain clearly visible (Fig. 11). From the pattern of the filaments, it 
is possible to deduce the position of the collagen fibrils. 
Without Cuprolinic Blue, no filaments are visible. Intracellularly the nucleus and the 
ribosomes stain (Fig. 7), because of the specific interaction of Cuprolinic Blue with 
nucleic adds (Scott, 1972). 
Discussion 
Both the Ruthenium Red-Alcian Blue and the Cuprolinic Blue staining procedures 
contrast particles in the basement membrane, but only Cuprolinic Blue can also clearly 
contrast filaments associated with collagen fibrils. Vaccaro and Brody (1979), using 
Ruthenium Red for identifying anionic sites in lung alveoli, contrasted granules in the 
alveolar basement membrane as well as granules associated with collagen fibrils, but 
they had to use the non-ionic detergent Triton X-100 in order to obtain good penetration 
of the dye. The absence of Ruthenium Red-Alcian Blue-positive, collagen-associated 
granules might, therefore, be caused by a poor penetration of these dyes. After 
Cuprolinic Blue staining, however, filaments associated with collagen fibrils can be 
detected easily. As Triton X-100 severely damages the lung ultrastructure, Cuprolinic 
Blue staining is preferable for contrasting anionic sites in lung aveoli. 
Clearly,, these two staining procedures contrast the same anionic sites in the 
alveolar basement membrane but there is a striking difference in their appearance. The 
Cuprolinic Blue-positive structures are visualized as filaments, while the Ruthenium 
Red-Alcian Blue-positive structures appear as granules. Furthermore, the length of the 
Cuprolinic Blue-positive filaments depends on the MgCl2 concentration used during 
staining. Addition of MgCl2, therefore, seems important for keeping the anionic 
structures in a more extended form, although a specific interaction of Cuprolinic Blue 
might also contribute to the difference in appearance compared to that given by the 
Ruthenium Red-Alcian Blue method. 
It is also possible to derive information concerning the nature of the anionic sites. The 
Ruthenium Red-Alcian Blue-positive granules continue to stain even at pH 2.6, at 
which level the carboxylic acid groups are poorly ionized, in contrast with sulphate 
groups. This indicates that sulphate groups are probably present. The Cuprolinic Blue 
staining is performed in the presence of MgCl2. It has been shown (Scott, 1972) that, due 
to the competitive action of Mg2+ ions, cationic dyes are easily displaced from carboxylic 
groups at a relatively low concentration of MgCl2 (about 0.05 M), but sulphate groups 
need considerably higher concentrations of MgCl2 for displacement. Hence, it is likely 
that the Ruthenium Red-Alcian Blue and Cuprolinic Blue-positive structures con-
tain sulphate groups, indicating that these anionic sites contain sulphated 
glycosaminoglycans. Furthermore, after applying the modified Cuprolinic Blue staining 
procedure, the appearance of the filaments closely resembles that of spread 
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proteoglycan monomers with the glycosammoglycan chains condensed (Hascall, 1980, 
Buckwalter & Rosenberg, 1982, Buckwalter et al., 1982) Therefore, the filaments 
probably represent proteoglycans. This is m agreement with the study of Hascall (1980), 
who showed that the Ruthenium Red-positive granules, as observed in rat 
chondrosarcoma, correspond to the condensed form of proteoglycan monomers This 
also corresponds with the study of Scott (1980), who considered the Cuprolmic 
Blue-positive filaments, as observed in rat tail tendon, to be proteoglycans, the 
filamentous structure would be caused by the collapse of the glycosammoglycan chams 
on the protein core of the proteoglycan The Cuprolmic Blue staining procedure, 
however, still gives a better representation of the proteoglycans than, for mstance, 
Ruthenium Red 
In the alveolar basement membrane, the Cuprolmic Blue-positive filaments he m one 
plane and are parallel to the epithelial plasma membrane. They are arranged in such a 
way as to almost enclose the alveolus completely Hence, it seems probable that the 
alveolar wall contains a continuous sheet of anionic sites. 
The Cuprolmic Blue-positive filaments associated with the collagen fibrils are 
separated from each other accordmg to the main banding period of the collagen fibrils 
(± 60 nm), indicating a specific interaction between these two components However, 
this distance is probably somewhat larger m vwo, smce it is known that glutaraldehyde 
fixation results in a shrinkage of the collagen fibril (Meek, 1981) 
Ultrastructural association of catiomc dye-positive structures and collagen fibnls is 
well documented in a vanety of tissues other than lung alveoli, for instance, predentine 
(Nygren et al , 1976), arteries (Wight & Ross, 1975), and embryonic comea (Trelstad 
et al., 1974). In these tissues, stained with either Ruthenium Red or Alcian Blue, the 
anionic granules were mostly observed to be next to the collagen fibrils However, Scott 
(1980), usmg Cuprolmic Blue and a critical electrolyte concentration method, noted that 
m the tendon, electron-dense filaments were present around the collagen fibnls, and 
there were also filaments running parallel to the fibnl axis. In our study we found few 
filaments running parallel to the axis m companson to those runnmg perpendicularly. 
Futhermore, filaments connecting collagen fibrils to each other could be detected. 
Hence, it is possible that collagen fibnls in the lung alveoli are enclosed by a network of 
these anionic filaments and m such a way provide structure coherence. 
In conclusion, there are several indications pointing to the proteoglycan nature of the 
Cuprolmic Blue-positive filaments descnbed here, the difference m length and 
localization of the vanous filaments suggests a difference m chemical composition of 
these anionic structures. In the accompanying paper, the charactenstics of these 
filaments are descnbed further 
References 
BUCKWALTER J A & ROSENBERG L С (1982) Electron microscopic studies of cartilage 
proteoglycans Direct evidence for the vanable length of the chondroitin sulfate-nch region of 
proteoglycan subunit core protein ƒ btol Chem 257, 9830-9 
37 
VAN KUPPEVELT, D O M E N , CREMERS a n d KUYPER 
BUCKWALTER, J. A , POOLE, A R , REINER, A & ROSENBERG, L С (1982) Immunofemtin 
binding to proteoglycan monomers. An electron microscopic study, ƒ. biol. Chem. 257, 
10529-32. 
FRANSSON, L -A , HAVSMARK, в & SHEEHAN, J К (1981) Self-association of heparan sulfate. 
Demonstration of binding by affinity chromatography of free chains on heparan 
sultate-substituted agarose gels. J. bio/. Chem. 256, 13039-43. 
GOLDBERG, M., GENOTELLE-SEPTIER, D к WEILL, R (1978) Glycoprotéines et proteoglycans 
dans la matnce prédentinaire et dentinaire chez le rat: une étude ultrastructurale, ƒ. biol. 
buccale 6, 75-90. 
GORDON, j R & BERNFIELD, M R (1980) The basai lamina of the postnatal mammary 
epithelium contains glycosaminoglycans in a precise ultrastructural organization. Devi Biol. 
74, 118-35. 
H ASC ALL, G. к (1980) Cartilage proteoglycans: comparison of sectioned and spread whole 
molecules, ƒ. Ultrastruct. Res. 70, 369-75. 
HASCALL, ν с & HASCALL, G К (1981) Proteoglycans. In Cell Biology of Extracellular Matrix 
(edited by HAY, E. D ) pp. 39-63. New York, London: Plenum Press. 
HORWITZ, A L , ELSON, N. A & CRYSTAL, R G (1976) Proteoglycans and elastic fibers. In The 
Biochemical Basts of Pulmonary Function; Lung Biology in Health andDtsease (edited by CRYSTAL, 
R G ) Vol 2, pp. 273-311. New York, Basel: Marcel Dekker, Inc. 
KANWAR, Y. S. & FARQUHAR, M G (1979) Anionic sites in the glomerular basement membrane. 
In vwo and in vitro localization to the laminae rarae by cationic probes, ƒ. Cell Biol. 81,137-53. 
KANWAR, Y S . L I N K E R , A & F A R Q U H A R , M G (1980) Increased permeability of the glomerular 
basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by 
enzyme digestion, f. Cell Biol. 86, 688-93. 
LAPIS, к. & T I M A R , J (1980) Cytochemical studies on the glycosaminoglycan components of the 
cell coat. Characteristics of in vitro transformed mouse fibroblasts. Biol. Cellulaire 39, 202-12. 
LAROS, С, D., KUYPER, С M. A & J A N S S E N , H. M. J (1972) The chemical composition of fresh 
human lung parenchyma. An approach to the pathogenesis of lung emphysema. Respiration 
29, 458-67. 
LASH, J w & VASAN, N. S. (1978) Somite chondrogenesis in vitro. Stimulation by exogenous 
extracellular matrix components. Dei>l Biol. 66, 151-71. 
LUFT, j H (1961) Improvements in epoxy resin embedding methods. /. Biophys. Biochem. Cytol 9, 
409-14. 
LUFT, J H (1971) Ruthenium red and violet. I. Chemistry, purification, methods of use for 
electron microscopy and mechanism of action. Anat. Ree. 171, 347-68. 
МЕЕк, κ M (1981) The use of glutaraldehyde and tannic acid to preserve reconstituted collagen 
for electron microscopy. Histochemistry 73, 115-20. 
MOCZAR, M , LAFUMA, С , LANGE, F , BIGNON, J , ROBERT, L & MOCZAR, E (1980) 
Glycosaminoglycans in elastase induced emphysema. Bull. Europ. Physwpath Resp. 16, 
(suppl.) 99-104. 
ΜΟΓΟΜΙΥΑ, M., ARAI, H , SATO, н , YOKOSAWA, A , NAGAI, н & KONNO, к (1975) Increase 
of dermatan sulfate in a case of pulmonary fibrosis. Tohoku ]. Exp. Med. 115, 361-5. 
MYERS, D В , H I G H T O N , τ С & RAYNS, D G (1973) Ruthenium Red-positive filaments 
interconnecting collagen fibrils. /. Ultrastruct. Res. 42, 87-92. 
NAGAI, H., ARAI, H., ARIJI, F , ASOO, Ν , ISHIKAWA, Τ , SATO, Η , YOKOSAWA, Α , 
ΜΟΤΟΜΙΥΑ, Μ & ΚΟΝΝΟ, κ (1977) Morphology and biochemistry of the lung from guinea 
pig after repeated injections of Freund's complete adjuvant. Lung 154, 113-23. 
NYGREN, Η , HANSSON, Η -A. 4 L I N D E , A. (1976) Ultrastructural localization of proteoglycans 
in the odontoblast-predentin region of rat incisor. Cell Tiss. Res. 168, 277-87. 
R E Y N O L D S , Ε. S (1963) The use of lead citrate at high pH as an electron opaque stain in electron 
microscopy, ƒ. Cell Biol. 17, 208-11. 
38 
Staining of proteoglycans in lung alveoli 
ROSENBERG, L., H E L L M A N N , w. & K L E I N S C H M I D T , А. к. (1974) Electron microscopic studies of 
proteoglycan aggregates from bovine articular cartilage, ƒ. biol. Chem. 250, 1877-83. 
SCOTT, J. Е. (1972) Histochemistry of a Ida η blue. III. The molecular biological basis of staining by 
alcian blue 8GX and analogous phthalocyanins. Histochemie 32, 191-212. 
SCOTT, J. E. (1973) Affinity, competition and specific interactions in the biochemistry and 
histochemistry of polyelectrolytes. Biochem. Soc. Trans. 1, 787-806. 
SCOTT, J E . (1980) Collagen-proteoglycan interactions. Localization of proteoglycans in tendon by 
electron microscopy. Biochem. }. 187, 887-91. 
SHEPARD, N. & MITCHELL, N. (1976) Simultaneous localization of proteoglycan by light and 
electron microscopy using Toluidine Blue O. A study of epiphyseal cartilage, ƒ. Histochem. 
Cytochem. 24, 621-9. 
S I L B E R S T E I N , G. в. & D A N I E L , С. w. (1982) Glycosaminoglycans in the basal lamina and 
extracellular matrix of the developing mouse mammary duct. Dei'l Biol. 90, 215-22. 
THYBERG, ]., LOHMANDER, S. & HEINECARD, D. (1975) Proteoglycans of hyaline cartilage. 
Electron-microscopic studies on isolated molecules. Biochem. J. 151, 157-66. 
T R E L S T A D , R. L., HAYASHI, к. & TOOLE, в. P. (1974) Epithelial collagens and 
glycosaminoglycans in the embryonic comea. Macromolecular order and morphogenesis in 
the basement membrane, ƒ. Cell Biol. 62, 815-30. 
VACCARO, C. A. & BRODY, J S (1979) Ultrastructural localization and characterization of 
proteoglycans in the pulmonary alveolus. Am. Rev. Resptr. Dis. 120, 901-10. 
W I G H T , T. N. & ROSS, R. (1975) Proteoglycans in primate arteries. I. Ultrastructural localization 
and distribution in the intima, ƒ. Cell Biol. 67, 660-74. 
39 

CHAPTER 3 
Staining of proteoglycans in mouse lung alveoli. 
II. Characterization of the Cuprolinlc Blue-positive^ 
anionic sites. 
TOIN H.M.S.M. VAN KUPPEVELT, FRANS P.M.CREMERS, JOS G.W. DOMEN 
AND CHARLES M.A. KUYPER 
Reprinted with permission from Histochemical Journal _16^ , 671-6Θ6, 
19Θ4, Chapman and Hall Ltd.. 
41 

Histochemical Journal 16, 671-686 (1984) 
Staining of proteoglycans in mouse lung alveoli. 
II. Characterization of the Cuprolinic 
Blue-positive, anionic sites 
T. H. M. S. M. VAN KUPPEVELT, F. P. M. CREMERS, J. G. W. 
DOMEN and C. M. A. KUYPER 
Department of Chemical Cytology, Faculty of Science, University of Nijmegen, Toernooweld, 6525 ED 
Nijmegen, The Netherlands 
Received 24 June 1983 and m revised form 31 August 1983 
Summary 
The nature of Cuprolinic Blue-positive anionic filaments in mouse lung alveoli has been 
characterized. The contrast of hlaments in the alveolar basement membrane of type I epithelial 
cells was lost on treatment with nitrous acid and pronase (without préfixation). In contrast, neither 
neuraminidase, chondroitinase ABC or AC, nor Streptomyces hyaluromdase had any effect. 
Treatment with pronase (after prefixation) and 2.0 M MgC^ (after prefixation) also had no effect, 
indicating that the hlaments are heparan sulphate proteoglycans. The filaments in the alveolar 
basement membrane of type II epithelial cells and in the capillary basement membrane of the 
endothelial cells were also nitrous acid sensitive, but chondroitinase ABC-insensitive. A model in 
which the whole alveolus contains a single layer of heparan sulphate-containing proteoglycan 
monomers is proposed. Furthermore, the collagen fibril associated filaments remained unaffected 
after treatment with nitrous acid, neuraminidase or Streptomyces hyaluromdase, or after digestion 
with pronase (after prefixation) and treatment with 2.0 M MgCl2 (after prefixation). These 
filaments, however, could no longer be detected when digestion with chondroitinase ABC or 
pronase (without prefixation) was applied; chondroitinase AC treatment clearly affected the 
hlaments, although they still were visible. These results indicate that the hlaments are dermatan 
sulphate-containing proteoglycans. Some functional aspects of the proteoglycans are discussed. 
Introduction 
Several types of glycosaminoglycans exist, varying in either the hexosamine component, 
the uronic acid component or the number and localization of sulphate groups. The 
hexosamine constituent in dermatan sulphate and chondroitin 4-/6-sulphate is 
galactosamine, whereas in hyaluronic acid, heparan sulphate and heparin it is 
glucosamine. Glucuronic acid is the uronic acid constituent in hyaluronic acid and 
chondroitin sulphate, but a considerable part of the uronic acid in dermatan sulphate, 
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heparan sulphate and heparin is iduronic acid. Keratan sulphate is the only 
glycosaminoglycan without an uronic acid component. The presence of hyaluronic acid, 
dermatan sulphate, chondroitin sulphate, heparan sulphate and heparin has been 
demonstrated in lung (Horwitz & Crystal, 1975; Sampson et al., 1979; Schmid et al., 
1482), keratan sulphate being present only in the tracheobronchial cartilage (Horwitz 
et al., 1976). 
Specific roles of the various pulmonary glycosaminoglycans can be assumed from 
observations such as the changing of glycosaminoglycan constitution during lung 
development (Horwitz & Crystal, 1975, Schmid et al., 1982) and the distribution of 
different glycosaminoglycans in various lung structures (Radhakrishnamurthy et al., 
1980; Schmid et al., 1982). 
Λ correlation of the type of glycosaminoglycan or proteoglycan with its precise ultra-
structural localization is of great importance, since it can give information about the 
function of the specific glycosaminoglycan or proteoglycan. This is a prerequisite when 
studying a disease in which glycosaminoglycans or proteoglycans might be involved. 
In this paper the Cuprolinic Blue-positive anionic sites, as described in the previous 
paper, are characterized further, mainly by the use of enzymes. 
Materials and methods 
Male mouse lung blocks were obtained and degassed as descnbed in the accompanying paper. 
Enzyme digestion 
In order to determine the nature of the Cuprolinic Blue-positive filaments, vanous enzymes were 
used according to the conditions given in Table 1. All the enzyme solutions (except pronase) 
contained 5 т м benzamidine HCl (Aldnch-Europe, Beerse, Belgium) and 0 1 м 6-amino-n-caproic 
acid (Janssen Chimica, Beerse, Belgium) (Maeda et αι., 1981) to avoid damage to the tissue by 
proteolytic enzymes, which are either from the tissue itself or are contaminants of the enzymes 
employed. Glycosaminoglycan-degrading enzymes and nitrous acid were tested for their 
specificity using cellulose acetate electrophoresis (see below). Unless otherwise stated, the tissue 
was degassed (on ice) in the enzyme solution and placed in a waterbath at 37° С As controls, the 
same solutions were used without the enzyme. 
In one case, two enzymes (chondroitinase ABC and Streptomyceb hyaluronidase) were used. First, 
chondroitinase ABC was employed under the conditions shown in Table 1 The tissue was then 
washed (10 mm, 0° С) in the solution containing protease inhibitors and no enzyme, washed again 
(10 mm, 0° С) in sodium chloride-acetate buffer containing protease inhibitors and finally, 
subjected to hyaluronidase digestion (Table 1). 
Pronase treatment was carried out either directly or after prefixation of the tissue; no protease 
inhibitors were used. Prefixation (2 h, 4° C) was carried out in 0.025 M sodium acetate buffer (pH 
5.6) containing 2.5% glutaraldehyde, and after washing twice (10 mm, 4° С) in Tris buffer 
(ennched. Table 1), the tissue was placed in the pronase solution (Table 1). 
Nitrous acid treatment 
In order to degrade specifically heparan sulphate and heparin, nitrous acid was used (Kosher & 
Searls, 1973): 5% NaNO and 33% acetic acid (1:1 v/v) were mixed and allowed to stand for 90 
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Table 1. Enzymes used and conditions employed for characterization of the Cuprolinic Blue-positive, anionic sites 
Enzyme Source Concentration + buffer pH Temperature 
Time 
(mm) Reference * 
Chondroitinase ABC 
Chondroitmase AC 
Hyaluronidase 
Neuraminidase 
Pronase 
Proteub vulgaris lU/ml enriched Tns 
(Sigma) buffer1' 
Arthrobacter lU/ml ennched Tns 
aurescens (Sigma) buffer 
Streptomyces 
(Calbiochem) 
Clostridium 
perfnngens 
(Sigma) 
Streptomyces 
gnseus 
(Calbiochem) 
buffer^ 
lU/ml NaCl-acetate 
buffer 
15U/ml ennched 
Tris buffer 
8 0 
8 0 
5 4 
5 4 
37 "C 
37° С 
37° С 
37° С 
45 
45 
45 
45 
Vaccaro & Brody, 1979, 
Ausprunk, 1981 
— 
Kanwar et al , 1980, 
Vaccaro & Brody, 
1979 
Kanwar & Farquhar, 
1979. 
8 0 37° С 45 
'The enzyme conditions have been adopted from the references given here, occasionally some modificahons have been introduced 
+0 25 M Tns, 0 18 M NaCl, 0 05% BSA 
TT R U = Turbidity Reducing Units 
$0 1 M sodium acetate, 0 15 M NaCl 
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min at room temperature, after which 5 mM benzamidine HCl and 0 1 M 6-amino-í¡-caproic aad 
were added The tissue was first subjected to prefixation with glutaraldehyde (see Pronase 
digestion) and after rinsing twice in 0 2 M sodium acetate containing protease inhibitors, the lung 
blocks were incubated in nitrous acid for 90 mm at room temperature As a control a 0 2 M sodium 
acetate solution, also containing protease inhibitors, was used with the same pH as the nitrous acid 
solution 
MgC/2 treatment 
In order to investigate the nature of the interaction between the glycosaminoglycans and proteins 
the tissue was subjected to treatment with MgC^ Lung blocks were allowed to stand for 2 h (room 
temperature) m 0 025 м sodium acetate buffer, pH 5 6, containing protease inhibitors and 0 2 or 
2 0 M MgCl2 This was followed by three 10 mm washes at room temperature in the same solution, 
one wash (10 mm, room temperature) in buffer without MgC^ and finally a rinse (10 mm, room 
temperature) in buffer containing 0 2м MgC^ in order to make the tissue suitable tor staining and 
fixation Staining and fixation are also performed in the presence of 0 2 MMgC^ (see below) In one 
instance, the 2 0 м MgC^ treatment was preceded by prefixation followed by one wash (10 mm, 
room temperature) in the sodium acetate buffer containing protease inhibitors and 2 0м MgC^ 
Fixation and Cuprolimc Blue staining 
After enzymic or nitrous acid treatment, the specimen was washed once (10 mm, 0° С) in the 
control solution and after being washed once again (10 mm, 0° C) in 0 025 м sodium acetate buffer 
(pH 5 6) containing protease inhibitors, the lung blocks were fixed and stained (overnight, room 
temperature) in 0 025 M sodium acetate buffer containing 2 5% glutaraldehyde, 0 2% Cuprolimc 
Blue and 0 2 м MgC^ After fixation and staining the matenal was washed three times in the 
fixative solution without Cuprolimc Blue, three times in 1% aqueous sodium tungstate and 
dehydrated in ascending concentrations of ethanol, the 30 and 50% concentrations containing 1% 
sodium tungstate Lastly, the lung blocks were embedded in Epon and ultrathin séchons were 
examined with a Philips 201 electron microscope 
Cellulose acetate electrophoresis 
In order to test the specificity of the glycosammoglycan degrading en/ymes and nitrous aad а 
mixture of pure glycosaminoglycans was subjected to treatment with enzyme or nitrous acid, after 
which electrophoresis was performed in cellulose acetate strips using copper acetate (Stefanovich 
& Gore, 1967) as buffer 
Results 
As described in the previous paper, four kinds of electron-dense filaments became 
visible in lung alveoli after Cuprolimc Blue staining one (basement membrane filaments 
I) in the alveolar basement membrane of type I epithelial cells was closely associated 
with the plasma membrane, one (basement membrane filaments II) associated with the 
alveolar basement membrane of type II epithelial cells, another (basement membrane 
filaments III) was located in the basement membrane of the capillary endothelium, and 
the last type associated with collagen fibrils Due to the specificity of the staining 
procedure the Cuprolimc Blue-positive filaments are sometimes the only structures 
clearly visible The electron density of collagen fibrils is variable, poststaining with lead 
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Table 2. Effects of vanous treatments on the basement membrane filaments I (bmf I) and the 
collagen associated filaments (caf) 
Effect 
on collagen 
Effect on aiboaated 
Treatment Substrate bmf I filaments 
Neuraminidase sialoglycoproteins -
Streptomyceb hyaluromdase hyaluronic acid - -
Chondroitmase ABC chondroitm sulphate, dermatan sulphate - + 
Chondroitmase AC hyaluronic acid, chondroitm sulphate, - ± 
dermatan sulphate only where it 
contains a glucuronic residue 
Chondroitmase ABC + hyaluronic acid, chondroitm sulphate, - + 
btreptomyces hyaluromdase dermatan sulphate 
Nitrous acid heparan sulphate, hepann + 
Pronase (after prefixahon) proteins - -
Pronase (without prehxation) proteins + + 
2 0 M MgCb (after ionic bonds 
prehxation) 
2 0 M MgCl2 (without ionic bonds - + 
prehxation) 
- no effect 
*, filaments no longer visible, 
±, stainability of filaments reduced 
citrate, with or without uranyl acetate, however, is not always desirable since it may 
obscure the Cuprohnic Blue-positive filaments The length of the filaments, as described 
in the previous paper, is sometimes diminished, possibly as a result of the pretreatment 
of the tissue 
Neuraminidase treatment, which splits off sialic acid from glycoproteins, has no effect 
on the stainability of the basement membrane filaments type I (Fig la) or the collagen 
associated filaments (Fig lb) Digestion with Streptomyces hyaluromdase, which 
degrades hyaluronic acid specifically, also has no effect On the other hand, treatment 
with chondroitmase ABC, which digests chondroitm sulphate and dermatan sulphate, 
results in the complete disappearance of the stainability of the collagen associated 
filaments (Fig 2b), the basement membrane hlaments I remaining unaffected (Fig 2b). 
In the control (Fig 2a) both kinds of hlaments are clearly visible. When lung tissue is 
treated with chondroitmase AC, which breaks down hyaluronic acid and chondroitm 
sulphate, but breaks down dermatan sulphate only where it contains a glucuronic acid 
residue, a complete removal of the staining of the collagen associated filaments is not 
obtained, although these hlaments are clearly affected by the enzyme treatment (Fig. 
2c). Occasionally, however, this effect is less pronounced. The basement membrane 
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filaments 1, again, remain unaltered. Using a combination of Streptomyces hyaluronidase 
and chondroitinase ABC all glycosaminoglycans are degraded, with the exception of 
heparan sulpate and heparin (and keratan sulphate, which is not present, however, in 
lung alveoli). After treatment with this combination of enzymes, basement membrane 
filaments type I remain unaffected (Fig. 3a), the collagen associated filaments are no 
longer detectable (Fig. 3b). Nitrous acid treatment, which causes degradation of heparan 
sulphate and heparin,"has an opposite effect: the basement membrane filaments I 
are no longer stained (Fig. 4a), while the collagen associated filaments are not affected 
(Fig. 4b). 
After pronase digestion, without prefixation, the basement membrane filaments I and 
collagen associated filaments (Fig. 5b) can no longer be detected. When, however, 
prefixation with glutaraldehyde (which fixes proteins by cross-linking) (Geyer, 1973; 
Cheung & Nimni, 1982) is applied, the pronase has no influence on the staining (Fig. 
5a). Furthermore, treatment of the tissue with 2.0 M MgCl2 (which will attack ionic bonds) 
after prefixation, has no effect on the filaments (Fig. 6a,b). After treatment with 2.0 M 
MgClj without prefixation, however, the basement membrane filaments I remain stained 
(Fig. 7a), but the collagen associated filaments are no longer visible (Fig. 7b); when the 
Fig. 1. Part of alveolar wall after neuraminidase treatment, (a) The Cuprolinic Blue-positive 
filaments (bmf 1) in the basement membrane of type I epithelial cells remain unaffected, (b) The 
Cuprolinic Blue-positive, collagen hbnl associated filaments (cat) also are not affected a, alveolus; 
c, collagen hbnl. 
Fig. 2. Part of alveolar wall after chondroitinase ABC or AC treatment, (a) Control, the basement 
membrane filaments type I and collagen associated filaments are clearly visible, (b) Chondroitinase 
ABC digeshon: the basement membrane filaments type 1 remain unaffected, while the collagen 
associated filaments are not detectable anymore, (c) Chondroitinase AC: the collagen associated 
filaments are clearly affected but remain visible, el, elastm. 
Fig. 3. Part of alveolar wall after chondroitinase ABC + Streptowyceb hyaluronidase treatment, (a) 
The basement membrane filaments 1 are not affected by this combination of enzymes, (b) The 
collagen associated filaments are no longer visible. 
Fig. 4. Part of alveolar wall after nitrous acid treatment, (a) The basement membrane filaments I 
are no longer visible, (b) The staining of the collagen associated filaments remain unaffected, abm, 
alveolar basement membrane; en, endothelium, cap, capillary; ep, epithelium. 
Fig. 5. Collagen hbnls in the alveolar wall after pronase treatment with/without prefixation. (a) 
Pronase digestion after prefixation· the staining of the collagen associated filaments is not affected. 
(b) Pronase digestion without prefixation: the collagen associated filaments are no longer 
detectable. 
Fig. 6. Part of the alveolar wall after treatment with 2.0 M MgCl2 after prefixation. (a) The 
basement membrane filaments I remain visible after this treatment, (b) The collagen associated 
filaments also are not attected. 
Fig. 7. Part of the alveolar wall after treatment with 2.0 M MgCl2 without prefixation. (a) The 
basement membrane filaments I are not affected by this treatment, (b) The collagen associated 
filaments are no longer visible. 
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Fig. 8. Collagen fibrils in the alveolar wall after treatment with 0.2 м MgC^ without prefixation. 
The collagen associated filaments are not affected. 
Fig. 9. Part of the alveolar wall after treatment with chondroitinase ABC. The Cuprolinic Blue-
positive filaments (basement membrane filaments III) in the basement membrane of the capillary 
endothelium are not affected, cbm, capillary basement membrane. 
Fig. 10. Part of the alveolar wall after treatment with chondroitinase ABC. The Cuprolinic 
Blue-positive Hlaments (basement membrane filaments II) in the alveolar basement membrane of 
type II epithelium cell (ect II) are not affected, mb, multilamellar body; rib, ribosomes. 
Fig. 11. Part of alveolar wall after treatment with nitrous acid. The basement membrane filaments 
II cannot be detected anymore. 51 
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2.0 M is replaced by 0.2 M MgCl2 the collagen associated filaments are unaffected (Fig. 8). 
The effects of the various treatments are summarized in Table 2. 
When the stain intensity of the basement membrane filaments I is compared with that 
of the collagen associated filaments, the former is always the most electron dense (Fig. 
2a). 
The basement membrane filaments III of the endothelial cells are hardly affected by 
chondroitinase ABC (Fig. 9), while nitrous acid clearly affects these structures; the 
basement membrane filaments II of epithelial cell type II show the same sensitivity 
towards chondroitinase ABC (Fig. 10) and nitrous acid (Fig. 11). 
Discussion 
Basement membrane filaments 
The Cuprolinic Blue-positive filaments in the alveolar basement membrane of type I 
epithelial cells disappear after nitrous acid treatment, while other glycosaminoglycan 
degrading procedures as well as neuraminidase digestion have no effect. This means 
that the stainability of the filaments is caused by either heparan sulphate or heparin or 
both. This is in good agreement with the results obtained for rat lung alveoli (Vaccaro & 
Brody, 1981). Hyaluronic acid cannot be visualized by the Cuprolinic Blue staining 
procedure since the 0.2 M MgCl2 used during fixation prevents staining of this type of 
glycosaminoglycan (Scott, 1972). Hyaluronic acid, however, is probably not involved in 
the filaments themselves, becauâe Streptomyces hyaluronidase did not have any effect on 
the filaments. After pronase digestion without prefixation, the filaments can no longer 
be detected. Application of this proteolytic enzyme, after prefixation with 
glutaraldehyde, has no effect. This indicates that the glycosaminoglygans are complexed 
with protein, but it does not elucidate the nature of the bond between the sugar and the 
protein. Treatment with 2.0 M MgC^ after prefixation has no effect suggesting a covalent 
bond between the glycosaminoglycan and the protein, since 2.0 M MgCl2 will break 
ionic bonds. Hence, it is likely that the Cuprolinic Blue-positive filaments are 
proteoglycans. Each filament would represent a proteoglycan monomer since, applying 
a modified Cuprolinic Blue staining procedure (accompanying article), they closely 
resemble proteoglycan monomers with the glycosaminoglycan-chains condensed as 
seen using the spreading technique. 
As to the involvement of heparan sulphate or heparin (or both), the following may be 
said. Heparan sulphate is the main glycosaminoglycan in the renal glomerular basement 
membrane (Kanwar & Farquhar, 1979), as well as in the basement membrane of the 
bovine lens capsule (Parthasarathy & Spiro, 1982). A basement membrane producing 
tumour also contains heparan sulphate as the predominant glycosaminoglycan 
(Hassell et al., 1980), which is also the case for a basement membrane producing cell-line 
(Oohira et al., 1982); glomerular epithelial cells in vitro have been shown to synthesize 
largely heparan sulphate (Farin et al., 1980). Furthermore, it is known that heparin is 
largely confined to the mast cells (Lindahl & Höök, 1978; Nakamura et al., 1981) and 
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recently, a good correlation has been found between the number of mast cells and the 
amount of heparin (Straus et al., 1982). It is, therefore, likely that heparan sulphate is the 
only type of sulphated glycosaminoglycan in the proteoglycans of the alveolar basement 
membrane of type I epithelial cell. The use of the enzyme heparitinase, which 
degrades only heparan sulphate, would make it possible to deduce whether heparan 
sulphate and/or heparin are involved (Linker & Hovingh, 1972). 
The heparan sulphate-containing proteoglycan visualized electron microscopically 
could be a similar proteoglycan to the one isolated from bovine lung gas exchange tissue 
by Radhakrishnamurthy et al. (1980); the glycosaminoglycan composition of this 
proteoglycan was shown to be nearly 100% heparan sulphate. Kanwar et al. (1981) found 
that only 55% of the proteoglycans synthesized was extracted from the renal glomerular 
basement membrane after treatment for 24 h with 4.0 M guanidinium chloride. This is in 
agreement with our observation that the heparan sulphate proteoglycan cannot be 
removed from the alveolar basement membrane by 2.0 M MgC^ without prefixation. The 
heparan sulphate-containing proteoglycan is apparently tightly anchored in the 
basement membrane. 
The filaments in the alveolar basement membrane of epithelial cell type II are 
sensitive to nitrous acid but are chondroitinase ABC-insensitive which indicates that the 
stainability of these filaments is also attributable to heparan sulphate. 
As described in the accompanying paper, the filaments appear in one plane in the 
alveolar basement membrane. This would mean that the whole alveolus contains an 
envelope of a single layer of heparan sulphate-containing proteoglycans, making up a 
space-filling structure of negative charges. This model is shown in Fig. 12. A filtering 
function seems likely for this structure, a function which has also been recognized for 
the heparan sulphate-containing proteoglycans of the renal glomerular basement 
/ epitnehum (type I ce l l ) 
alveolar basement membrane 
Fig. 12. Schematic representation of the heparan sulphate containing proteoglycan-envelope in 
the alveolar basement membrane. E, erythrocyte; HSPG: heparan sulphate containing 
proteoglycan. 
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membrane (Kanwar et al , 1981), removal of the glycosaminoglycans leads to mcreased 
permeability of the glomerular basement membrane to serum albumin (Kanwar & 
Farquhar, 1980) This filter could play a role in regulating the transport of biomolecules 
from the blood to the epithelium (and eventually to the alveolar airspace) and vice versa 
Transport of fluid from the airspace into the interstitium has been suggested (Matthay 
et al , 1982, Olver et al , 1981) 
Another role of this negative sheet of heparan sulphate-containing proteoglycans 
might be in reducing the effect of the surface tension at the alveolar-air interface It is 
well established that the surfactant system contams surface-active phospholipids, which 
reduce the surface tension of the alveoli, thereby preventing a collapse Due to the 
mutual repulsion of their negative charges, the heparan sulphate-containing 
proteoglycan shell may also have a function m defining the minimal diameter of the 
alveolus, thereby playmg an important role in the physiological functionmg of the lung 
The basement membrane of the capillary endothelial cells contains Cuprolinic 
Blue-positive filaments which are also nitrous acid-sensitive, but are hardly affected by 
chrondroitinase ABC digestion, heparan sulphate therefore is the predominant 
glycosammoglycan This agrees with the studies of Clowes et aï (1982) who, using 
antibodies to a heparan sulphate-containing proteoglycan, showed the rat capillary 
endothelial basement membrane to be a major site of such proteoglycans Furthermore, 
Cantor et al (1977) demonstrated that rat lung endothelial cells in vitro may secrete 
heparan sulphate Vaccaro & Brody (1981) showed that Ruthenium Red-positive 
granules in the basement membrane of rat lung alveoli contained heparan sulphate 
Collagen associated filaments 
The collagen fibril associated filaments disappear completely after chondroitinase ABC 
digestion, but they remain after nitrous acid treatment One can conclude from these 
observations that the stainability of the filaments arises from the presence of either 
dermatan sulphate or chondroitin sulphate or both as has also been observed earlier for 
rat lung (Vaccaro & Brody, 1979) and kidney (Farquhar & Kanwar, 1982) The use of the 
enzyme chondroitinase AC results in a decrease, but not in a disappearance, of the 
electron density of the filaments The remaining electron density has to be attnbutable to 
dermatan sulphate, the electron density lost, however, may be either chondroitin 
sulphate or glucuronic acid residues containing dermatan sulphate or both After 
pronase digestion without prefixation, the filaments are no longer detectable, pronase 
digestion after fixation, however, has no effect Treatment with 2 0 м MgC^ after 
prefixation, also has no effect Therefore the collagen associated filaments represent 
proteoglycan monomers with dermatan sulphate (and possibly chondroitin sulphate) as 
the glycosammoglycan component This dermatan sulphate-containing proteoglycan is 
less electron dense than the heparan sulphate-containing proteoglycan of the alveolar 
basement membrane This could be due to more glycosammoglycan chains per length 
of the heparan sulphate proteoglycan-filament, more sulphate groups per disacchande 
group of the heparan sulphate chains and/or longer heparan sulphate chains 
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Scott and his colleagues (1981) demonstrated in a comparative electron microscopical 
and biochemical study that small foetal collagen fibrils m rat tail tendon seemed to be 
preferentially associated with chondroitm sulphate and hyaluronic acid, while for coarse 
collagen hbnls dermatan sulphate was the predommant glycosammoglycan. Our 
observation, that some areas are less chondroitinase AC-sensitive might, therefore, 
reflect areas where the proteoglycans contain more dermatan sulphate. A correlation of 
different glycosaminoglycans with specific types of collagen has been suggested 
(Junqueiraefa/., 1981). 
Fibroblasts might be the site of the dermatan sulphate-containing proteoglycan 
production smce it has been shown (Castor et al., 1979) that the major sulphated 
glycosammoglycan synthesized by guinea-pig lung fibroblasts in culture was dermatan 
sulphate. Furthermore, Ehrlich (1981) demonstrated that hbroblast-like lung cells of the 
rat in culture secreted a dermatan sulphate/chondroitin sulphate-containing 
proteoglycan in the medium, while human embryonic lung fibroblasts in culture 
secreted dermatan sulphate proteoglycans as the major proteoglycan fraction (Vogel & 
Peterson, 1981). 
The nature of the interaction of the dermatan sulphate proteoglycan with the collagen 
hbnls is probably ionic since after treatment with 2 0 M MgC^ without prefixation this 
proteoglycan can no longer be observed. This is in agreement with the studies of several 
authors who demonstrated that the interaction of glycosaminoglycans and 
proteoglycans with collagen can be abolished by increasing the ionic strength (Mathews, 
1965; Obnnk, 1973a; Greenwald et al., 1975). 
As described earlier, the correspondence of the distance between the filaments and 
the collagen fibn] main banding pattern is an indication of a specific structural 
interaction between these two components of the connective tissue. It has been 
demonstrated by Obrink (1973a) that dermatan sulphate and dermatan sulphate-
containing proteoglycan can interact with collagen; dermatan sulphate binds to 
(lathyntic) collagen more strongly than chondroitm sulphate, the iduronic acid residue 
being an important determmant in the strength of bmding. A strong interaction of 
dermatan sulphate with collagen has been noted previously by Toole & Lowther (1968): 
dermatan sulphate extrachon from tendon and heart valves was far more difficult 
than extrachon of other glycosaminoglycans. Furthermore, Wusteman (1972) has 
demonstrated for bovine lung parenchyma, that dermatan sulphate is closely 
associated with collagen hbnls, smce collagenase digestion removed more dermatan 
sulphate than either salt extraction or elastase digestion. Possibly the dermatan 
sulphate-containing proteoglycan maintains the interconnection of the collagen hbnls m 
lung alveoli and in such a way provides structural coherence; the localization of this 
proteoglycan, as visualized in this study, is consistent with this view. 
Another role of this proteoglycan might be in hbnllogenesis. Dermatan sulphate, as 
well as dermatan sulphate-containing proteoglycan, can precipitate collagen molecules 
(Obnnk, 1973a), while both have an effect on fibril formation (Obrink, 1973b), Snowden 
& Swann (1980) also noticed a marked effect of dermatan sulphate on hbnl formation, in 
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f У ~~ — · Г ---»А basement membrane 
Fig. 13. Schematic representation of the localization of the various proteoglycans in mouse lung 
alveoli seen after applying the Cuprolinic Blue staining procedure. HSPG, heparan sulphate 
containing proteoglycan; DSPG, dermatan sulphate containing proteoglycan. 
contrast with chondroitin-6-sulphate, which had a much smaller influence. 
Furthermore, dermatan sulphate seems to be associated with the more coarse collagen 
fibrils (Scott et aï., 1981; Eyre & Muir, 1975); an increase in dermatan sulphate content, 
prior to an increase of collagen deposition has also been noticed (Kawamoto & Nagai, 
1976), as well as an influence of dermatan sulphate on the mechanical properties of 
collagen fibrils (Danielson, 1982). Hence, it may be possible that the dermatan 
sulphate-containing proteoglycan plays a role in the fibrillogenesis of collagen fibrils in 
lung alveoli. Moreover, a shift in glycosaminoglycan composition during lung 
development (Horwitz & Crystal, 1975) may reflect alterations in collagen fibrils, as 
already shown for tendon (Scott et al., 1981). It seems plausible that this proteoglycan 
plays a role not only in the development of collagen fibrils in lung, but also in 
determining the tensile strength of these fibrils once formed. A disturbance in the 
amount or nature of these proteoglycans could well lead to a loss of stability of the 
alveoli, thus leading to pathological conditions such as emphysema. 
Fig. 13 gives a schematic representation of the localization of the various 
proteoglycans in mouse lung alveoli. 
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CHAPTER Ц 
Localization of proteoglycans In tissue using the critical 
electrolyte concentration method. Comparison with biochemical 
data from literature. 
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Summary 
Several connective tissues were stained for proteoglycans using the cationic 
dye Cuprolinic Blue according to the critical electrolyte concentration me-
thod. This method visualizes proteoglycans as electron-dense filaments. In 
most tissues two types of proteoglycan-filaments are present: a small (maxi-
mum length 60 nm), thin, collagen fibril-associated filament, and a thick, 
heavily staining filament which is predominately localized between bundles 
of collagen fibrils. Cartilage contains very large (about 300 nm) proteogly-
can-filaments while in cornea they are very small. Comparison with biochemical 
data from literature suggests that the appearance of the proteoglycan-fila-
ments may be indicative for the glycosaminoglycan/protein ratio and for the 
molecular weight of the part of the protein core to which glycosaminoglycans 
are attached. The data thus obtained on the localization and structure of a 
proteoglycan may be useful when planning a strategy for its isolation. 
Introduction 
Connective tissue is characterized by a relatively high amount of extracel-
lular matrix. In this matrix a fibrillar and an amorfous component can be 
distinguished; collagen and elastin are elements of the former, while proteo-
glycans are major elements of the latter. Proteoglycans are macromolecules 
consisting of a protein core to which glycosaminoglycans are covalently atta-
ched in addition to (in most cases) some oligosaccharides (Hascall & Hascall, 
1981). By virtue of carboxylic and sulfate groups the glycosaminoglycans (and 
hence the proteoglycans) are highly negatively charged molecules. There is 
a great variety of proteoglycans and several physiological functions such as 
acting as a filter barrier (Kanwar et al., 1980) and absorbing compressive 
load (Hascall & Hascall, 1981) have been ascribed to them. 
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There are several ways for the ultrastructural detection of proteoglycans 
in tissue. The most commonly used method is the application of cationic pro-
bes such as Alcian Blue (Goldberg et al., 1978), Ruthenium Red (Gordon & Bern-
field, 1980) and cationized ferritin (Kanwar & Farquhar, 1979). The inter-
action between the dye and the proteoglycan is probably of an ionic nature 
(Scott, 1973) and consequently the specificity of these stains is not very 
high (i.e. all negatively charged molecules may bind the dye). Specificity, 
however, can be increased when the critical electrolyte concentration method 
is used (Scott, 1980). In this method the staining solution contains a salt 
(e.g. MgCl ) in such a molarity that only sulfate groups can bind the dye 
and hence only sulfated molecules are stained. In practice this means that 
in the extracellular matrix proteoglycans are about the only components to 
be contrasted. 
Another method for the ultrastructural detection of proteoglycans is the 
application of antibodies raised against a particular proteoglycan (Longas 
and Fleischmajer, 1985; Aquino et al., 1984). Although the specificity of this 
method is better than that using cationic probes, resolution is not. Phtalo-
cyanin-like dyes (e.g. Alcian Blue, Curpolinic Blue, Cupromeronic Blue) used 
according to the critical electrolyte concnetration method allow an accurate 
localization of proteoglycans in tissue (Ruggeri et al., 1975; Scott, 1981; 
Van Kuppevelt et al., 1984a,b, 1985a). Furthermore, addition of cationic dyes 
to the fixative reduces the loss of proteoglycans during tissue processing to 
less than 1% (Chen & Wight, 1984). 
In this study proteoglycans are localized in several connective tissues 
using Cuprolinic Blue according to the critical electrolyte concentration 
method; an attempt will be made to correlate ultrastructural observations with 
biochemical data from the literature. 
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Materials and Methods 
Materials 
Bovine flexor tendon, achilles tendon, nasal septum cartilage, ear cartilage, 
cornea, skin and periodontal ligament were obtained from the local slaughter-
house. Cornea from New Zealand White rabbits and skin from female Sprague-
Dawley rats were obtained from the Central Animal Laboratory, University of 
Nijmegen. Samples were taken at random. After dissection, the specimens were 
immediately put into the fixative. Reconstituted collagen fibrils with and 
without small dermatan sulfate proteoglycans (Danielsen and Uldbjerg, 1983,-
Damelsen, 1982) were a kind gift of Dr. C.C. Danielsen, University of Aarhus, 
Denmark. 
Methods 
The Cuprolinic Blue staining procedure has been outlined previously (Van Kup-
pevelt et al., 1985a). Briefly, specimens were fixed overnight (room tempera-
ture) in 0.05 M sodium acetate (pH 5.6) containing 2.5% glutaraldehyde, 0.2% 
Cuprolinic Blue and 0.2 M MgCl„. After rinsing, the tissue blocks were fur-
ther stained with 1% aqueous Na WO and dehydrated in ascending ethanol con-
centrations, the 30 and 50% containing 1% Na.WO . Embedding was in Epon 812. 
Sections (± 80 nm) were cut with a diamond knive and poststained with 2% aque-
ous uranyl acetate. Sections were examined with a Philips 201 electron micros-
cope; the magnification was calibrated using a cross grating replica (2160 
lines/mm,- Balzers Union, Liechtenstein) . 
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Results 
It has been well documented (Scott and Orford, 1981; lozzo, 1984; Van Kuppe-
velt et al., 1984a,b, 1985a), and some additional proof will be presented 
below, that the electron-dense filaments in tissue appearing after the Cupro-
linic Blue staining procedure, represent proteoglycans (PG); the Cuprolinic 
Blue-positive filaments will therefore be referred to as PG-filaments. 
There are two main problems in estimating the real length of PG-filaments. 
1. A filament may lie obliquely with respect to the plane of sectioning; the 
measured length then is smaller than the real length. The use of a goniometer 
device did not satisfactorily solve this problem. 
2. A filament may be only partially included in the section; m this case 
also the measured length is less than the actual length of the filament. 
In this study the maximum length observed within a class of filaments was 
taken as the real length. In such way, however, a genuine class of small PG-
f ilaments may be overlooked. Only regularly occunng PG-f ilaments associated 
with or in the vicinity of collagen fibrils were studied here. Other PG-fi-
laments, likely to occur in distinct areas of the tissue, were not taken in-
to consideration. 
Reconstituted collagen fibrils with dermatan sulfate proteoglycans 
Proteoglycans appear as electron-dense filaments after the Cuprolinic Blue 
staining procedure (Fig. 1). Their maximum length is about 60 nm; large aggre-
gates may be present. In the control (i.e. no proteoglycans added) no such 
structures can be observed (Fig. 2). 
Tendon 
The PG-filaments of tendon (Fig. 3) can be distinguished into at least two 
ma^or classes; one class consists of thin, small (maximum length about 60-70 
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Fig. 1. Reconstituted collagen fibrils (с) to which dermatan 
sulfate proteoglycans (DSPG) have been added. Cuprolinic Blue 
staining procedure. The proteoglycans appear as electron-dense 
filaments. Bar: 150 nm. 
Fig. 2. Reconstituted collagen fibrils (c) . No proteoglycans 
added. Cuprolinic Blue staining procedure. No electron-dense 
filaments are present (compare with Fig. 1). Bar: 150 nm. 
Fig. 3. Bovine acbilles tendon after the Cuprolinic Blue 
staining procedure. Thin, small proteoglycan (PG)-filaments 
(small arrows) are present in addition to larger, thick, 
heavily staining PG-filaments (large arrows). The small 
PG-filaments can be seen regularly associated with collagen 
fibrils (c). Bar: 150 nm. 
Fig. 4. Bovine sclera after the Cuprolinic Blue staining 
procedure. Thin, small PG-filaments (arrows) are visible. 
The ones orientated perpendicularly with respect to the 
collagen fibril (c) axis are predominately associated with 
the d-band of the fibril. Bar: 150 nm. 
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nm) PG-filaments while the other class consists of larger, thick and heavily 
staining PG-filaments which are preferentially localized around bundles of 
collagen fibrils or at places where the collagen fibrils are somewhat sepa-
rated from each other. PG-filaments running parallel as well as perpendicular 
with respect to the collagen fibrils are present. Sometimes extraordinarily 
large PG-filaments (upto 200 nm) can be observed; they lie in a parallel fas-
hion with respect to the collagen fibrils. 
Sclera 
The coarse collagen fibrils of the sclera are also associated with small, 
thin PG-filaments with a maximum length of 50-60 nm (Fig. 4), similar to 
those found in human and rabbit sclera (Young, 1985). Between bundles of 
collagen fibrils thick, heavily staining filaments are present. 
Periodontal ligament 
In this tissue also, two major classes can be distinguished; a class of small, 
thin, collagen fibril-associated, PG-filaments (maximum length about 60 nm) 
and a class of larger, thick and heavily staining PG-filaments, which are 
localized between bundles of collagen fibrils (Fig. 5). 
Skin 
The collagen fibrils of skin are associated with small, thin PG-filaments 
(Fig. 6) with a maximum length of 50-60 nm. Furthermore, capricious PG-fila-
ments can be sometimes detected, which are mostly localized at places where 
bundles of collagen fibrils of different orientation meet (Fig. 5). Especial-
ly in the skin of the rat a very small PG-filament seems to be present. 
Cornea 
Sections of cornea present a somewhat different image when compared to other 
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Fig. 5 Bovine periodontal ligament after the Cuprolinic Blue 
staining procedure. Thin, small PG-filaments (small arrows) 
are associated with collagen fibrils (c). Larger, thick, 
heavily staining PG-filaments (large arrows) have an inter-
fibrillar localization. Bar: 150 nm. 
Fig. 6. Rat skin after the Cuprolinic Blue staining procedure. 
Small, thin PG-filaments (smaal arrows) are detectable. At 
places where bundles of collagen fibrils (c) of different 
orientation meet, capricious PG-filaments (large arrows) 
are present. Bar: 150 nm. 
Fig. 7. Bovine cornea after the Cuprolinic Blue staining procedure. 
Dot-like PG-"fi laments" (triangles) are visible in addition to 
very small PG-filaments (small arrows), c: collagen fibril. 
Bar: 150 run. 
Fig. 8. Bovine ear cartilage after the Cuprolinic Blue 
Staining procedure. Very large, thick, heavily staining 
PG-filaments (large arrows) are visible, c: collagen fibril. 
Bar: 150 nm. 
tissues. The PG-filaments are very small and often appear as dot like struc­
tures (Fig. 7) . A ma;jor class of about 30 nm is present. A considerable part, 
however, seems to be in a genuine globular state. Another class, which Is 
present in a low proportion, has a maximum length of about 50 nm. 
Cartilage 
The PG-filaments of cartilage (Fig. Θ) appear as irregular structures which 
are very large (maximum length about 300 nm), thick and intensely stained. 
No direct relation to the collagen fibrils seems to be present. Occasionally 
large aggregates of these PG-filaments can be observed. Sometimes small PG-
filaments are seen associated with collagen fibrils. 
It was determined that for tendon, sclera and skin the small, thin PG-fila-
ments which are orientated perpendicular with respect to the collagen fibrils, 
are predominately (70-80%) located at the d-band of the collagen fibril. 
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Discussion 
The Cuprolinic Blue staining procedure reveals proteoglycan monomers as elec-
tron-dense filamentous structures, formed by the collapse of the glycosamino-
glycan side-chains onto the protein core during specimen processing (Van Kup-
pevelt et al., 1984a,b, 1985a; Scott, 1980, Figs, land 2). These structures, 
being reflections of intact proteoglycans, may therefore contain some infor-
mation regarding the chemical nature of the proteoglycans. 
A small, thin PG-filament with a maximum length of about 60 nm is abundant-
ly present in most connective tissues studied here; those orientated perpen-
dicularly with respect to the collagen fibril axis are predominately associa-
ted with the d-band of the collagen fibrils. The dermatan sulfate proteogly-
cans added to the reconstituted collagen fibrils (Fig. 1) also belongs to this 
class, although no specific d-band association could be observed. This pro-
teoglycan, isolated from human uterine cervix (Uldbjerg et al., 1983) belongs 
to a group of proteoglycans named PG-Sm-DS according to the nomenclature sug-
gested by Heinegärd and co-workers (1985) in which PG stands for proteoglycan, 
Sm for small and DS for dermatan sulfate. This class of proteoglycans is cha-
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racterized by a M of around or less than 100'10 , a protein core of 40-60· 10 
with high contents of leucine, aspartic acid/asparagine and glutamic acid/ 
glutamine, the core bearing one or only few dermatan sulfate side-chains. 
Small proteoglycans isolated from bovine achillus tendon (Anderson, 1975) and 
flexor tendon (Vogel and Heinegärd, 1985) , sclera (Coster and Fransson, 1981), 
skin and periodontal ligament (Pearson and Gibson, 1982) with such character-
istics have been described. The dermatan sulfate proteoglycan from rat skin 
(Miyamoto and Nagese, 1980), however, seems to have a very small M . We sug-
gest that the small, thin PG-filaments visualized by the Cuprolinic Blue stal-
ing procedure, are the electron microscopical reflections of the PG-Sm class. 
These proteoglycans are associated with coarse collagen fibrils (tendon, sclera) 
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as well as with smaller collagen fibrils (skin, periodontal ligament). A role 
in regulating the diameter of a collagen fibril seems therefore questionable; 
they can, however, be of importance in inhibiting the lateral growth of a 
fibril. The observation of Vogel and Heinegard (1983) that addition of a small 
dermatan sulfate proteoglycan to a collagen solution leads to a reduced in-
crease of absorbance, may be explained in this way. 
The corneal stroma contains smaller PG-filaments (Fig. 7) and a part of 
the proteoglycans appear as globular structures. It has been reported for rab-
bit cornea (Gregory et al., 1982) that four different proteoglycans are pre-
sent: two keratan sufate proteoglycans and two dermatan sulfate proteoglycans, 
the latter being larger than the former. A keratan sulfate proteoglycan from 
bovine corneal stroma has been shown to contain intrachain disulfide bonds 
(Axelsson and Heinegard, 1978); cleavage of the disulfide bonds altered the 
size of the molecule. The dot-like appearance of a part of the proteoglycans 
in our study may therefore be caused by the folding of this proteoglycan into 
a globular structure. 
For bovine tendon (Vogel et al., 1985; Anderson, 1975), sclera (Coster and 
Fransson, 1981) and periodontal ligament (Pearson and Gibson, 1982) it has been 
described that besides a small proteoglycan, a larger proteoglycan is present 
with a higher glycosaminoglycan/protein ratio. For periodontal ligament it was 
suggested that this proteoglycan has an interfibrillar localization, a place 
where we find thick heavily staining PG-filaments. We suggest that the thick, 
heavily staining PG-filaments represent this class of proteoglycans, their 
electron microscopical appearance being the result of the higher glycosamino-
glycan/protein ratio, i.e. more glycosaminoglycan side-chains attached to the 
protein core. The main proteoglycan from cartilage which possesses about 130 
glycosaminoglycan side-chains also appears as a thick heavily staining fila-
ment (Fig. 8). Its irregular shape is probably the result of an incomplete 
collapse of the glycosaminoglycans onto the core. Interestingly, lozzo (1984) 
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isolated a heparan sulfate proteoglycan (M about 950-10 ; M core protein 
about 240-10 ), which appears as a long (maximum length 220 nm), thin fila­
ment after the Cuprolinic Blue staining procedure. The stain intensity of the 
filament is considerably less when compared to that of the cartilage proteo­
glycan, which has a core protein of similar M (about 200-10 ) but a laraer 
M (2000-3000-10 ) and a higher glycosaminoglycan/protein ratio (Hascall and 
Kimura, 1982; Schwarz et al., 19Θ5) explaining the difference in staining 
capacity. The ultrastructural appearance of a PG-filament may therefore give 
an indication of the glycosaminoglycan/protein ratio of a proteoglycan. 
The length of a PG-filament may give an indication of the molecular weight 
of the part of the protein core to which the glycosaminoglycans are attached. 
It should be noted that in the case of small proteoglycans the glycosamino-
glycan side-chain(s) will occupy a large part of the protein core after col­
lapse, even when only one glycosaminoglycan side-chain is present at the end 
of the protein core as is the case in most dermatan sulfate proteoglycans 
from bovine skin (Chopra et al., 1985) . Taking a molecular weight of HODa 
and a length of 0.2 nm per amino acid residue (Hascall, 1980), the protein 
core of the small proteoglycan (length about 60 nm) would have a M of 33-10 . 
This value approaches the M obtained for the whole protein core by biochemi­
cal methods (sodium dodecyl sulfate polyacrylamide-gel electroforesis), which 
is 40-50-10 . The cartilage proteoglycan has a maximum length of about 300 nm 
which is similar to the value obtained for spreaded molecules (Thyberg et al., 
1975). The molecular weight of the glycosaminoglycan-decorated part of the 
protein core would therefore be 165-10 . It can be calculated that the M ob­
tained by biochemical methods is about 150-10 (Hascall and Kimura, 1982). 
The glycosaminoglycan associated part of the protein core of a proteoglycan 
from human colon carcinoma cells (maximum length 220 nm, lozzo, 1984) would 
have a molecular weight of 121-10 . The M of the whole protein core is how­
ever about 240·10 , suggesting that only a part of the core is occupied by 
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the glycosammoglycans, as in cartilage. This may be due to its localization 
at the cell surface; a part of the core protein Is possibly inserted into the 
cell membrane. However, one has to be careful in applying such calculations. 
For instance, the protein core may be folded (see above); furthermore it has 
been shown for a basement membrane proteoglycan from mouse alveoli (but not 
from human alveoli. Van Kuppevelt et al., 19843, 1985a) that the length of 
the PG-filament is dependent on the MgCl_ concentration used during staining. 
The Cuprolinic Blue staining procedure might also give a clue as to which 
extraction solution may be used when a specific proteoglycan has to be iso-
lated. Interfibnllar proteoglycans can be extracted by use of 0.1 M NaCl 
(Pearson and Gibson, 1982) , while collagen fibnl-associated dermatan sulfate 
proteoglycans require harder methods such as treatment with 4 M guanidine HCl 
(Damle et al., 1982; Vogel and Heineglrd, 1985) or 2 M C3CI (Van Kuppevelt 
et al., 1985b). Cell associated proteoglycans can be solubilized by the use 
of a detergent or by mild trypsimzation (lozzo, 1984). 
In conclusion the Cuprolinic Blue staining procedure may be useful not only 
in precisely localizing proteoglycans in tissue but also in indicating the 
apparant molecular weight of the part of the protein core to which glycosami-
noglycans are attached and the glycosaminoglycan/protein ratio. Such data may 
be useful in planning a strategy for the isolation of a specific proteoglycan. 
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Ultrastructural localization and characterization of 
proteoglycans in human lung alveoli. 
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Lung alveoli ~- basement membrane — collagen —proteoghcans 
In order to localize and characterize proteoglycans in human lung 
alveoli, we have used the calióme dye С uprolmic Blue according 
to the critical electrolyte concentration method After staining, five 
types of Cuprohmc Blue positive filaments become apparent two 
types in the basement membranes oftvpe I and type II epithelial 
cells respectively and lying in one or two layers one type, more 
scattered, localized m the basement membrane of the endothelial 
cells and another kind associated with collagen fibrils and sepa 
rated from each other according ю the main banding period 
(±60 nm) of these fibrils binally, there was a type of filament 
which was only locally present at a variety of places The basement 
membrane filaments were sensitive to hepannase, hcpantinasc, 
pronase (without prefixation) and nitrous acid treatment, but not 
to Streptomyces Hyaluronidase, neuraminidase, chondroitmase 
ABC, chondroitmase AC, pronase (after prefixation) and 2 0 M 
MgCl; treatment The basement membrane filaments, therefore, 
represent heparan sulphate containing proteoglycans On the other 
hand, the collagen fibnl associated filaments were sensitive to 
treatment with hepannase, chondroitmase ABC and pronase 
(without prefixation), but insensitive to Streptomyces hyaluroni 
dase, neuraminidase, nitrous acid, hepantinase, chondroitmase 
AC, pronase (after prefixation) and 2 0 м MgCl· (after préfixa 
tion) treatment These filaments thus represent iduronic acid-rich 
derm ata η sulphate containing proteoglycans Several physiologi 
cal functions for these proteoglycans are discussed 
Introduction 
There are seven types ol glycosaminoglycans (GAGs) hya­
luronic acid, dermatan sulphate, chondroitin-4-sulphate, 
chondroitin-6-sulphdte, heparan sulphate, heparin and 
keratan sulphate GAGs are polysaccharides consisting of 
repeating disacchandcs of which one is an amino sugar, 
the other an uronic acid (with the exeption of keratan sul­
phate, which lacks uronic acid) All seven types of GAGs 
are present in the lung [8, 27], keratan sulphate being re­
stricted to only the tracheobronchial cartilage [9] In tissue 
the GAGs (except probably hyaluronic acid) are covalently 
bound to a protein core, thus forming the so called proteo-
') Drs Tom H M S M van Kuppevelt, Department of Chemical 
Cytology, Faculty of Science, University of Nijmegen, Toernooi 
veld, 6525 FD Nijmegen/The Netherlands 
glycans (PCs) Among the functions ascribed to PGs are 
those of acting as a filler barrier [11], playing a role in mor­
phogenesis [17] and absorbing compresine load [7] Histo-
chemical studies at the electron microscopic level make the 
precise localization of PGs in tissue possible, thereby pro­
viding information which may greatly attribute to the elu­
cidation of the function of the PG under study 
PGs (GAGs) are thought to play a role in several patho­
logical conditions For lung, changes in GAGs have been 
shown to occur in pulmonary emphysema [13, 16] and pul­
monary fibrosis [1, 24], data were obtained from biochemi­
cal studies However, such studies are hampered due to the 
structural complexity of the lung Alveoli, small blood ves­
sels and bronchioli are completely integrated, making it 
impossible to estimate the GAG-content of the separate el­
ements properly This may explain the conflicting data 
concerning changes in GAG-content in pulmonary emphy­
sema Histochemtcal studies do not have these limitations 
and may therefore be useful when studying pathological 
conditions 
To locali/e PGs in human lung alveoli, we have used 
the cationic phthalocyanm-like dye Cuprohmc Blue ac­
cording to the critical electrolyte concentration method 
[28] Previous studies [33, 34] have shown that this method 
is very well suited for localizing PGs at the electron micro­
scopic level 
Materials and methods 
Small lung blocks ( ± 1 mm1) were obtained from lung lobes imme 
diately after lobectomy or pneumonectomy The samples were 
taken from peripheral lung tissue, nol showing any sign of the 
process for which the patient was operated (mosti) a central carci­
noma) The lung blocks were degassed in the first solution which 
they were placed in, in order to obtain good penetration of the so­
lution 
Enzyme nitrous acid and МдСІг treatment 
Unless stated otherwise, treatment with enzymes and nitrous acid 
is preceded by prefixation of the lung blocks for 2 h (4 "С) in 
0 025 M sodium acetate buffer (pH 5 6), containing 2 5% glutaral-
dehyde Pilot expenments have shown that prefixation does not al­
ter the effects of the glycosidases or nitrous acid, the lung ultra-
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structure, however, is better preserved if prefixation is applied 
The procedures for (reatmeni with Streptomyces hyaluromdase, 
neuraminidase, chondroitinase ABC, chondroitinase AC, pronase, 
nitrous acid or MgCb have been outlined previously [34]; chon­
droitinase AC was also used at a concentration of 2 U/ml in the 
enzyme controls the enzyme has been omitted; as a control for ni­
trous acid treatment a 0 2 M sodium acetate solution with the same 
pH as the nitrous acid solution was taken 
Digestion with crude hepannase (a kind gift from Dr. A- Linker. 
University of Utah) was performed in 0.1 N sodium acetate buffer 
{pH 7.0) containing 2 mg heparinase/ml for 90 min al 37 0 C . In or­
der to prevent damage to the tissue due to proteolytic enzymes 
either from the tissue itself or as contaminants from the enzyme 
applied. 5 mM benzamidme HCl (Aldnch-Europe, Beerse, Bel­
gium) and 0.1 M 6-amino-n-caproic acid (Janssen Chimica, Beerse, 
Belgium) were added. After incubation, the specimen was washed 
once {10 min, 0 o C ) in the solution without enzyme and once 
( 10 min, 0 ^С) in 0.025 M sodium acetate buffer (pH 5 6) containing 
0-2 M MgCl and protease inhibitors. 
Digestion with heparitinase (Seikagaku Kogyo Co.. Tokyo, Ja­
pan) was as follows. After prefixation the lung blocks were washed 
twice (10 min, 0 С) in Ol N sodium acetate (pH 7.0) containing 
10 mM CaAc and protease inhibitors Incubation (2 h. 43 J C) was 
performed in the same solution containing 10 U heparitinase/ml-
Next, the tissue was washed once (10 mm. 0 C) in the solution 
without enzyme and once in 0.025 M sodium acetate buffer 
{pH 5.6) containing 0.2 M MgCl· and protease inhibitors, 
The substrate(s) of all the treatments employed are given in Ta­
ble I. After the enzyme, nitrous acid or MgCU treatment the lung 
blocks were subjected to the Cuprolinic Blue staining procedure 
(see below). 
Cuprolinu Blue sfammy 
Lung specimens were fixed (overnight, room temperature) in 
0.025 M sodium acetate buffer ipH 5 6). containing 2.5% glutaral-
dehyde. 0.2% Cuprolinic Blue (CB) (BDH-chemicals, Poole. U.K.) 
and 0 15 to 0,30 м MgCl· . When the solution became turbid, it 
was renewed. After CB staining the tissue was washed (3 times 
10 min) in the staining solution without CB, washed again (3 times 
10 min) in aq, dest, containing 1% sodium tungstate, and dehy­
drated in ascending concentrations of ethanol, the 30 and 50% 
concentrations containing 1% sodium tungstate Embedding was in 
Epon [21] In order to select alveoli for electron microscopical ex-
Fig. 1. Part of an alveolar wall The most occurring cell types are 
type I epithelial cell (ect I), type II epithelial cell (ect II), endothe­
lial cells (en) and fibroblasts (f) The basement membranes of the 
epithelial cells (alveolar basement membrane, abm) and the endo­
thelium (capillary basement membrane, cbm) are visible The 
blood-air barrier (bab) is formed by ect I, the abm, the cbm and the 
en The multilamellar bodies (mb) of ect II appear empty because 
the phospholipids have been washed out, a Alveolus, с Col­
lagen. — e Erythrocyte — Post-stained with uranyl acetate and 
lead citrate. — Bar Ι μτη. 
Fig. 2. Blood-air barrier after Cuprolinic Blue (CB) staining. — 
a. CB-positive filaments (bmf I) become apparent in the basement 
membrane of type 1 epithelial cells, they appear to lie in one 
plane. The capillary basement membrane also contains CB-posi-
tive filaments (bmf III). — Bar 0,5 μην — b. After post-staining 
with uranyl acetate and lead citrate the basement membranes of 
the type I epithelium and endothelium respectively become ob­
vious; the bmf I and bmf III respectively can be seen associated 
with them, — Note the second layer of bmf 1 Furthermore, CB-po-
sitive collagen associated filaments (caf) become apparent. — Bar 
0.5 μτη. 
aminaíion. semithin sections (Ι μτη) were stained with toluidin 
blue and basic fuchsine [2] and studied light microscopically. Ul-
trathin sections were collected on formvar or parlodion coated 
grids. When necessary, poststaimng was performed with lead ci­
trate [26] and uranyl acetate this is indicated in the legend to the fig­
ures. Sections were examined in a Philips 201 electron micro­
scope. 
Results 
C o m m o n cell types in the wall of an a lveolus (Fig. I) are 
epithel ia l cells, e n d o t h e l i a l cells a n d f ibroblasts. T h e r e are 
three types of ep i the l ia l cells: t h e s q u a m o u s type I cell, 
m a k i n g u p a b o u t 9 3 % of the total epithel ial surface (31, the 
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phospholipid producing cuboidal type II cell, accounting 
for about 7% of the epithelium and the very rare brush cell 
[22]. The epithelial and endothelial cells are accompanied 
by an alveolar and a capillary basement membrane respec­
tively. The blood-air barrier, the thin layer of tissue sepa­
rating the alveolar airspace from the blood, is formed by 
the type I epithelial cell, its basement membrane, the base­
ment membrane of the endothelium and the endothelium 
itself. The two basement membranes can be in close appo­
sition in the blood-air barrier [10]. Among the connective 
tissue elements, collagen and elastin are conspicuous. 
Cuprolinic Blue staining 
After Cuprolinic Blue (CB) staining various electron-dense 
filaments become evident. The basement membrane of 
both type I (Figs. 2a, 2b) and type II epithelial cells con­
tain CB-positive filaments. They appear to lie in one plane 
and their length is mostly within the range of 40 to 60 nm. 
A dependance of the length of the filaments on the MgCU 
concentration, as noticed in mouse lung alveoli [33], could 
not be observed. Sometimes a second layer of basement 
Fig. 3. Collagen fibrils after CB staining. No post-staining. No 
collagen fibrils can be detected; the caf, however, remain clearly 
visible; they are separated according to the main banding period 
of the fibrils ( ± 60 nm). — Note caf lying parallel with respect to 
the fibril axis (arrows). When compared to the bmf I the caf are 
less electron-dense. — rib Ribosomes. — Bar 0.25 μιτι. 
membrane filaments becomes obvious (Figs. 2b, 7a), fur­
ther away from the epithelial cell membrane; its filaments 
are somewhat shorter and form a less continuous layer. A 
second layer is not present in mouse lung alveoli [33]. The 
capillary basement membrane also contains CB-positive 
filaments (Figs. 2a, 2b); they are, however, more scattered 
and less electron-dense when compared to the alveolar 
basement membrane filaments (Fig. 2a). 
The collagen fibrils are also associated with CB-positive 
filaments (Fig. 2b). When post-staining is omitted (Fig. 3), 
the collagen fibrils are no longer visible, but the filaments 
can be easily detected. They lie, highly ordered, perpendic­
ular with respect to the fibril long axis and are separated 
from each other according to the main banding period of 
the collagen fibrils ( ± 6 0 nm); their length is about 40 nm. 
When compared to the alveolar basement membrane fila­
ments they are clearly less electron-dense (Fig. 3). Fila­
ments lying parallel to the fibril axis can also be seen 
(Fig. 3), as well as filaments connecting two fibrils. Finally, 
there is a large, heavy staining type of CB-positive filament 
(Fig. 4). These filaments are only locally present and are 
Fig. 4. Part of alveolar wall after CB staining Besides the caf 
and bmf 1, large, heavy staining filaments are present; they can be 
seen at the boundary of collagen fibrils (double mangles) and asso­
ciated with the alveolar basement membrane (single triangles). The 
epithelial cell layer has been stripped off. — Bar 0,5 μπι. 
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seen, among others, al the boundary of bundles of collagen 
fibrils and associated with basement membranes 
Without CB no filaments are visible Due to the specific 
interaction of С В with nucleic acids [28], intracellular nbo-
somes stain (big 3) 
Characterization of the CB-positwe filaments 
The CB-positive filaments localized in the alveolar and ca­
pillary basement membranes are no longer visible dfter 
treatment with crude hepannase, nitrous acid (Fig 5) or 
hepantinase (Fig 6) On the other hand, digestion with 
Streptomyces hyaluronidase, neuamimdase, chondroiti-
nase ABC (Fig 7a) or chondroitinase AC have no effect 
Treatment with pronase (after prefixation) or 2 0 м MgCh 
(with or without prefixation. Fig 10) has no influence 
cither, after digestion with pronase without prefixation, 
however, no filaments can be detected 
The stainability of the collagen associated filaments dis­
appears after digestion with crude hepannase, chondroiti­
nase ABC (Fig 7b) or pronase without prefixation (Fig 9) 
Digestion with nitrous acid, hepantinase or Streptomyces 
hyaluronidase has no influence, as is the case for treatment 
with neuraminidase, pronase (after prefixation) or 2 0 м 
MgCl, (after prefixation) Furthermore, chondroitinase 
AC has hardly, if at all, any effect on the filaments (Fig 8) 
After extraction with 2 0 м MgCI2, without prefixation, 
the filaments are partially lost (Fig 10), 0 2 м MgCl2, 
without prefixation, however, has no influence 
A summary of the effects of the various treatments on 
the basement membrane and collagen associated filaments 
is given in Table I 
Discussion 
After CB staining five types of CB-posilive filaments be­
come visible in the human alveolar wall Three types of fil­
aments are localized in the basement membrane of type I 
and type II epithelial cells respectively and of the endothe­
lial cells, another type is associated with collagen fibrils in 
a regular manner and finally there is a large heavy staining 
type of filament, which is locally present at a variety of 
places Since (he canonic dye CB is used under such con­
ditions (0 15-0 30 M MgCb) that only sulphate groups and 
nucleic acids stain [28], it is likely that the extracellular fil­
aments contain sulphate groups There is no contnbution 
of sulphated glycoproteins to the stainability of the fila­
ments since a complete disappearance of the contrast of 
the filaments is obtained following certain, specific, GAG 
degrading procedures 
Basement membrane filaments 
The specific susceptibility of the filaments to some GAG 
degrading enzymes and to nitrous acid (Tab I) malees it 
obvious that heparan sulphate (HS) is the only sulphated 
GAG present The stainability of the filaments disappears 
after pronase digestion, but not when this is preceded by 
glutaraldehyde fixation HS is therefore associated with 
protein, probably in a covalent manner, since treatment 
with 2 0 м MgClj has no effect The basement membrane 
filaments thus represent proteoglycans that contain HS 
(HSPGs), each filament probably being a PG monomer 
since this is also the case in mouse lung alveoli [33] The 
presence of HSPGs in basement membranes has been 
shown for a variety of tissues [14, 18, 19, 31, 32] A proteo­
glycan with HS as the only GAG has been isolated from 
the gas exchange tissue from bovine lung [25], the base­
ment membrane filaments might be the electron microsco­
pical visualization of such a PG The insensitivity of the 
HSPGs to extraction with 2 0 м MgCI2 (Fig 10) suggests 
that they are firmly anchored in the basement membrane, 
studies by others [12, 25] support this 
In comparison with the HSPG-filaments in the alveolar 
basement membrane of mouse alveoli [33], those described 
here are in general shorter this might reflect a larger mo­
lecular weight for the protein core of the former, since the 
filaments arc thought to be formed by the collapse of the 
GAG chains on the protein core [29, 33] 
The alveolar basement membrane HSPGs appear to lie 
closely together in one plane (Fig 2a) sometimes a second 
Tab I Effects of various treatments on the basement membrane filaments type 1, II and III (bmf I, I 
collagen fibnl associated filaments (caf) 
and 111 respectively) and on the 
Neuraminidase 
Crude hepannase 
Streptomyces hyeluronidasi 
Nitrous acid 
Hepantinase 
Chondroitinase ABC 
Chondroitinase AC 
Pronese (after prefiietion) 
Pronase (without prefiKstion) 
2 0 M MgCl] (after prefixation) 
2 0 м МдСІ! (without prefixation) 
0 2 M MgClj (without prefixation) 
Substrate' 
sialoglycoprotems 
all GAGs except keratan sulphate 
hyaluronic actd 
heparin and heparan sulphate 
heparan sulphate 
chondroitm sulphate and 
dermalen sulphate 
hyaluronic acid chondroitm sulphate end 
dermatan sulphate where it contains a 
glucuronic acid residue 
proteins 
proteina 
tome bonds 
weak юте bonds 
Effect on 
bmf) 
_ 
+ 
-+ 
+ 
-
-
-+ 
-
-
-
" The specificity of the GAG degrading enzymes has been checked eleclrophoretically on cellulose acetate strips using copper acetate as buffer [42] No effect -
λ Filaments no longer visible — ± Filaments partially lost 
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Fig. 11. Schematic representation of the localization of the \ar 
lous proleoglyLans in human lung alveoli — HSPG Heparan sul 
phatc containing proteoglycan DSPG Dermatan sulphate con­
taining proteoglycan — Note the second HSPG layer, localized in 
the alveolar basement membrane and facing the inlerstitium might 
not always be as continuous as drawn here 
layer becomes obvious The whole alveolus, therefore, con­
tains at least two envelopes of these strongly negatively 
charged molecules The possible role of these envelopes in 
regulating the diameter of the alveolus and in influencing 
transport of biomolecules (filtration) has been outlined 
previously [34] The more scattered appearance of the 
HSPGs in the capillary basement membrane together with 
their being less electron dense (Fig 2a), may indicate dif­
ferent types of HSPGs in the two basement membranes 
The large range in sulphate content of HS chains from 
lung [4, 20], might explain the difference in electron densi 
ty Differences in HSPGs may contribute to the hetero­
geneity of the alveolar and capillary basement membranes 
[10] 
Collagen associated filaments 
From the sensitivity towards various enzymatic and chemi­
cal treatments (Tab I), the filaments can be identified as 
Fig 5 Part of alveolar wall after nitrous acid treatment The bmf 
I and bmf III are no longer visible Bar 0 5 μπι 
Fig 6. Part of alveolar wall after digestion with hepantinase The 
bmf 1 cannot be delected anymore — Bar 0 5 μπι 
Fig 7 Part of alveolar wall after treatment with chondroitinase 
ABC a. The bmf I are not influenced Note Ihe double layer 
of bmf I — Bar 0 25 μπι — b The caf can no longer be detected 
Post-stained with uranyl acetate and lead citrale Bar 0 25 μπι — 
с Control ITic caf are clearly visible Post stained with uranyl 
acetate and lead citrate — Bar 0 25 μη 
Fig 8 Part of alveolar wall after treatment with chondroitinase 
AC The caf are hardly, if at all, affected Bar 0 5 um 
Fig 9. Collagen fibrils after treatment with pronase without pre-
fixation The caf are no longer visible Post slaincd with uranyl 
acetate and lead citrate — Bar 0 5 μη 
Fig. 10 Part of alveolar wall after treatment with 2 0м MgCb 
without prefixation The bmf I remain unaffected, but the caf are 
partially lost Bar 0 25 μπι 
proteoglycans that contain dermalan sulphate (DSPGs), 
the dermalan sulphate (DS) being rich in iduronic acid re­
sidues DSPGs have been isolated from a variety of tissues 
such as skin and tendon [5, 23, 35] and they are character 
ized by only few (1 4) DS chains The DSPG being less 
electron-dense in comparison with the HSPG of the alveo­
lar basemenl membrane (Fig 3) might be due to this lim­
ited number of GAG chains in the DSPG The collagen as­
sociated PG of mouse alveoli is chondroitinase AC sensi­
tive [34], in contrast, with that described here This reflects 
the presence of chondroitin sulphate and/or more glucu 
rome acid residues containing DS m the former Ц should 
be noted that the mice were young adults, while the lung 
specimens used here were from elderly patients (average 
age S8 years) Scott [30] noticed thai during maturation the 
collagen associated GAGs shifted from chondroitin sul­
phate + hyaluronic acid to DS A similar effect might ap 
pear in humans during lifetime 
The DSPGs are separated from each other according to 
the mam banding period of the collagen fibrils (Fig 3), 
DSPGs connecting collagen fibrils could also be detected 
It seems that the collagen fibrils are surrounded by these 
PCs, that they are, as it were, embedded in a DSPG matrix 
Iduronic acid-rich DS has been shown to bind specifically 
to collagenous fibres in a culture system [6] 
Laros and co workers [15, 16] have stressed the impor­
tance of the GAGs (PCs) for the mechanical stability of 
human lung parenchyma We can now, at leasl in part, ex­
acerbate this to the DSPG, by connecting collagen fibrils 
with each other the DSPG may conmbule to the lying in 
register of the fibrils and to achieve their functioning to­
gether as fibres, rather than as separate fibrils In such a 
way they may provide structural coherence as already 
pointed out in greater detail for mouse lung alveoli [34] 
Qualitative and/or quantitative alterations of the DSPGs 
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m a y c a u s e a mal funct ion of t h e col lagen fibrils, t h e r e b y 
l e a d i n g to p a t h o l o g i c a l c o n d i t i o n s 
Because of t h e varying p r e s e n c e of t h e large, h e a v y 
s t a i n i n g f i laments a n d b e c a u s e t h e m e t h o d of identif ica­
t i o n u s e d in this s tudy are n o t o p t i m a l for these s t ructures , 
the i r n a t u r e r e m a i n s to be es tab l i shed 
A r e p r e s e n t a t i o n of t h e loca l izat ion of t h e different P C s 
in h u m a n lung alveoli is given in Figure 11 
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Isolation and characterization of a collagen fibril-
associated dermatan sulphate proteoglycan from bovine 
lung. 
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JsoJation and characterization of a collagen fibril-associated 
dermatan sulphate proteoglycan from bovine lung 
Abstract 
Dermatan sulphate proteoglycans have been extracted from bovine lung with 
2.0 M CaCl„ and isolated using CsCl density gradient centrifugation, DEAE 
ion exchange chromatography, gel chromatography and preparative SDS-poly-
acrylamide gel electrophoresis. Ultrastructurally these proteoglycans are 
specifically associated with collagen fibrils. Dermatan sulphate 
3 3 (M 15· 10 - 35·10 , with a strong prevalence for the higher M ) is linked 
via an O-glycosidic bond to a protein core, which is rich in Asx, Glx and 
Leu. Of the total uronic acid, 91% is iduronic acid. A part of the glucu-
ronic acid residues is located near the protein core and a large cluster 
of disaccharides is devoid of glucuronic acid residues. 
An inhibition enzyme immuno assay has been developed to quantitate the 
proteoglycan; 50% inhibition occures at about 150 ng dermatan sulphate 
proteoglycan/ml sample. 
A model for the interaction between dermatan sulphate proteoglycans 
and collagen fibrils is proposed. 
Introduction 
During breathing the lung undergoes a constant change in volume. It might 
be expected that this characteristic calls for special demands upon the 
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pulmonary connective tissue skeleton. This applies especially to lung 
alveoli, the structural elements in which the gas exchange process takes 
place. They have to possess several "opposite" characteristics in order 
to function efficiently. Their walls have to be 1) thin, in order to 
obtain a proper gas exchange; 2) firm, in order to prevent the alveolus 
from a collapse; 3) flexible, in order to cope with the volume change 
during breathing. 
The three main components of the extracellular matrix of the lung con-
2 
nective tissue are elastin, collagen and PGs . PGs can be classified 
according to the type(s) of glycosaminoglycans they possess. The type of 
glycosaminoglycan seems to be related to the function of the PG (Poole, 
1986). For example heparan sulphate PGs, located in the glomerular 
basement membrane, play a role as selective barrier (Kanwar et al., 1980); 
the huge chondroitin sulphate/keratan sulphate PG of cartilage is involved 
in absorbing compressive load (Hascall and Hascall, 1981) , while DSPGs 
are thought to play a role in the functioning of collagen fibrils (Van 
Kuppevelt et al., 1985). Dermatan sulphate PGs have been isolated from 
a variety of collagenous tissues such as skin (Miyamoto and Nagase, 1980), 
sclera (Coster and Fransson, 1981) and tendon (Anderson, 1975; Vogel and 
Heinegard, 1985). These studies, however, do not deal with the ultra-
structural localization of the proteoglycan. We here wish to report the 
isolation and characterization of a DSPG from bovine lung as well as the 
ultrastructural localization of this PG, using the critical electrolyte 
concentration method (Scott, 1980). 
2 
The abbreviations used are: PG, proteoglycan; DSPG, dermatan sulphate 
proteoglycan; DS, dermatan sulphate; SDS-PAGE, sodium dodecyl sulphate-
polyacrylamide gel electrophoresis; TBS: 0.05 M Tris/HCl + 0.85% NaCl pH 7.5; 
TBST: TBS + 0.1% Tween 20; BSA: bovine serum albumin 
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Materials and Methods 
Materials 
Bovine lung, obtained from a local slaughterhouse, was put on ice, trans­
ported and used directly. Acrylamide, N, N'-methylenebisacrylamide, benza-
midine HCl, 6-amino-n-caproic acid, CsCl, Alcian Blue 8GX and guanidine 
HCl were all from Janssen Chimica (Beerse, Belgium). Before use the gua­
nidine HCl was treated with activated charcoal until the A (room tem-
perature, 1 cm light-path) was below 0.05. 
Chondroitinase ABC (EC 4.2.2.4), chondroitinase AC (EC 4.2.2.5), phenyl-
methylsulphonyl fluoride, iodoactamide, chondroitin-4-sulphate from whale 
cartilage, hyaluronic acid from human umbilical cord, dermatan sulphate 
from porcine skin, bovine serum albumin (fraction V) and fibronectin 
(from human plasma), were obtained from Sigma Chemical Co. (St. Louis, 
MO, U.S.A.). Dermatan sulphate from bovine lung was a kind gift from 
Dr. J.A. Cifonelli, University of Chicago, IL, U.S.A.. Toluidine Blue, 
Coomassie Blue R250, 1,9-dimethylmethylene Blue, disodium EDTA and 
Tween 20 (polyoxyethylenesorbitanmonolaurate) were from Merck-Schuchardt 
Darmstadt, F.R.G.). Basic fuchsine was from U.C.В., Brussels, Belgium. 
Papain (EC 3.4.22.2) was from Worthington (Freehold, NJ, U.S.A.). SDS and 
marker proteins for SDS-polyacrylamide gel electrophoresis were obtained 
from Serva (Heidelberg, F.R.G.). DEAE-Sephacel, Sephadex G25 (coarse) 
Sephadex G75, and CNBr-activated Sepharose 4B were from Pharmacia (Uppsala, 
Sweden). Cellulose polyacetate electrophoresis was carried out on 25.5 χ 
14.5 cm cellulose polyacetate strips (Schleicher & Schüll, Dassel, F.R.G.) 
in a semimicroelectrophoresis chamber obtained from Gelman Instrument Com-
pany (Ann Arbor, MI, U.S.A.). Protamin. HCl was from Kabi AB, Stockholm, 
Sweden. Polystyrene microtiter plates were from Costar, Cambridge, MA, 
U.S.A.; polyvinyl microtiter plates were obtained from Linbro, Flow Lab., 
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Inc. Mclean, VA, U.S.A. 
Peroxidase conjugated goat anti-rabbit igG (gamma + light Ch. Sp., purified 
by affinity chromatography) was from Tago, Inc., Burlingame, CA, U.S.A. 
Rabbit peroxidase-anti-peroxidase was obtained from American Qualex Inter-
nat., Inc., La Mirada, CA, U.S.A. 
Laminin was a kind gift from Dr. R. Timpl, Max Planck Institut für Biochemie, 
Martinsried, F.R.G. Chondroitin sulphate/keratan sulphate PG was a kind gift 
from Dr. R.J. van de Stadt, Jan van Breemen Institute, Amsterdam, The 
Netherlands. 
Type I, III, IV and V collagen were isolated from human placenta by limited 
pepsin digestion and salt precipitation (Miller & Rhodes, 1982, Abedin et 
al., 1981); stock solutions were made containg 1 mg collagen/ml 0.5 M HAc. 
Methods 
Isolation of DSPGs 
During the isolation, all seeps were carried out at 40C, unless stated 
otherwise. The following protease inhibitors were present up to DEAE-Sepha-
cel chromatography: 0.1 M 6-amino-n-caproic acid, 5 mM benzamidine HCl, 
1 mM phenylmethylsulphonyl fluoride, 10 mM disodium EDTA and 1 mM iodoace-
tamide. Lung tissue, devoid of cartilage, pleura and great vessels was 
grinded with a meat-grinder, degassed (in order to obtain a good penetra-
tion of the solutions) and centrifuged (10 min, 1500 g). After rinsing 
the tissue overnight in deionized water, centrifugation (45 min, 20,000 
g), rinsing overnight again in 0.15 M NaCl and centrifugation (45 min, 
20,000 g), the DSPGs were extracted for 3 h with 3 vol. of a CaCl 
solution, the final concentration being 2.0 M CaCl . After centrifugation 
(30 min, 20,000 g ) , the supernatant was dialyzed versus deionized water 
and the resulting precipitate, after centrifugation at 20,000 g for 45 
min, dissolved in 7 vol. 4 M guanidine HCl. CsCl density gradient centri-
fugation (Beekman SW-40 rotor, po = 1.48 g/ml, 100,000 g, 24 h) of this 
material resulted in the appearance of a gel-like substance floating at 
the top of the gradient. These "gels" were then pulverized in a chilled 
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mortar and carefully suspended in 10 vol. 2.0 M CaCl. in a potterdevice; 
the suspension was left overnight under continuous stirring. After cen-
trifugation (30 m m , 20,000 g), precipitation of the proteoglycans was 
achieved by mixing the supernatant with 3 vol. of ethanol saturated with 
sodium acetate and allowing it to stand for 5 h at -20 0C. After centnfu-
gation (30 m m , 20,000 g) the precipitate was washed once with 80% etha­
nol (2 h, -20 oC), centrifuged (30 min, 20,000 g) and dissolved in 50 vol. 
0.05 M Tns/HCl pH 6.8 containing 7 M urea and 0.30 M NaCl. Next, this 
solution was mixed with one vol. of filtered DEAE-Sephacel, previously 
equilibrated with 0.05 M Tris/HCl (pH 6.8) containing 7 M urea (starting 
buffer) and stirred for 2 h . Subsequently, the slurry was washed until 
no protein could be detected in the buffer (assayed with Α,ΗΟ'" A f t e r 
mixing with 1 vol. of starting buffer containing 0.5 M NaCl for 1 h., the 
slurry was washed with the same solution. The fractions were assayed via 
the Farndale microassay (see below), and those containing the DSPGs were 
collected. At this point two different procedures were followed: 
I. The collected fractions were pooled and CsCl was added until a po 
of 1.45 g/ml was reached, and CsCl density gradient centrifugation 
was carried out (48 h, 100,000 g). The bottom frdction (1/5 of the 
total volume) was then chromatographed on a Sephadex G-75 column 
(40 cm χ 2.5 cm) equilibrated with deionized water; the material 
eluting near the void volume, containing the purified DSPG, was col­
lected and lyophylized. 
II. The collected fractions were pooled and gel chromatography on Sepha­
dex G-75 was performed as described above. After lyophylizing, about 
10 mg of the material was subjected to SDS-PAGE (see below). The gel was 
washed overnight in 45% methanol containing 5.5% acetic acid and the DSPG 
was extracted from the gel using a electrophoretic sample concentrator 
(Model 1750, ISCO, Lincoln; NE, U.S.A.). The extracted material was subjected 
to gel chromatography on Sephadex G-25, which had been equilibrated with 
deionized water. The void volume was lyophylized. 95 
Extraction and identification of glycosaminoglycans 
Glycosaminoglycans were extracted according to a modified method of 
Hoffman (196Θ). Lung specimens were kept in aceton for 24 h at -20oC, 
dried in an exsiccator and (after grinding) further defatted in ether/ 
methanol (1:1) for 48 h (4<,C) . All other samples were used directly. 
Samples were suspended in 40 vol. of 0.75 M NaOH containing 10 mM NaBH. 
and allowed to stand for 1 h at 730C followed by chilling and neutraliz­
ing with 10 M HCl. In one case 0.1 M NaOH/10 mM NaBH was used at 40C, 
overnight. Ice-cold 20% trichloroacetic acid was then added to a final 
concentration of 5%. After 1 h on ice and centrifugation (15 min, 2000 g) 
the resulting pellet was washed once with 5% trichloroacetic acid and 
centrifuged again. The supernatants were pooled and 3 vol. of cold ethanol 
saturated with sodium acetate was added; after 24 h at 40C the mixture was 
centrifuged (15 min, 2000 g) , the pellet washed once with 80% ethanol (2 h, 
-20oC) and centrifuged again. The resulting pellet, representing the glyco­
saminoglycans, was dried and subjected to cellulose polyacetate electropho­
resis according to Stevanovich and Gore (1967) using 0.1 M copper acetate 
(pH 3.1) as buffer. Strips were stained with 0.1% Alcian Blue in 5% acetic 
acid/10% ethanol and destained in 5% acetic acid. 
Preparation of DS-peptides 
The material obtained by precipitation with ethanol (see under isolation of 
DSPG) was used as starting material. At this stage DSPG is the only PG pre­
sent (as determined by SDS-PAGE). After dissolving 600 mg of the ethanol 
precipitate in 50 ml 4 M guanidine HCl, CsCl density gradient centrifugation 
(po 1.45 g/ml, 100,000 g, 4Θ h) was carried out and the bottom fraction (1/5 
of the total) was dialysed versus deionized water and lyophylized. Papain 
digestion (enzyme : substrate = 1:100) was carried out for 24 h at 650C in 
0.05 M sodium phosphate buffer (pH 7.0) containing 1 M NaCl, 0.05 M disodium 
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EDTA and 0.01 M cysteine HCl. After precipitation for 1 h in 10% ice-cold 
trichloroacetic acid and centrifugation (8000 g, 15 min), the supernatant 
was desalted and lyophylized. DEAE-chromatography was performed batchwise 
with 0.05 M Tris HCl/0.06 M NaAc pH Θ.0 as starting buffer. After elution 
with buffer containing 0.25 M NaCl and 0.35 M NaCl the fraction eluting 
with 1 M NaCl was desalted and lyophylized. 
Molecular weight determination of DS-peptides 
DS-peptides were chromatographed on Sephadex G-200 according to Wasteson 
(1971). Fractions of 1 ml were collected and quantified using the Farndale 
microassay (see below). Lung DS (M of 40·10 ) and pig skin DS (Μ 26·10 , 
Damle et al., 1982) were used as markers. 
SDS-PAGE 
SDS-PAGE was done according to Laemmli (1970). Gradient gels (6-18%) were 
used unless stated otherwise. Molecular weight determination of the DSPG and 
the protein core was done on 10% and 12.5% gels. Gels were stained with 
0.25% Coomassie Brilliant Blue R-250, Toluidine Blue according to Rosenberg 
et al. (1985), or with periodic acidSchiff reagent according to Konat et 
al. (1984). 
Enzymetic treatments 
Digestion with Chondroitinase ABC and chrondroitinase AC was performed at 
370C for 17 h in 75 ul 0.05 M Tris/HCl - 0.06 M NaAc pH 8.0 containing 
about 1.3 mg DSPG. Both enzymes were used at a concentration of 1,7 и/ml; 
in one case chondroitinase AC was applied at a concentration of 8,5 U/ml. 
Addition of protease inhibitors had no influence. 
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Analytical methods 
PGs (glycosaminoglycans) were detected using the microassay which was de-
veloped by Farndale et al. (1982) and is based on a metachromatic shift in 
absorption maximum of 1,9-dimethylmethylene Blue. 100 yl Sample was mixed 
with 1 ml 0.0016% 1,9-dimethylmethylene Blue and the change in absorbance 
at 535 nm was determined. This method is not entirely specific (nucleic 
acids may interfere) but it provides a simple and fast way for the evalu-
ation of separation procedures. When no interfering substances are present 
the assay can be used quantitatively. 
The percentage iduronic acid of the total uronic acid content was 
assayed by measuring the amount of unsaturated glycuronosyl residues for-
med after chondroitinase digestion; a slightly modified procedure according 
to Hascall et al. (1972) was used. Briefly, DS-peptides were treated with 
chondroitinase ABC or chondroitinase AC and oxidated with 0.04 M NalO. in 
4 
0.08 M H SO . After neutralizing with 2% NaAsO in 0.5 M HCl, 0.3% thio-
barbituric acid was added. After 15 min at 100oC the chromophore formed 
was extracted into cyclohexanon (Warren, 1959) and measured spectrophoto-
metrically at 549 nm. 
Hydroxyproline content was measured according to the method of Huszar 
et al. (1980). Alkaline hydrolysis was for 2 h at 120°C. 
The presence of nucleic acids was evaluated by mixing the sample with 
an equal volume of 0.2% ethidium bromide in 0.01 M Tris HCl/1 mM disodium 
EDTA buffer (pH 8.0) (Maniatis et al., 1982). Samples were examined under 
UV illumination (254 nm). Calf thymus DNA was used as a standard. 
Amino acid analysis was performed after hydrolysis under vacuum in 
6 M HCl at 105oC for 24 h, using a Varian LC 5000 HPLC amino acid analyser. 
Electron microscopy 
The Cuprolinic Blue staining procedure, using the critical electrolyte 
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concentration method, as well as the enzymatic procedures have been out­
lined previously (Van Kuppevelt et al., 1985). Chondroitinase ABC and 
chondroitinase AC were used in a concentration of 2 U/ml for 1.5 h. Sec­
tions were poststained with 2% aqueous uranyl acetate. 
Enzyme immunoassay 
Immunization 
DSPG was isolated after SDS-PAGE, electrophoretic extraction from the gel 
and chromatography on Sephadex G-25 (see above). After lyophilization, 
DSPG was dissolved in 0.85% NaCl (1 mg/ml) and mixed with an equal volume 
of complete Freunds adjuvant. A total of 2 ml was injected subcutaneously 
in New Zealand white rabbits at different places. After 4 weeks, rabbits 
were boostered with the same amount of antigen, but mixed with incomplete 
Freunds adjuvant. Two weeks thereafter the rabbits were bleeded and the 
serum collected. 
Immunoadsorption 
About 4 mg DSPG in 0.8 ml coupling buffer (0.1 M NaHCO , 0.5 M NaCl, pH 8.3) 
was incubated with 0.5 ml of CNBr-activated Sepharose 4B slurry for 16 h 
at 40C. After blocking the remaining active groups with 0.2 M glycine 
(pH 8.0) for 16 h at 40C, the excess of adsorbed protein was washed away 
by 5 cycles of coupling buffer followed by 0.1 M HAc/0.5 M NaCl (pH 4.0). 
The gel was washed again with coupling buffer and stored at 40C in TBS 
containing 0.05% NaN . Immunoadsorption was accomplished by putting 0.5 ml 
slurry into a 1 ml column and pumping 150 μΐ serum (diluted in TBS con­
taining 1% BSA) around for 90 min. (room temperature). The column was 
washed with TBS and the bounded antibodies were eluted with 1 ml 1.0 M 
HAc. The eluens was immediately neutralized with 4 M Tris. After addition 
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of BSA to a final concentration of It, the material was dialysed versus 
TBS. 
Nonequilibnum inhibition enzyme immunoassay 
Wells of polystyrene microtiter plates were coated with protein core 
obtained by overnight digestion of DSPGs (1 mg/ml 0.05 M Tris/HCl + 0.06 
M NaAc, pH Θ.0) with chondroitinase ABC (0.1 U/ml) at 370C. After dilution 
in TBS, each well was incubated (overnight, 40C) with 100 μΐ containing 
an amount of protein core derived from 1 yg DSPG (1 ]ig DSPG equivalences). 
After incubation the wells were treated with ¿00 μΐ TBS containing 1% BSA 
for 1.5 h at room temperature and washed (3 times) with TBST. 
In the wells of round-bottomed polyvinyl microtiter plates, 50 yl of 
an antibody solution (either serum or purified antibodies were used) was 
added to 100 yl of the sample to be tested; dilutions were made in TBST 
containing 1% BSA. After incubation overnight at 4 0C, 100 yl of each well 
was transferred to a well of a polystyrene plate previously coated with 
protein core. The free antibody was allowed to complex with the coated 
antigen for 30 m m (nonequilibnum condition, Rennard et al., 1980). 
After washing three times with TBST, the antibodies bound to the protein 
core were detected by incubation (1.5 h, room temperature) with goat anti-
rabbit IgG conjugated with peroxidase (1:1000 in TBST containing 1% BSA). 
After washing, 100 yl of a peroxidase-anti-peroxidase complex (1:500 in 
TBST containing 1% BSA) was added and incubation was for 1.5 h at room 
temperature followed by washing. Subsequently 100 yl of enzyme substrate 
(0.04% o-phenylenediamine and 0.016% H.O in 24 mM citric acid/51 mM 
Na HPO ) was added and the reaction was allowed to proceed for 30 rain at 
room temperature and stopped by addition of 100 yl 4 M H-SO . The colour 
developed was spectrophotometrically measured at 492 nm using a Titertek 
multiscan. 
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Direct enzyme immunoassay 
In this assay, serum is added directly to the coated polystyrene micro-
titer plates. Before coating with DSPG, papaine-digested DSPG, DS and 
calf thymus DNA, wells were pre-incubated for 2 h at room temperature, 
with 100 yl TBS containing 50 \ig protamine HCl (Faaber et al., 1984). 
Papaine treatment of DSPGs was done according to CSster and Fransson 
(1981). Collagene, fibronectin and laminin were diluted in 0.02 M car­
bonate buffer, pH 9.6 (Rennard et al., 1980) to a final concentration 
of 10 pg/ml. All other coating substances were diluted in TBS to a final 
concentration of 10 yg/ml, except for DNA (25 yg/ml). Wells were coated 
with 100 ul overnight at 40C. After blocking with TBS containing 1% BSA 
and washing 100 μΐ of serum diluted 1:1000-1:9000 with TBST containing 
1% BSA, was added. Incubation with serum, goat anti-rabbit IgG conjugated 
with peroxidase, and peroxidase-anti-peroxidase complex (see above) was 
either for 30 min at 370C (Rosenberg et al., 1984) or 1.5 h at room tem­
perature. Detection of peroxidase was as described above. As a control, 
pre-immune serum instead of immune serum was used. 
Results 
Ultrastructural localization of DSPGs. 
PGs appear as electron-dense filaments after the Cuprolinic Blue staining 
procedure (Van Kuppevelt et al., 1985). The PGs associated with collagen 
fibrils from alveolar septa (Fig. la) are regularly arranged and separated 
from each other according to the main banding pattern of these collagen 
fibrils (about 60 nm). Most PGs are located perpendicular with respect to 
the collagen fibril axis although some have a parallel orientation. The 
collagen fibril-associated PGs are sensitive to chondroitinase ABC (Fig. 
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Fig. 1. Collagenous area in a bovine alveolus after the Cuprolinic Blue 
staining procedure. Poststained with uranyl acetate. Bar: 150 nm. 
a) Proteoglycans (PCs) are associated with collagen fibrils (c) and 
are separated from each other according to the main banding period 
(about 60 nm) of the collagen fibrils. Note PCs (big arrows) lying 
parallel with respect to the collagen fibril axis. 
b) After digestion with chondroitinase ABC, no proteoglycans can be 
observed. 
c) After treatment with chondroitinase AC, the proteoglycans appear 
hardly affected. 
Fig. 2. Collagenous area in the wall of a small blood vessel of lung after 
the Cuprolinic Blue staining procedure. Poststained with uranyl acetate. 
Bar: 150 nm. Proteoglycans (PCs) are present similar to those associated 
with alveolar collagen fibrils. 
Fig. 3. Collagenous area of lung after some purification steps. 
The Cuprolinic Blue staining procedure has been applied. Poststained 
with uranyl acetate. Bar: 150 nm. 
a) Collagenous area after grinding, degassing and rinsing in deionized 
water and 0.15 M NaCl. These treatments have no effect on the amount 
or location of the collagen fibril-associated proteoglycans (PCs), 
b) Collagenous area after treating the lung tissue with 2 M СаС1
г
. 
For further experimental details see the text. The collagen fibrils (c) 
are swollen; no proteoglycans are detectable. 
Fig. 4. Gel-like material obtained after CsCl density gradient centri-
fugation of the material extracted with 2 И CaCl2. For further details 
see the text. Stained according to the Cuprolinic Blue procedure. 
Poststained with uranyl acetate. Bar: 150 nm. 
Proteoglycans (PCs) resembling those associated with collagen fibrils 
are abundant. 
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lb) while chondroitinase AC has hardly any effect (Fig. 1c); this indi-
cates that they represent DSPGs. PGs associated with collagen fibrils from 
the wall of small bloodvessels (Fig. 2) and bronchioli are similar to those 
of alveoli with respect to their orientation as well as their sensitivity 
towards the glycosidases. The PGs are predominately located at the d-band 
of the collagen fibrils and in general 2-3 perpendicularly orientated PGs 
are present for each D-period. 
Isolation of DSPGs. 
The starting lung material contains hyaluronic acid, heparan sulphate, der-
matan sulphate , chondroitin sulphate and some heparin (Fig. 5a). Grin-
ding, degassing and rinsing in deionized water and in 0.15 M NaCl have no 
influence on the location or amount of DSPGs associated with collagen fi-
brils (Fig. 3a); hyaluronic acid is partially extracted by these treatments. 
Subsequent treatment with 2 M CaCl« results in the extraction of the 
DSPGs ; the collagen fibrils remaining behind appear to be swollen 
(Fig. 3b). Dialysis of the 2 M Caci extract versus deionized water results 
in a precipitate which, after CsCl density gradient centrifugation, reveals 
a gel-like substance (p = 1.26 g/ml) floating at the top of the gradient. 
This "gel" contains DS as the predominant glycosaminoglycan; small amounts 
of heparan sulphate and chondroitin sulphate, however, are still present. 
Electron microscopical observation (Fig. 4) indicates that the "gel" con-
tains PGs resembling to those associated with collagen fibrils as observed 
in situ; no collagen fibrils can be detected. The Hyp content is 1.0 vq/mq 
gel. Partially dissolving the gel-like substance in 2 M CaCl- followed by 
treatment of the extract with ethanol saturated with sodium acetate results 
in a precipitate in which DS is the only glycosaminoglycan present (Fig. 5b). 
DEAE-Sephacel Chromatography of this precipitate reveals one fraction posi-
tive in the Farndale assay and eluting at 0.5 M NaCl (Fig. 6). After CsCl 
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Fig. 5. CeiJulose polyacetate electrophoresis of 
glycosaminoglycans (GAGs) extracted from material at 
various stages of the isolation procedure. 
a) GAG-composition of the lung. Hep: heparin. 
b) GAG-composition of the material extracted from 
the gel-like material obtained after CsCl density 
gradient centri fugation. For further details see 
the text. 
c) Reference GAGs. HA: hyaluronic acid; HS: heparan 
sulphate; DS: dermatan sulphate; CS: chondroitin-4-
sulphate. 0.5 ug of each GAG was applied. 
d) GAG-composition of the isolated proteoglycan. 
Because an overload of GAGs was applied, the centre 
__ of the DS-band appears unstained. 
ΔΑ280 Fig. 6. DEAE-Sephacel chromatocjraphy of the 
material extracted with 2 M Cad2 from the gel­
like material obtained after CsCl density gradient 
centrifugation. After precipitation with ethanol 
saturated with sodium acetate, the pellet was 
dissolved in 0.05 M Tris/HCl pH 6.8 containing 
7 M urea and 0.3 M NaCl and subjected to DEAE-
Sephacel chromatography. Elution was performed 
with starting buffer containing 0.5 M NaCl and 
1.0 M NaCl, respectively. Separation was done 
batchwise. Protein was detected via the A ; 
glycosaminoglycans were assayed by measuring 
the shift in absorption maximum (A ) of 
1,9-dimethylmethylene blue according to 
Farndale et al. (1982). 
10 Fraction number 
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Fig. 7. Gel chromatography on Sephadex G-75 of 
the 0.5 M NaCl fraction obtained after DEAE-
Sephacel chromatography. Elution was performed 
with deionized water. The presence of protein was 
assayed by measuring the A ; glycosaminoglycan 
detection was done by measuring the shift in 
absorption maximum (Α^-,ι-) o f 1,9-dimethyl-
methylene blue according to Farndale et al. 
000 Each fraction represents about 5 ml. 
(1982) . 
density gradient centrifugation of this fraction, DSPG is about equally 
distributed along the gradient (p = 1.43-1.55 g/ml); the bottom fraction, 
however, contains only one contaminating low-molecular weight protein which 
can be removed by gel-chromatography on Sephadex G-75. The peak eluting 
near the void volume contains the purified DSPG. DSPG is obtained in higher 
yield, however, when the second CsCl density gradient centnfugation step 
is omitted. In this case, the material eluting at 0.5 M NaCl is chromato-
graphed directly on Sephadex G-75 (Fig. 7) and the material eluting near 
the void volume is subjected to SDS-PAGE. DSPG is electrophoretically ex­
tracted from the gel. Only a trace of nucleic acids (about 0.1%) can be 
detected in this preparation. 
Characterization of the DSPG. 
After SDS-PAGE, the DSPG appears as a single broad Coomassie Blue-positive 
band, which also stains with periodic acid-Schiff reagent and metachroma-
tically with Toluidine Blue (Fig. Θ). Addition of 0-mercaptoethanol has no 
influence. The M of the DSPG is 50· 10 -80-10 . Staining with Toluidine 
Blue and periodic acid-Schiff reagent also reveals a less intense, slower 
migrating broad band (Fig. 8), its midpoint corresponding to a M of 
100-10 . Cellulose polyacetate electrophoresis reveals that DS is the 
only glycosaminoglycan present (Fig. 5d); its mobility is somewhat slower 
when compared to DS from pig skin. Of the total uronic acid content 91% 
is iduronic acid; in DS from pig skin we found 86% iduronic acid, a 
value which is in good agreement with the literature (Damle et al., 19Θ2). 
The M of the protein core, obtained after digestion with chondroitinase 
ABC, is 17-10 . It should be noted that the protein core is much more 
Coomassie Blue-positive than the intact DSPG; the protein core did not 
stain with Toluidine Blue (Fig. 8). Only when a large overload was applied, 
the protein core faintly stained with periodic acid-Schiff reagent. In 
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from 
Fig·. S. SDS-polyacrylamide gel electrophoresis of 
the dermatan sulphate proteoglycan (DSPG) before 
and after treatment with chondroitinase ABC. 
a-f: Coomassie Blue staining. 
g,h: Toluidine Blue staining. 
i,j: periodic acid Schiff reagent staining. 
a) reference protein: cytochrome с (M 12.5· 
b) reference proteins : bovine serum albumin 
(M 68-1Q ) , ovalbumine (only weakly visible, 
Μ
 Ι45·10 ) , carbonic anhydrase (M 29-10 ;. 
с, g, i) DSPG. 
d) reference proteins: Phosphorylase В 
(M 92.5-10 ;, bovine serum albumin, ovalbumin, 
carbonic anhydrase and cytochrome c. 
e, h, j) DSPG after treatment with chondroitinase 
ABC. 
f) chondroitinase ABC. 
И. 
• a " 
dye front f 9 
Fig. 9. SDS-polyacrylamide gel electrophoresis of the 
dermatan sulphate proteoglycan (DSPG) after NaOH/NaBH 
treatment. 
a - c: Coomassie Blue staining. 
d-g: Toluidine Blue staining. 
a, e) DSPG after treatment with 0.1 M NaOH/10 mM NaBH 
at 4 C, overnight. The position of the protein core 
is indicated. 
0.75 M NaOH/10 mM NaBH b, d) DSPG after treatment with 
for 1 h at 730C. 
c) reference proteins: bovine serum albumin 
ovalbumin (only weakly visible, Μ 45·10 ) , 
(Μ 68·103). 
carbonic anhydrase 
f) reference DS (M 
(M 29-10 
4b-10 ) . 
g) reference DS (if 26·10 ) . 
) and cytochrome с (M 12. 
г 
5·10 ) . 
ι 'ι 
ι 
d β f g 
Fig. 10. SDS-polyacrylamide gel electrophoresis of the 
dermatan sulphate proteoglycan (DSPG) after treatment 
with chondroitinase AC. 
a-c: Coomassie Blue staining. 
d-g: Toluidine Blue staining. 
a) reference proteins: carbonic anhydrase (M 29-І0 ; 
r 
and cytochrome с (M 12.5·10') 
b) DSPG after chondroitinase AC treatment (1.7 U/ml). 
The protein core is indicated. 
c) chondroitinase AC. 
d) DSPG after chondroitinase AC treatment (8.5 U/ml). 
e) DSPG. 
f) reference DS (M 40·10 ) . 
g) reference DS (bf 26-10 ) . 
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case of a large overload, also a protein core with a M of about 45-10 
r 
becomes detectable. Amino acid analysis of the DSPG (Table I) indicates 
that the protein core is rich in Asx, Glx and Leu residues. 
Chromatography on Sephadex G-200 indicates that the M of the DS-pep-
tides ranges from 15·10 -35-10 , with a strong prevalence for the higher 
molecular weights. SDS-PAGE of DS obtained after treatment with 0.1 M 
NaOH/10 mM NaBH (Fig. 9) also shows that the majority of the DS is in 
the upper part of that range (30-10 -35-10 ). When DSPG is subjected to 
treatment with 0.1 M NaOH/10 mM NaBH at 40C, overnight, a large part is 
split into the protein core and DS (Fig. 9). When digestion is performed 
at harder conditions (0.75 M NaOH/10 mM NaBH , 1 h, 73 0Ο , the protein 
core is largely degraded while the liberated DS has a somewhat lower M 
when compared to that obtained after mild treatment (Fig. 9). 
Digestion of the DSPG with chondroitinase AC (Fig. 10) results in the 
appearance of the protein core and DS of which a large part comigrates 
with pig skin DS, even when the enzyme is applied at a concentration of 
Θ.5 U/ml. Smaller fragments, however, also occur. 
Inhibition enzyme immunoassays and/or direct enzyme immunoassays demon­
strate that the anti-DSPG antiserum reacts with DSPG and protein core, but 
not with type I, III, IV and V collagen, laminin, fibronectm and DNA 
(data not shown). It also does not react with papaine-digested DSPG and 
DS, indicating that the antibodies are raised against the protein core 
rather than the DS. The purified antibodies react equally well with DSPG 
and protein core (Fig. 11); they do not bind with a chondroitin sulphate/ 
keratan sulphate PG from cartilage. The DSPG concentration required for 
50% inhibition was about 150 ng/ml sample (Fig. 11). 
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As χ 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
Val 
Cys 
Met 
He 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
116 
42 
69 
130 
90 
79 
61 
57 
nda 
9 
51 
12Θ 
13 
32 
60 
28 
35 
Table I. Amino acid composition of the dermatan sulphate 
proteoglycan. Values are expressed as residues per 
1000 residues and are not corrected for destruction 
during hydrolysis. a: not determined. 
ι ι ι ι ι ι ι ' ι i _ _ 
03 08 27 82 25 74 222 666 2000 6000 
test Bubstance (ng) 
Fig. 11. Inhibition enzyme immunoassay with purified antibodies raised 
against dermatan sulphate proteoglycans (DSPGs). 
100 \il of test substance was incubated overnight, 4 C, with purified 
antibodies. Next, 100 μ2 of this mixture was transferred to a corresponding 
well previously coated with an amount of protein core derived from 1000 ng 
DSPG after digestion with chondroitinase ABC (i.e. 1000 ng DSPG equivalences) . 
After incubation for 30 min. at room temperature, the antibodies bound to the 
well were detected as described in the text. The absorbance at 429 nm is 
expressed as a percentage in comparison with that without the test substance, 
which is taken as 100%. 
• · · .· DSPG 
·- -•- -• .· protein core as expressed in DSPG equivalences 
0—-0 O; chondroitin sulphate/keratan sulphate proteoglycan 
from cartilage. 
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Discussion 
Electron microscopical study shows that collagen fibrils in lung are asso­
ciated with small proteoglycans; enzymatic digestions reveal that these 
proteoglycans contain dermatan sulphate rich in iduronic acid residues. 
Chondroitinase ABC sensitive PGs have been shown to occur in sheep lung 
(Sampson et al., 1979) while it has also been reported that DSPGs are pre­
sent in rabbit and bovine lungs (Radhakrishnamurty et al., 1980, 19Θ5). 
A major concern in the isolation of PGs is the possibility of degradation. 
3 3 
The major DSPG isolated in this study has a M of 50-10 -80-10 and a 
protein core with a M of 17-10 . Usually we also observed a larger DSPG. 
The midpoint of the broad band representing this DSPG corresponds to a 
M of about 100-10 . When applying an overload, a protein core became 
detectable with a M of about 45-10 . Recent information on DSPGs from the 
lungs of guinea pigs and rats indicate a M of 100-10 for the PG and a M 
of about 47-10 for the protein core (Hernnas et al., 1986). Furthermore, 
small DSPGs isolated from a variety of collagenous connective tissues 
3 3 
seem to have a M of about 100-10 and a protein core with a M of 40-10 -
60-10 (Heinegard et al., 1985; Hasseil et al., 1986). In the light of 
these literature data it may be possible that the major DSPG isolated 
in this study is not the intact PG. Despite the presence of protease 
inhibitors, the protein core could have been degraded; in this case, the 
observed larger DSPG could be the intact DSPG with a protein core with 
a M
r
 of about 45-10 . 
DSPGs were extracted with 2.0 M CaCl_. Although in most studies 4 M 
guanidine HCl is used for extraction of the DSPG, 2 M CaCl has (in our 
case) the advantage of leaving most other PGs (e.g. heparan sulphate PGs 
from basement membranes) behind in the residue. During CsCl density gra-
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dient centrifugation a gel-like substance (p: 1.26 g/ml) is formed con­
taining DSPG as the predominant PG. This material contains no collagen 
fibrils and only little collagen (as judged by the Hyp content). In a 
study on cardiac valve PGs, Honda et al. (1977) mentioned a similar gel­
like substance at the top of the gradient; it contained < 1% Hyp, had a 
ρ of 1.32 g/ml and was composed predominantely of DSPG and glycoproteins. 
ftt present we cannot explain the gel formation. 
The DSPG of lung contains a very high content of iduronic acid resi­
dues compared to those of other tissues (Poole, 1986). After digestion 
with chondroitinase AC, which digests DS only where it contains a glucu­
ronic acid residue, a considerable portion of the DSPGs is split into the 
protein core and a DS which comigrates with pig skin DS (M about 26-10 ). 
This indicates that a part of the glucuronic acid residues is located near 
the protein core as in pig skin DSPG (Fransson & Malmström, 1971). It 
furthermore points to the presence of a large cluster of disacchandes in 
the DS-chain lacking glucuronic acid residues. In an ultrastructural study 
on DSPGs from human alveoli, we found that chondroitinase AC has no effect 
when applied for 90 m m at 2 U/ml (Van Kuppevelt et al., 1985); however, 
when digestion is performed for 16 h at 4 U/ml the DS is split off (un-
published results). A possible explanation is that the enzyme may come 
close to the protein core only at an elevated concentration and a prolong-
ed incubation time. This also indicates that glucuronic acid residues are 
positioned near the protein core. Since DS is degraded by chondroitinase 
AC into fragments of various molecular weights it is likely that glucu-
ronic acid residues also occur in other regions of the DS-chain. 
After treatment with 0.1 M NaOH/10 mM NaBH , the DSPGs are split into 
the protein core and DS. Mild alkaline/borohydride treatment is known to 
split O-glycosidic bonds between protein and sugar-chain through the pro-
cess of ^-elimination (Stern et al., 1971; Spiro, 1972). N-Glycosidic bonds 
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are not affected, provided that the borohydride concentration is sufficient-
ly low (Rasilo & Renkonen, 1981). This result therefore indicates that an 
O-glycosidic linkage exists between DS and protein core. Xylose and serine 
are involved in this linkage in pig skin DSPG (Stern et al., 1971). 
Taking together the data on the DSPG, a model can be constructed in 
which a small protein core bears, via O-glycosidic bond(s), 1-3 DS chains 
rich in iduronic acid residues. The lung DSPG seems to belong to a class 
of DSPGs, derived from collagenous tissues, and characterized by a rela-
tively low M , a small protein core rich in Leu, Asx and Glx, a relative-
ly high protein/glycosaminoglycan ratio and one or few iduronic acid-rich 
DS-chains (Miyamoto & Nagase, 1980; Fujii & Nagai, 1981; Coster & Fransson, 
1981,- Pearson & Gibson, 1982; Uldbjerg et al., 1983; Nakamura et al., 1983; 
Vogel & Heinegârd, 1985). These DSPGs seem to be immunologically related 
to each other (Heinegârd et al., 1985). 
During the Cuprolinic Blue staining procedure, the glycosaminoglycan 
side chains collapse onto the protein core (scott, 1980; Van Kuppevelt, 
1984), thereby causing the PGs to appear as filaments rather than extended, 
open structures. This means that the electron-dense filaments indicate the 
location of the protein core. It might therefore be argued that it is the 
protein core that specifically binds to the collagen fibril. An interaction 
between collagen and the protein core of a small DSPG of tendon has been 
noted (Vogel et al., 1984). For each D-period there would be 2-3 DSPG mole-
cules orientated perpendicularly with respect to the collagen fibril axis. 
The bond between collagen and the protein core is probably (at least part-
ly) ionic in nature since DSPGs can be removed from the collagen fibril by 
treatment with 2 M MgCl (Van Kuppevelt et al., 1984a) or 2 M CaCl . Glutar-
aldehyde, which fixes proteins (Cheung and Nimni, 1982), prevents removal 
(Van Kuppevelt et al., 1984a). The protein core is rich in Asx and Glx and 
may therefore contain a considerable amount of acidic amino acids. In a part 
of a protein core of a DSPG from bovine skin all Asx and Glx are present as 
Asp and Glu, respectively (Pearson et al., 1983). Such amino acids would 
favour an ionic bond and may bind to the basic amino acids of the d-band to 
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: PROTEIN CORE 
¡DERMATAN 
SULPHATE-CHAIN 
-unniiCONTACT ZONE 
¡COLLAGEN FIBRIL 
¡COLLAGEN FIBRIL 
Fig. 12. Schematic model of the interaction between dermatan sulphate proteoglycans 
(DSPGs) and collagen fibrils, a) lateral view; b) top view). 
The protein core of the DSPG binds specifically to the collagen fibrils, while the 
dermatan sulphate chains bind to each other. In addition, dermatan sulphate chains 
binding to collagen fibrils occur, as well as protein cores interconnecting fibrils. 
In this was the DSPG may act as a cementing substance and link collagen fibrils 
together, thereby providing structural coherence. 
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which the protein core is predominantely associated. The question as to 
why it is the d-band, remains unanswered; other bands on the collagen fi-
bril contain basic amino acids as well (Tzaphlidou et al., 1982; Chapman 
et al., 1981). Studies on DSPGs from bovine sclera (Fransson et al., 1982) 
have shown that DSPGs are capable of self-association, DS being of major 
importance. Taking a length of 1 nm/disaccharide (Atkins & Isaac, 1974; 
Hascall, 1980), a DS-chain of 35 kDa would be about 80 nm, which is long 
enough to enable association with DS-chains from other DSPGs (e.g. located 
on adjacent collagen fibrils). Taking together these data we propose the 
following model (Fig. 12). The protein core of a DSPG is attached speci-
fically to a collagen fibril while the DS-chain(s) is (are) associated to 
DS-chains of other DSPGs. Binding of DS-chains to collagen fibrils may 
also occur as well as protein cores connecting collagen fibrils to each 
other. In this way DSPGs link collagen fibrils to each other and form a 
stable matrix. The possible physiological function of DSPGs has been dis-
cussed elsewhere (Van Kuppevelt et al., 1984a, 1985). Whether or not 
fibronectin, which is also periodically distributed along a collagen 
fibril (Yamada, 1981; Torikata et al., 1985), plays a role in the DSPG-
collagen interaction remains to be established. 
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By use of the cationic dye Cuprolinic Blue in a critical electrolyte 
concentration method, heavily staining, generally large, filaments 
have been demonstrated in human lung alveoli. In some lung spec­
imens they are abundant, while in others they are very scanty. The 
filaments are seen: I) around bundles of collagen fibrils, 2) at 
places which seem electron microscopically almost empty. 3) asso­
ciated with basement membranes 4) around elastin, and 5) some­
times associated with individual collagen fibrils. After poststaining 
tiny threads —connecting the filaments— could sometimes be ob­
served. The filaments are resistant to treatment with nitrous acid, 
heparitinase or pronase after prefixalion. After digestion with 
chondroitinase ABC, chondroitinase AC or pronase without pre-
fixation. the filaments are no longer detectable. The tiny threads 
are chondroitinase ABC resistant. It is concluded that the Cupro­
linic Blue-positive filaments represent proteoglycans which contain 
chondroitin sulfate and/or glucuronic acid-rich dermatan sulfate. 
The possible role of these proteoglycans in tissue repair is dis­
cussed. 
Introduction 
Proteoglycan monomers can be visualized at the electron 
microscopical level by using the cationic dye Cuprolinic 
Blue according to the critical electrolyte concentration 
method 114]. In such a way we have localized in human 
lung alveoli heparan sulfate-containing proteoglycans as 
well as dermatan sulfate (DS)-containing proteoglycans 
1191. We furthermore reported on the presence of a large, 
heavily staining filament which, however, could not be 
characterized at that time. In this paper we now wish to 
describe the ultrastructural localization and characteriza­
tion of this Cuprolinic Blue-positive filament. 
Materials and methods 
Human lung specimens were obtained as described previously 
[191. 
" Drs. Toin H. M. S. M. van Kuppevelt, Department of Chemical 
Cytology, Faculty of Science, University of Nijmegen, Toernooi-
veld, 6525 ED Nijmegen/The Netherlands. 
Enzyme and nitrous acid trcafmcni 
Due to the large amount of staining material bound lo the Cupro­
linic Blue-positive filaments, the incubation times and or enzyme 
(nitrous acid) concentrations used before |19]. had to be increased 
in most cases. Table I gives the incubation times and the enzyme 
(nitrous acid) concentrations applied in this stud> ; the substrate(s) 
sensitive to these treatments are indicated as well. Other parame­
ters {e.g. /JH, temperature, buffer) remained the same [19]. In all 
Fig. I. Part of an alveolar wall. The epithelium is formed by the 
squamous type I epithelial cell (ect I) and the cuboidal type II epi­
thelial cell (ect II), both associated with an alveolar basement 
membrane (abm). Furthermore, endothelial cells (en) with their ca­
pillary basement membrane (cbm) and fibroblasts (0 are pres­
ent. — cap Capillary. — с Collagen fibrils. — leu Leucocyte. — a Al­
veolar airspace. — Post-stained with uranyl acetate and lead ci­
trate. — Bar 2 μπι. 
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cases, except prondse, the enzyme or nitrous acid treatment is pre­
ceded by prefixation with 2 S0« gluiaraldehyde in 0 025 M sodium 
acetate buffer (pH 5 6) for 2 h (4 Χ) After the enzyme or nitrous 
acid digestion the lung specimens are subjected to the Cuprohnic 
Blue staining procedure 
Cuprohnic Blue staining procedure 
The Cuprohnic Blue staining method has been outlined previously 
[19] Briefly, the lung blocks are fixed overnight (room tempera­
ture) in 0 025 M sodium acetate buffer (pH 5 6) containing 2 5% 
gluiaraldehyde, 0 2% Cuprohnic Blue and 0.2 M MgCh After 
washing in buffer without Cuprohnic Blue, the specimens are 
nnsed in aq dest containing 1% sodium tungstate and dehydrated 
in ascending concentrations of ethanol where the 30 and 50% con­
centrations contain 1Q/o sodium tungstate. The tissue is embedded 
in Epon Ultrathin sections are examined ¡n a Philips 201 electron 
microscope When necessary, poststdining with uranyl acetate 
(with or without lead citrate) is applied. 
Results 
Figure 1 depicts the cell types and their extracellular prod-
ucts commonly found in human alveoli. Among them are 
type I and type II epithelial cells and their alveolar base-
ment membranes, endothelial cells with their capillary 
basement membrane and fibroblasts. In the extracellular 
matrix the collagen fibrils are obvious. As described pre-
viously [19], heparan sulfate-containing proteoglycans are 
localized in the basement membrane while DS-containing 
proteoglycans, neh in iduronic acid residues, are asso-
ciated with collagen fibrils We also made mention of a 
large, heavily staining Cuprolinic Blue-positive filament; 
this will now be studied further. 
Ultrasfructural localization of the heavily staining filaments 
(hsf) 
In general, the hsf are large (upto 200 nm), but smaller 
forms exist. In some lung blocks they are abundant, while 
in others they are very scanty. One of the main places at 
which they appear is around bundles of collagen fibrils 
(Figs. 2a, b), although they may also be associated with in-
dividual fibrils (Fig 3) Furthermore, they can be seen in 
association with basement membranes (mainly at the inter-
stitial side, Fig. 4) and in places which seem electron mi-
croscopically almost empty (Fig 5). To a lesser extent the 
hsf appear associated with elastin (Fig. 6). At places where 
type II epithelial cells transform into type I epithelial cells 
they are often associated with the basement membrane 
(Fig. 7). Sometimes the hsf are connected with each other 
by very tiny threads (Fig. 2a), which are visible only after 
poststaining. 
Characlerizalion of the hsf 
The main difficulty in charactenzing the hsf lies in their 
capricious occurrence, only lung specimens in which they 
were abundant were used for studying their chemical na-
ture After treatment with nitrous acid (2 or 24 h. Fig. 8), 
heparitinase or pronasc following prefixation the stainabil-
ity of the hsf is unaffected. Digestion with chondroitinase 
ABC (Fig 9) or chondroitinase AC (Fig. 10) results in a 
disappearance of this stainability, although after relative 
short incubation times (2 h) some remnants may be pres-
ent. After digestion with pronase without prefixation no 
hsf can be detected. Table 1 summarizes these results. The 
tiny threads, connecting the hsf, appear to be chondroiti-
nase ABC resistant, when applied during 45 mm, and I U/ 
ml 
Discussion 
The regular morphology of the filaments indicates a defi-
nite structure rather than an accidental cluster of smaller 
elements. From Table I it may be concluded that the Cu-
prolinic Blue-positive, heavily staining filaments represent 
proteoglycans (PCs). The glycosammoglycans of these 
PCs are chondroitin sulfate (CS) and/or DS which is rich 
in glucuronic acid residues (compare the intact staining ca-
pacity of the small collagen-associated DSPG in Figure 10 
after chondroitinase AC). The length of this CS/DSPG is 
rather large, probably reflecting a large protein core [17]: 
its heavy staining character points to the presence of many 
sulfate groups (carboxylic groups do not contribute to the 
contrast of the filaments because of the MgCU present 
during staining [13]). In this way the CS/DSPGs resemble 
the well known cartilage PCs [5]. The PCs may be synthe-
Tab. I. Incubation time, concentration, substrate and the effect on the heavily staining filaments (hsf) of the enzyme and nitrous acid 
treatmenls used for characterization 
Treatment 
Chondroitinase ABC 
Chondroitinase AC 
Hepentinese 
Nitrous acid 
Pronase (after ргеііне(іоп) 
Pronase (without préfixât ton) 
No effect - + Filaments no longer 
Incubation time 
90 mm 
16 h 
90 mm 
16h 
2h 
2h 
24 h» 
45 mm 
2h 
45 mm 
2h 
visible — + ' 
Concentration 
2 U/ml 
4 U/ml 
2 U/ml 
4 U/ml 
10 U/ml 
15 U/ml 
IS U/ml 
1
 Sometimes remnants are present -
Substrate(s) 
chondroitin sulfate and 
dermalen sulfate 
chondroitin sulfate 
hyaluronic acid and demtetan 
sulfate where π contains 
a glucuronic acid residue 
heparan sulfate 
heparan suHate end 
heparin 
proteins 
proteins 
- " The nitrous acid solution was renewed three times 
Effect on hsf 
+ · 
+ 
+ • 
+ 
-
-
-
+ 
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Fig. 9. Collagenous area after digestion with chondroitinase 
ABC for 90 min. The hsf as well as the dermatan sulfate-contain-
ing proteoglycans are no longer visible. — Post-stained with uranyl 
acetate and lead citrate. — Bar 0.25 μηι. 
sized by fibroblasts; it has been shown [4] that human skin 
fibroblasts in culture produce DS rich in iduronic acid as 
well as in glucuronic acid. The thread-like structures, con­
necting the PGs do not contain sulfate groups, as they are 
only contrasted by post-staining. Corresponding structures 
have been observed in embryonic cornea [8] and aorta [5]; 
the filaments in the cornea were Hyaluronidase sensitive. 
Fig. 2. Collagen-rich area in alveolar wall after Cuprolinic Blue 
staining.— a. Part of a bundle of collagen fibrils surrounded by 
heavily staining filaments (hsf)· Tiny threads farrows) sometimes 
arise from the hsf. Note the dermatan sulfate-containing proteo­
glycans (DSPG) associated with collagen fibrils. — Post-stained 
with uranyl acetate and lead citrate. — Bar 0.25 μηι. b. Collagen 
bundle surrounded by hsf. Because the post-staining has been 
omitted, the fibrils themselves are not visible: the DSPG, however. 
mark their localization. Bar 0.5 μηι. 
Fig. 3. Heavily staining filaments (hsf) associated with Individual 
collagen fibrils. In general, the hsf lie perpendicular or parallel in 
respect to the collagen fibril long axis. — Post-stained with uranyl 
acetate and lead citrate. — Bar 0.5 μτη. 
Fig. 4. Heavily staining filaments (hsf) associated with the inter­
stitial side of the alveolar basement membrane (abm). — HSPG 
Heparan sulfate-containing proteoglycan. — a Alveolar air­
space. — Bar 0.5 μηι. 
Fig. 5. Heavily staining filaments (hsf) localized in areas which 
seem electron microscopically almost empty. — Post-stained with 
uranyl acetate and lead citrate. Bar 0.5 μην 
Fig. 6. Heavily staining filaments (hsf) associated with elastln 
(el). — Post-stained with uranyl acetate and lead citrate. — Bar 
0.25 μηι. 
Fig. 7. Heavily staining filaments (hsf) associated with the base­
ment membrane (bm) of a type 1 epithelial cell being formed out of 
a type II epithelial cell, pointing to repair processes. — mb Multila­
mellar body. — HSPG Heparan sulfate-containing proteoglycan. — 
Post-stained with uranyl acetate and lead citrate. — Bar Ι μτη. 
Fig. 8. Alveolar basement membrane (abm) after treatment with 
nitrous acid for 24 h. The hsf remain unaffected ; the alveolar base­
ment membrane-associated heparan sulfate-containing proteogly­
cans are no longer detectable. The epithelial cell layer is no longer 
present. — Post-stained with uranyl acetate. — Bar 0.25 μτη. 
• .
HSPG
'! 
m 
® · , Щ—Ш ' 
Fig. 10. Collagenous area after digestion with chondroitinase AC 
for 90 min. The hsf are no longer detectable; the dermatan sulfate-
containing proteoglycans are not affected. — Post-stained with ura­
nyl acetate and lead citrate. — Bar 0.5 μηί. 
The most striking feature of the CS/DSPGs is their ir­
regular presence. Obviously, they are involved in local 
processes in human lung tissue. One of such processes is 
tissue repair. It might be expected that in older lungs (the 
lung specimens used in this study were from elderly per­
sons, average age 63 years) destruction and repair phenom­
ena are more common than in young lungs. In this respect 
it is noteworthy that the CS/DSPGs were not observed in 
the lungs of young, adult mice [17, 18). Furthermore, the 
appearance of type II epithelial cells transforming into 
type I epithelial cells (Fig. 7) points to alveolar cell re­
newal [3]. 
An increase in hyaluronic acid and/or CS/DS has been 
observed in various healing tissues such as healing tendon 
[12], regenerating liver [2). open skin wounds [1], healing 
myocardial infarction [15] and regenerating ear cartilage 
[7). Interestingly, Hassell and coworkers [6] noticed the ap­
pearance of an unusually large CS/DSPG in regenerating 
cornea. This PG, with an increase in sulforylation of the 
glycosaminoglycan-chains, disappeared when transpar­
ency of the cornea was restored. Hay [8] observed large 
PG-granula in opaque embryonic cornea in contrast to 
small granula in the more mature cornea. 
The localization of the CS/DSPG may further 
strengthen the suggestion of their participation in tissue re­
pair processes. Basement membranes are important struc­
tures in cell attachment; they also play a prominent role in 
promoting cell differentiation and morphogenesis [9]. Cell 
movement often takes place in highly hydrated matrices 
[16]; the CS/DSPGs localized in areas which seem electron 
microscopically almost empty and consequently are very 
hydrated (although some material might have been ex­
tracted during tissue preparation) may be involved in 
creating and maintaining such matrices. The polyanionic 
character of the CS/DSPG is very suited for retaining 
large amounts of water; it is known that PGs from carti­
lage occupy large hydrodynamic volumes [5]. At the same 
time, the CS/DSPGs localized around collagen bundles 
may protect the collagen fibrils from an attack by pro­
teases by forming a strongly negatively charged shield. 
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Studies on hypertrophic scars in vitro [11] indicate that 
CS(PG) can prevent col lagenase from breaking down col­
lagen; corneal PGs (but not keratan sulfate) are able to in­
hibit collagen lysis by col lagenase (in vitro) for nearly 
100% [10] 
In the light of the points ment ioned above it would be 
interesting to look for the C S / D S P G s in an experimental 
or natural wound healing system in the lung 
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Abstract 
By use of the cationic dye Cuprolinic Blue in a critical electrolyte 
concentration method, the lungs of mice ranging from the late fetal stage 
(17 days of gestation) to the puberal stage (27 days) were surveyed for 
their proteoglycans. An unusually large proteoglycan is present within 
the connective tissue of lungs of late fetal and young postnatal mice. 
This large proteoglycan is mostly located at the boundary between large 
extracellular matrix structures and electron microscopically empty areas, 
but sometimes also at the surface of fibroblast-like cells. The proteo-
glycan appears to be most abundantly around 2 days postnatally. From 
day 10 on, its number decreases dramatically, and it can be no longer 
observed in the lungs of 27 day old mice. The large proteoglycan is no 
longer detectable after digestion with chondroitinase ABC or chondroitin-
ase AC, but it is resistant to treatment with nitrous acid. It is there-
fore concluded that this large proteoglycan contains chondroitin sulfate 
and/or dermatan sulfate rich in glucuronic acid. Cellulose polyacetate 
electrophoresis of extracted glycosaminoglycans reveals that hyaluronic 
acid, heparan sulfate, dermatan sulfate and chondroitin sulfate are pre-
sent in all stages, and that the glycosaminoglycan composition changes 
considerably during mouse lung development. The possible role of this 
proteoglycan in cell attachment and in cell migration phenomena in the 
developing mouse lung is discussed. Based on literature data and our own 
results, it is proposed that large proteoglycans containing chondroitin 
sulfate and/or dermatan sulfate rich in glucuronic acid, may be a common 
feature of developing and healing tissues. 
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Introduction 
In our studies on proteoglycans (PGs) in lung alveoli we use the cationic 
dye Cuprolinic Blue according to the critical electrolyte concentration 
method, in order to visualize proteoglycans at the electron microscopical 
level. We recently reported on the presence of a large, heavily staining 
chondroitin sulfate and/or glucuronic acid-rich dermatan sulfate proteo-
glycan (CS/DS PG) in human lung alveoli (Van Kuppevelt et al., 1985b). 
Ascribing a role to this proteoglycan was difficult because both its pre-
sence and location in the alveolar interstitium is variable. Since lung 
samples were from persons with an average age of 58 years, an age at 
which destruction of alveolar tissue becomes a common phenomenon (Thurl-
beck, 1967; Yamanaka, 1970), we assumed that this proteoglycan might be 
involved in lung tissue repair processes. 
Several studies have indicated that healing tissues show a remarkable 
increase in chondroitin sulfate content, compared with normal-tissue 
counterparts (Edward et al., 1980; Reid and Flint, 1974; Shetlar et al., 
1978). This elevated content in chrondroitin sulfate is also known for 
developing tissues (Horwitz and Crystal, 1975; Radhaknshnamurthy and 
Berenson, 1980; Sampaio and Dietrich, 1981). Chondroitin sulfate content 
diminishes as the repair or developmental process is nearing its completion 
(Edward et al., 1980; Horwitz and Crystal, 1975; Kawamoto and Nagai, 1976; 
Sampaio et al., 1977). 
The hypothesis underlying the present study is that the chondroitin 
sulfate present in healing and developing tissues manifests itself, at 
least in part, in the shape of the large proteoglycan described above, 
and that this proteoglycan may be a characteristic component of such 
tissues. To obtain evidence for this hypothesis we examined developing 
mouse lungs in which this kind of proteoglycan should be present. Several 
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stages of lung development ranging from the late fetal (17 days of gesta-
tion) to the puberal (27 days old) lung were used. These stages cover a 
period in which mouse lung morphology changes most dramatically (Ten Have-
Opbroek, 1981). In earlier studies we did not find a large CS/DS PG in 
the lungs of young adult mice (Van Kuppevelt, 1984a,b). 
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Materials and methods 
Tissue 
Lungs of K-strain (inbred) mice were used. In order to obtain lungs from 
late fetal mice, 17 day pregnant mice were sacrificed (expected term at 
day 20, the moment of appearance of the vaginal plug was taken as t=0). 
The embryos were dissected and their lungs removed. Young mice, 2, 6, 10, 
13 and 27 days old, were killed and their lungs removed. For Cuprolinic 
Blue staining, enzyme and nitrous acid treatment, small lung blocks (S 1 mm3) 
were cut and degassed in the first solution they were placed in. 
Chemicals 
Cuprolinic Blue was obtained from BDH Chemicals Ltd, Poole, England; chron-
droitinase AC (from Proteus vulgaris), chondroitinase ABC (from Arthrobac-
ter aurescens), chondroitin-4-sulfate (from whale cartilage), hyaluronic 
acid (from umbilical cord) and dermatan sulfate (from porcine skin), were 
obtained from Sigma Chemical Company, St. Louis, USA. Heparan sulfate 
(from bovine lung) was a kind gift from prof. J.A. Cifonelli, University 
of Chicago, Illinois, USA. 
Cuprolinic Blue staining 
The Cuprolinic Blue staining procedure was performed as outlined previously 
(Van Kuppevelt et al., 1985a) . Occasionally lung specimens were postfixed 
after the Cuprolinic Blue staining procedure, with 1% aqueous osmium tetro-
xide for 2 hr. 
Enzyme and nitrous acid treatment 
Except for the lung samples from 10 day old mice, lung samples from all ages 
were subjected to enzyme and nitrous acid treatment. Before these treatments, 
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lung specimens were prefixed for 2 hr (40C) in 25 mM sodium acetate buffer 
(pH 5.6) containing 2.5% glutaraldehyde. For late fetal lung this prefix-
ation was insufficient to prevent a wash out of extracellular matrix (ECM) 
components during the subsequent enzyme and nitrous acid digestion. There­
fore late fetal and 2 day old mouse lung specimens were incubated over­
night (40C) in 25 mM sodium acetate buffer (pH 5.6) containing 4% glutar­
aldehyde. After prefixation the lung blocks were rinsed once for 10 min 
(4<,C) in the same buffer without glutaraldehyde. The conditions of the 
enzyme and nitrous acid treatments (e.g. pH, temperature and buffer) were 
as described earlier (Van Kuppevelt et al., 1985a). In Table I the incu­
bation time and concentrations of the enzymes and nitrous acid used are 
given, together with the substrates sensitive to these treatments. After 
the enzyme and nitrous acid digestions the lung blocks were stained with 
Cuprolinic Blue, dehydrated and embedded in Epon (Van Kuppevelt et al., 
1985a) . 
Light and electron microscopy 
The morphological development of the mouse lung was studied light micros­
copically. For this purpose semithin sections (1 urn) were cut on a Sorvall 
MT 5000 microtome, and stained with Toluidine Blue and Basic Fuchsine. 
Electron microscopy was carried out on ultrathin sections, collected on 
parlodion and coal coated grids, and poststained with 3% aqueous uranyl 
acetate for 8-15 min. The sections were examined in a Philips 201 electron 
microscope. 
Extraction and separation of glycosaminoglycans (GAGs) 
GAGs were extracted according to a modified method of Hoffman (1968) . Lungs 
were kept in aceton for 24 hr at -гоос, dried in an exsicator and (after 
grinding) further defatted in ether/methanol (1:1) for 48 hr (4 0C). 
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The material was dried again, suspended in 40 vol. of 0.75 M NaOH contain-
ing 10 mM NaBH and allowed to stand for 1 hr at 730C, followed by chill-
ing and neutralizing with 10 M HCl. Ice-cold 20% trichloroacetic acid was 
then added to a final concentration of 5% and, after 10 hr on ice and 
centrifugation (15 m m , 2000 g) , the resulting pellet was washed once with 
5% trichloroacetic acid and centnfuged again. The supernatants were pool-
ed and 3 vol. of cold ethanol saturated with NaAc was added. After 24 hr 
at 40C the mixture was centnfuged (15 min, 2000 g), the pellet was washed 
once with 80% ethanol (2 hr, -20oC) and centnfuged again. The resulting 
pellet, representing the GAGs, was dried and subjected to cellulose poly-
acetate electrophoresis according to Stevanovish and Gore (1967) using 
0.1 M Cu(Ac) (pH 3.1) as buffer. Strips were stained with 0.1% Alcian 
Blue in 5% acetic acid/10% ethanol and destained in 5% acetic acid. After 
making the strips transparent with paraffin oil, they were scanned densi-
tometncally with a Zeis PMQ II spectrophotometer at 600 nm. 
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Results 
Lung morphology. The morphological appearance of the lungs examined is 
shown in the Figs. la-5a. Development of the mouse lung seems similar to 
the development of the rat lung (Burri, 1974). At 17 days of gestation the 
airspaces are separated by very thick septa (Fig. la) . Although the inter-
stitium represents by far the largest part of the tissue, little ECM is 
present within it (Fig. lb). Between 17 days of gestation and 2 days post-
natally the airspaces are considerably dilatated, and the septa of the now 
called saccules have become much thinner (Fig. 2a). In the lungs of 6 day 
old mice the originally smooth septa are covered with bud-like structures, 
bulging into the airspaces of the saccules (fig. 3a). The are the onset of 
the formation of new secundary septa which give rise to the alveoli. The 
original septa are called primary septa. The 13 day old mouse lung shows 
a further progressed septation, alveoli are now clearly recognizable (Fig. 
4a). The former saccules have become alveolar sacs. The structure of the 
lungs of 27 day old mice (Fig. 5a) resembles that of the adult mouse lungs. 
Compared with the 13 day old lung there has been a further thinning of the 
septa. At the electron microscopical level a distinct increase in the amount 
of the ECM can be observed during the period between 17 days of gestation 
and 27 days postnatal. Within the interstitium, fibroblast-like cells, which 
in the late fetal stage lie in areas with little ECM material (Fig. lb), 
end up almost completely surrounded by ECM compounds at day 27 (Fig. 5b). 
GAG composition in developing mouse lung. The relative proportions of 
the GAGs found in all stages of mouse lung development are presented in 
Fig. 12. It should be stressed that the cellulose polyacetate electropho-
resis used here to separate GAGs is only semiquantitative; only major chan-
ges in GAG composition will be revealed. In mouse lung of every stage chon-
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Fig. 1. Mouse lung, 17 days of gestation. 
a) The late fetal mouse lung at the light microscopical level. 
It is a relatively compact organ; the highly cellular mesenchym is 
prominent. Toluidine Blue and Basic Fuchsine. Bar: 4 \im. 
b) The interstitium of the late fetal mouse lung. It contains little 
extracellular matrix (ECU) components. Large proteoglycans (Ipg) are 
associated with individual collagen fibrils (c), which are hardly ordered. 
Besides the Ipg, two other two other types of proteoglycans are visible: 
small dermatan sulfate proteoglycans (DSPG), which are associated with 
collagen fibrils, and heparan sulfate proteoglycans (HSPG) in basement 
membranes (bm). 
f: fibroblast-like cell. 
Poststained with uranyl acetate. Bar: 0.3 um. 
Fig. 2. Mouse lung, day 2. 
a) The air chambers of the 2 day old mouse are greatly enlarged compaired 
with the late fetal stage. The walls of these so called saccules (s) are 
rather smooth. Toluidine Blue and Basic Fuchsine. Bar: 7 urn. 
b) Large proteoglycans (Ipg) are visible around a bundle of collagen 
fibrils (c), and at the surface of cell processes (cp). Note that there 
are no Ipg located within the bundle of ordered collagen fibrils. 
ep: epithelial cell. 
Poststained with uranyl acetate. Bar: 0.3 \im. 
Fig. 3. Mouse lung, day 6. 
a) The previously smooth walled septa have become covered with the 
outgrowths of small buds, bulging into the airspace of the saccules (s). 
The saccules are transforming into alveolar sacs. The forming secundary 
septa subdivide the saccules, giving rise to the alveoli (arrows). Toluidine 
Blue and Basic Fuchsine. Bar: 7 μ/π. 
b) Large proteoglycans (Ipg) are located at the surface of non-identified 
extracellular matrix structures and at the surface of a fibroblast-like 
cell (f). Note that there are still large areas (asterix) within the 
interstitium devoided of any visible structure. 
Poststained with uranyl acetate. Bar: 0.3 \im. 
Fig. 4. Mouse lung, day 13. 
a) In the 13 day old mouse lung the septation has proceeded further, and 
alveoli (a) can be clearly distinguished. The former saccules are transformed 
in alveolar sacs (as). The septa are becoming thinner. Toluidine Blue and 
Basic Fuchsine. Bar: 7 \im. 
b) The open spaces within the interstitium are largely filled up. Large 
proteoglycans (Ipg) have become enclosed by large extracellular matrix 
structures. 
Poststained with uranyl acetate. Bar: 0.4 pm. 
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droitin sulfate (CS) , dermatan sulfate (DS), heparan sulfate (HS) and 
hyaluronic acid (HA) are present. There are marked differences in the 
proportional distribution of the lung GAGs with development. There 
is a reduction of the relative amount of HA between day 2 and 6 postnatal, 
and of CS between day 6 and 13. The relative amount of HS increases during 
development; this is probably due to the extensive enlargement of the res­
piratory surface, and the concomitant increase of basement membranes. It 
has been shown that HS is an important constituent of basement membrane in 
rat lung (Vaccaro and Brody, 1979, 1981) and mouse lung (Van Kuppeveit et 
al., 1984a,Ь). 
Presence and ultrastructural localization of PGs in developing mouse 
lung. The late fetal mouse lung is poorly provided with connective tissue 
elements; many areas are electron microscopically almost devoid of ECM 
structures. The possibility of losing ECM materials during tissue process­
ing should be considered. No difference, however, can be observed between 
the appearance of the ECM after a normal Cuprolinic Blue staining, and 
after a Cuprolinic Blue staining procedure followed by a postfixation 
with 1% aqueous OsO for 2 hr. It has been shown that addition of cationic 
dyes reduces the loss of proteoglycans to less than 1% (Chen and Wight, 
1984). These data indicate that probably little or no wash out of ECM 
components occurs. 
In all stages of mouse lung development we found collagen fibril -
and basement membrane - associated PGs. The susceptibility of these PGs 
to the enzymes and nitrous acid, is identical in all stages of develop­
ment (Table I). This indicates that the collagen fibril associated PGs 
are DSPGs while the basement membrane associated PGs are HSPGs, as is the 
case in adult mouse lung (Van Kuppevelt et al., 1984a,b). 
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Lar£e__PG 
17 Days_of_ge5tation. In the late fetal mouse lung, a large heavily stain-
ing PG is quite common within the connective tissue. This large PG is often 
associated with individual collagen fibrils, or with amorphous, sometimes 
fibrlllar-like, material (Fig. lb). At this stage of mouse lung development 
collagen is seldom seen in compact bundles. In general the collagen fibrils 
are loosely organized. Whenever the collagen fibrils are assembled into 
tightly packed bundles, the large PG is located only at exterior of the 
bundles. Occasionally large PGs are located directly at the cell surface. 
Day_2. The lung is crowded with the large PG. Compared with the late fetal 
stage their number has increased markedly (Fig. 2b). Often they are situated 
around bundles of collagen fibrils or associated with non-identifled struc-
tures (Fig. 7). In general the large PG occurs at the boundary between ECM 
structures and electron microscopically empty areas. Sometimes large PGs are 
present on the surface of fibroblast like cells (Fig. 2b and 6). Besides the 
large PG, a small PG can be present on the cell surface as well. At the peri-
phery of the lung extraordinarily large PGs can be found (Fig. 8). 
Day 6. The large PG is still present in great numbers (Fig. 3b), although 
somewhat less abundant compared with day 2. Their ultrastructural localiza-
tion is the same as in the 2 day old mouse lung. 
Day 10 and 13. On day 10 the number of the large PG has fallen off sharp-
ly, while at day 13 they have become rather scarce. Over large tissue areas 
they have disappeared. Occasionally small numbers are left, mostly complete-
ly enclosed by ECM components (Fig. 4b). The large open spaces within the 
ECM, present in younger mouse lungs, are almost filled up now. 
Day 27. The large PG can no longer be detected (Fig. 5b). Light microscopi-
cally, the lung resembles the adult mouse lung. 
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Fig. 5. Mouse lung, day 27. 
a) The alveolar septa of the 27 day old mouse lung have become much 
thinner compared with the 13 day old mouse lung. Toluidine Blue and 
Basic Fuchsine. Bar: 7 um. 
b) No open spaces are left within the interstitium of the puberal 
mouse lung. Large proteoglycans are no longer present. 
el: elastin. 
Poststained with uranyl acetate. Bar: 0.3 ym. 
Fig. 6. Mouse lung, day 2. 
Large proteoglycans (Ipg) are present at the surface of cell processes (cp), 
which are located in electron microscopically empty areas. Besides the Ipg, 
small proteoglycans (large arrows) are visible at the surface of cell processes. 
Poststained with uranyl acetate. Bar: 0.3 um. 
Fig. 7. Mouse lung, day 2. 
Large proteoglycans (Ipg), associated with non-identified extracellular 
matrix material, lie in areas which are otherwise devoid of any electron 
microscopically visible structures. 
Poststained with uranyl acetate. Bar: 0.3 ym. 
Fig. 8. Mouse lung, day 2. 
In the periphery of the developing mouse lung extraordinary large 
proteoglycans (large arrows) are present. They are located at the boundary between 
electron microscopically empty areas and extracellular matrix structures 
or cells. 
Poststained with uranyl acetate. Bar: 0.4 um. 
Fig. 9. Mouse lung (day 2) after digestion with chondroitinase ABC (2 U/ml) 
for 2 h. 
Large proteoglycans and collagen-associated dermatan sulfate proteoglycans are 
no longer visible. Basement membrane-associated heparan sulfate proteoglycans (HSPG) 
are not affected. 
Poststained with uranyl acetate. Bar: 0.3 ym. 
Fig. 10. Mouse lung (day 2) after digestion with chondroitinase AC (2/ml) 
for 2 h. 
Large proteoglycans are not detectable; collagen-associated dermatan sulfate 
proteoglycans (DSPG) are affected and have sometimes disappeared. The basement 
membrane-associated heparan sulfate proteoglycans (HSPG) are not affected. 
The epithelial cell layer has disappeared during tissue processing. 
Poststained with uranyl acetate. Bar: 0.4 ]¡m. 
Fig. 11. Mouse lung (day 2) after treatment with nitrous acid for 22 h. 
Large proteoglycans (Ipg) and collagen-associated dermatan sulfate proteoglycans 
(DSPG) are not affected. 
Poststained with uranyl acetate. Bar: 0.3 um. 
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Characterization of the large PG. The results of the enzyme and nitrous 
acid treatment are summarized in Table I. The large PG appears to be extreme-
ly sensitive to chondroitinase AC and chondroitinase ABC. In all stages of 
mouse lung development this PG disappears completely when digested with either 
one of these enzymes. No difference can be observed in its susceptibility to 
chondroitinase AC or chondroitinase ABC even when used at a concentration of 
0,25 U/ml for 1 hr. Overnight treatment with nitrous acid has no influence 
on the stainability of this large PG. 
E600(arb units) 
E 600 (arb units) 
Fig. 12. Cellulose polyacetate electrophoresis of 
glycosammoglycans (GACs) extracted from mouse 
lungs at various stages of development. 
a) standard GAGs. CS: chondroitin sulfate; 
DS: dermatan sulfate; HS: heparan sulfate; 
HA: hyaluronic acid. 0.5 yg of each GAG was 
applied. 
b, c, d, e, f: GAG-composition of lungs from 
day 17 of gestation and day 2, 6, 10 and 27 
postnatally, respectively. 
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Table I. Incubation time and concentrations of the enzyme and nitrous acid treatments, and their effect on the collagen 
associated, basement membrane associated and large PG from all stages of mouse lung development examined. 
Effect in all stage on: 
Treatment 
Chondroitinase ABC 
incubation time 
1 h 
1 h 
2 h 
22 h 
concentration collagen associated PG 
1/4 U/ml + 
1 U/ml + 
2 U/ml + 
2 U/ml + 
Basement membrane 
associated PG 
Large PG 
Chondroitinase AC 1 h 
1 h 
2 h 
22 h 
1/4 U/ml 
1 U/ml 
2 U/ml 
2 U/ml 
Nitrous acid 22 h 
The substrates of : chondroitinase ABC are chondroitin sulfate and dermatan sulfate 
: chondroitinase AC are chondroitin sulfate, hyaluronic acid and dermatan sulfate where it contains a 
glucuronic acid residue 
: nitrous acid are heparan sulfate and heparin. 
no effect ±: stainability of PG partially lost +: PG no longer visible 
*: nitrous acid was prepared emanating from 5% NaNO and 33% HAc (Van Kuppevelt et al., 1984b) 
Discussion 
It is widely accepted that the elements of the ECM play an important role 
in tissue processes such as healing and development (Hay, 1978, 1981; Dolyn-
chuk and Bowness, 1981; Cintron et al., 1978). Although the role of the PGs 
and GAGs in these processes has achieved much attention, studies on their 
location and characterization in healing and developing tissues are scarce. 
Enzyme digestion studies (Table I) indicate that the large PG observed in 
developing mouse lung contains CS and/or DS which is rich in glucuronic acid 
residues. This large CS/DS PG is restricted to the lung connective tissue 
where it is mainly located at the boundary between ECM structures (e.g. 
bundles of collagen) and areas which seem electron microscopically empty. 
Sometimes large PGs are also seen at the surface of cells. 
In shape and localization the large CS/DS PG found in developing mouse 
lung resembles the earlier described large CS/DS PG of human lung (Van 
Kuppevelt et al., 1985b). However, there are some differences between the 
locations of both PGs; the large CS/DS PG in developing mouse lung is not 
or hardly found to be associated with a basement membrane, while the human 
lung CS/DS PG is seldom or not seen at cell surfaces (Van Kuppevelt et al., 
1985b). 
We suggest that the large CS/DS PG of developing mouse lung has a large 
protein core (Van Kuppevelt et al., 1984b), just as that of the adult human 
lung, and that its rather thick appearance and its heavily staining point to the 
presence of many GAG chains. It may therefore be able to occupy large hydro-
dynamic volumes. 
The CS/DS PG may have a specific function in developing mouse lung since it 
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is most abundant in the period between 17 days of gestation and 10 days 
postnatal with a maximum around 2 days postnatal and since it is not 
present in the lungs of young adult mice (Van Kuppevelt et al., 1984a,b) . 
Its function may be correlated with processes which are prominent 
at that time. In developing rat skin, large CS/DS PGs have been detected 
their concentration decreasing 4-fold within a few days (Habuchi et al., 
1986) . 
The association of the large CS/DS PG with ECM structures indicates its 
involvement in the proper formation and deposition of the ECM. Especially 
its association with individual collagen fibrils in the late fetal stage, 
and its location around bundles of collagen fibrils suggests a commit-
ment in the deposition of these fibrils. This idea is supported by the 
fact that in rabbit lung the collagen synthesis sharply increases in late 
fetal life, and although the rate of synthesis starts to fall off before 
term, it is not until the young adult stage before the collagen synthesis 
has reached a constant low level (Bradley et al., 1974). 
In developing rat lung, fibroblasts show a maximal proliferation at day 
4 postnatal and their proliferation rate remains high till 10 days postna-
tal (Kauffman et al., 1974). At this stage of rat lung development, cell 
migration must be of considerable importance. Supposing that a similar 
phenomenon occurs in mouse lung and taken into consideration that the main 
location of the CS/DS PG is at the boundary of ECM structures and that it 
occupies a large hydrodynamic volume, the CS/DS PG may mask ECM structures 
and prevent other structures (e.g. cell processes) from making extensive 
contact with the ECM. Exogenous CSPG inhibits the fibronectin mediated 
attachment of fibroblasts to a collagen matrix by binding to collagen or 
fibronectin (Brennan et al., 1983,Knoxand Wells, 1979; Rich et al., 1981). 
The attachment-inhibiting action of the CS/DS PG may be of importance for the 
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regulation of cell migration. It has been sucgested that this process occurs 
in a direction of increasing attachment, the velocity of migration falling 
off as the extent of cell attachment increases (Hay, 1981; Sugiraoto and 
Hagiwara, 1979; Pouysségur and Pastan, 1979) . By covering the electron 
microscopically empty areas the CS/DS PG may constitute a path for cell 
migration and prevent cells from premature attachment. The cells may ulti-
mately accumulate at places devoid of CS/DS PGs. In the interstitium of 
developing rat lung the occurence of GAGs in open spaces have also been 
observed as well as their disappearance when these areas are filled up 
(Sannes, 1980, 1986). An increase in CS/DS PGs concomitant with cells mi-
gration has been noted (Kinsella and Wight, 1986) . The occasionally obser-
ved cell surface-associated CS/DS PGs may promote the cells' interaction 
with the ECM, but only when this is not prevented by the CS/DS PGs cover-
ing these ECM structures. 
Hyaluronic acid (HA), a GAG characterized by a very large hydrodynamic 
volume (Comper and Laurent, 1978; Gibbs et al., 1968) and often present in 
large amounts in the early developmental stages of many tissues has also 
been associated with cell migration phenomena (Toole, 1981, 1982, et al. 
1984). Sometimes it is noted that the HA content diminishes as the CS con-
tent increases or stays the same in a developing tissue (Toole and Trelstad, 
1971; Toole, 1981). Our GAG analyses of the several stages of mouse lung 
development point in the same direction. We suggest that HA plays a role 
m the cell migration during the early stages of tissue development, but 
as development proceeds, and the need for a more refined control of cell 
migration is required, the 'smaller' CS/DS PG is used which can exert its 
effect more locally. 
Cellular and biochemical mechanisms associated with tissue develop-
ment are frequently similar to those associated with tissue healing (Brody, 
1980; Grant et al., 1983; Thet et al., 1983; Toole, 1981). If a 
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large CS/DS PG plays a prominent role in a developing tissue, the same 
large CS/DS PG may be present in a healing tissue. The large CS/DS PG ob-
served in adult human lung and supposed to be involved in healing phenome-
na (Van Kuppevelt et al., 1985b), and the CS/DS PG found in developing 
mouse lung might be an example of such a congruence. In this connection 
it is noteworthy to mention that Hay (1978) described the presence of a 
large PG m opaque embryonal chicken cornea compared with smaller PG 
granula in more mature cornea, while Hassell et al. (1983) found an un-
usually large CS/DS PG in healing rabbit cornea which disappeared when 
healing was completed. 
The large CS/DS PGs we found in developing mouse lung and adult human 
lung, are probably synthesized by fibroblasts. Large glucuronic acid-rich 
DSPGs have been detected both in the medium and at the cell surface of 
embryonal human skin fibroblasts in culture (Cöster et al., 1984). Embryo-
nic human lung fibroblasts in culture synthesize a large CSPG (Vogel and 
Peterson, 1981). 
In conclusion we suggest that the CS in the developing mouse lung mani-
fests itself at least in part in the shape of a large CS/DS PG. This 
CS/DS PG is restricted to the connective tissue of the lung, where it is 
located at the boundary of large ECM structures and at the cell surface. 
From its location and time of presence we deduce that it is associated 
with processes such as cell migration and cell attachment. The univer-
sality of these processes in development and healing suggests that 
large CS/DS PGs may be characteristic components of healing and developing 
tissues. 
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CHAPTER 9 
Proteoglycans^ glycosaminoglycans and glycosaminoglycan-
degrading enzymes in non-emphysematous and emphysematous 
human lung parenchyma. 
Toin H.M.S.M. VAN KUPPEVELT, HENRIET M.J. JANSSEN, ANDRE S.M.J. DOVEREN, 
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Abstract 
Proteoglycans, glycosaminoglycans and glycosaminoglycan-degrading 
enzymes were studied in specimens of non-emphysematous and 
emphysematous human lung parenchyma. Glycosaminoglycans constitute 
about 0.3* of the dry, defatted, peripheral lung tissue. Dermatan 
sulphate and heparan sulphate are the major glycosaminoglycans, 
followed by hyaluronic acid; chondroitin sulphate is present only in 
small amounts. When comparing specimens from non-emphysematous and 
emphysematous lung parenchyma, no significant differences could be 
observed in the contents of protein and uronic acid and the 
glycosaminoglycan composition This was also the case for the 
activities of a set of exoglycosidases involved in glycosaminoglycan 
degradation. Ultrastructurally, no differences could be observed in 
the type and the location of proteoglycans in the alveolar walls of 
emphysematous and non-emphysematous lungs. 
Introduction 
Connective tissue plays an important role in the maintenance of the 
structural integrity of the lung It accounts to a great deal for the 
mechanical behaviour of the lung during the respiratory cycle. A major 
non-fibri1 lar constituent of the extracellular matrix are the PGs* and 
GAGs. In lung, all types of GAGs have been demonstrated (Motomiya et 
al., 1982; Horwitz et al., 1976). In lung alveoli, HSPGs have been 
demonstrated in basement membranes, while DSPGs were found associated 
with collagen fibrils (Vaccaro & Brody, 1979; 1981; Van Kuppeveit et 
al., 1985a). Their location and their association with other 
extracellular matrix components make it likely that PGs (GAGs) play a 
role in the functioning of the connective tissue skeleton and basement 
membranes. 
•Abbreviations: PG: proteoglycan; GAG: glycosaminoglycan; CS: 
chondroitin sulphate; DS: dermatan sulphate; HS: heparan sulphate; 
HA: hyaluronic acid; 
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There is a general agreement that in emphysema a malfunctioning of 
the connective tissue skeleton occurs. Although most attention has 
been focussed on the fibrillar components (viz. elastin and collagen), 
non-fibri1 lar components should also be considered. Laros and 
associates (1972a,b; 197Θ) stressed the importance of GAGs (PGs) in 
the pathogenesis of emphysema. A defect in the constitution of GAGs 
(PGs) could result in a malfunctioning of the extracellular matrix and 
ultimately lead to emphysematous conditions. Several papers on the 
involvement of GAGs (PGs) in emphysema have been published (e.g. 
Karlinsky, 1982; Karlinsky et al., 1983; Lafuma et al., 1985; 
Radhakrishnamurthy et al., 1985; Konno et al., 1982). From these 
studies, however, no general pictures emerges on the concernment of 
PGs (GAGs) in emphysema. 
In this study PGs and GAGs were studied, biochemically as well as 
ultrastructurally, in specimens obtained from non-emphysematous and 
emphysematous human lung. Furthermore, exoglycosidases, involved in 
the catabolism of GAGs were investigated. 
Materials and methods 
Materials 
Hyaluronic acid from umbilical cord (grade I), chondroitin-4-sulphate 
from whale cartilage, dermatan sulphate from porcine skin, heparan 
sulphate from bovine kidney, bovine serum albumine (fraction V), 
Streptomyces hyaluromdase, p-nitrophenyl-N-acetyl-ß-D-glucosamimde, 
4-methylumbelliferyl-N-acetyl-B-D-galactosaminide, 
4-methy 1umbelliferyl-B-D-glucuromde, and 4-methylumbel1iferon were 
all from Sigma Chemical Co. (St. Louis, MO, U.S.A.); 
4-methylumbelliferyl-a-L-iduronide and 4-methylumbelliferyl-a-D-
glucosaminide were from Behring Diagnostics, (La Jol la, CA, U.S.A.) 
and p-mtrophenylphosphate and p-mtrophenol were from 
Merck-Schuchardt (Darmstadt, F.R.G.). Heparitinase (EC 4.2.2.8) from 
Flavobactenum heparinum was from Seikagaku Kogyo Co., (Tokyo, Japan). 
Alcian Blue 8GX and Triton X-100 were obtained from Janssen Chimica, 
(Beerse, Belgium). Cellulose polyacetate electrophoresis was carried 
out on 25.5 * 14.5 cm cellulose polyacetate strips (Schleicher & 
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Table I . Preoperative lung function of non-eiphysoiatous and aiphysanatous pa t ien ts . 
Paraireter Non-erçhysenatous Elrphysoretous 
pat ients (n=17) pat ients (n=17) 
Predicted v i t a l capacity (in 1) 4300 + 470 3910 + 205 
on the basis of height, sex and age 
Actual v i t a l capacity in % 102 + 12 101 + 17 
of predicted v i t a l capacity 
Residual volume in % 31 + 3 45 + 4 a 
of t o t a l lung capacity 
Forced expiratory оішге per sec 73 + 5 44 + 10 
as % of v i t a l capacity 
Forced inspiratory voluire per sec 94 + 4 B7 + 5 
as % of v i t a l capacity 
Elastance (in kPa) in relat ion 1.32 + 0.15 0.62 + 0.16 a 
t o functional residual volume (n=3) (n=13) 
Values are means + S.D.. For s t a t i s t i c analysis the Student t t e s t was applied.' 
different fron non-enphysematous patients with Ρ ( 0.01 
Schuil, Dassel, F.R.G.) in a semi-microelectrophoresis chamber 
obtained from Gelman Instrument Co. (Ann Arbor, MI, U.S.A). 
Lung tissue 
Lung samples were taken after lobectomy or pneumonectomy for bronchial 
carcinoma from peripheral, subpleural parts of human lung. The lung 
tissue was frozen into liquid N= and stored at -20°C. Grouping into 
non-emphysematous and emphysematous persons was done on clinical, 
radiological, pathophysiological and histological grounds as described 
by Laros et al., (1972). All persons were men; the average age (-
S.D.) of the non-emphysematous group was 62 - 10, that of the 
emphysematous group was 64-7. Data on preoperative lung function of 
this group of patients are given in Table I. 
Extraction of glycosaminoglycans 
Lung specimens were treated with aceton for 24 h at -20°C, dried above 
СаСІз and (after grinding) further defatted in ether/methanol (1:1) 
for 4 h (4°) . Dried samples were suspended in 40 vol. of 0.75 M NaOH 
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containing 10 mM NaBK» and allowed to stand for 1 h at 730C followed 
by chilling and neutralizing with 10 M HCl. Ice-cold 20* 
trichloroacetic acid was then added to a final concentration of 5%. 
After 1 h on ice and centrifugation (15 mm, 2000 g) , the resulting 
pellet was washed once with 5% trichloroacetic acid and centrifuged 
again. The supernatants were pooled and 3 vol. of cold ethanol 
saturated with sodium acetate was added. After 24 h at 4°C the mixture 
was centrifuged (15 min, 2000g), the pellet washed once with 80% 
ethanol (2 h, -20°C) and centrifugea again. The resulting pellet, 
representing the GAGs, was dried and dissolved in a appropiate volume 
of deiomzed water. 
Analysis of protein and glycosaminoglycans 
Protein was determined by the method of Lowry et al., (1951), using 
bovine serum albumin as a standard. Uronic acid was assayed according 
to the method of Blumenkrantz et al., 1973, using D-glucuromc acid as 
a standard. 
For the qualitative analysis of GAGs and the quantitative analysis 
of DS, the GAGs were electrophoretically separated on cellulose 
acetate strips using copper acetate as buffer (Stevanovich & Gore, 
1967). Strips were stained in a 25 mM NaAc solution containing 50% 
ethanol, 0.2% Alcian Blue 8GX and 0.05 M MgCl^; destaining was in the 
same solution without Alcian Blue (Bartold & Page, 1985). Strips were 
made transparent with paraffin oil and scanned densitometncal ly at 
600 nm using a Zeiss PMQ II spectrophotometer. For the quantification 
of DS, HS was eliminated prior to electrophoresis, because the HS-band 
partially overlaps the DS-band. HS was degraded by treatment of the 
GAG solution for 2 h with HNCfe, made by mixing 5% NaNOa with 33% HAc 
(1:1 v/v). DS was quantitated by measuring the surface occupied by the 
DS-band and comparing it with that of standard DS. 
HA and HS were quantified by digestion by specific lyases and 
determination of the resulting 4,5-unsaturated oligosaccharides by 
measuring the absorption at 232 nm (Yosizawa et al., 1983). 
For HA, 40 μΐ of a GAG-solution (corresponding to about 10 }ig GAG) 
was mixed with 45 μΐ 0.1 M NaAc-0.15 M NaCl buffer (pH 5.4) containing 
6.5 U Streptomyces hyaluronidase. After incubation for 17 h at 37°C, 
the reaction was stopped by heating for 2 min. in boiling water. After 
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chilling, 600 μΐ of 0 05 M HCl was added and the mixture was 
centnfuged for 30 mm. at 5000 g and 4°c, absorbance was read at 232 
nm. 
For HS determination, 20 μΐ of a GAG-solution (corresponding to 
about 10 pg GAG) was mixed with 30 μΐ 0.1 M NaAc buffer (pH 7.0), 
containing 10 mM Ca(Ac)2 and 0.5 U heparitinase. After incubation for 
17 h at 43°C, heating in boiling water and chilling, 10 μΐ containing 
20 цд HS was added to obtain precipitation of proteins (Yosizawa et 
al., 19Θ3) . After addition of 600 μΐ 0.05 M HCl and centrifugation, 
the absorbance at 232 nm was determined. 
The GAG composition in percentages was calculated by the 
determination of the relative portion of each GAG (i.e. HA, HS and DS) 
of their sum. CS. which is below 10% was not taken into account. 
Exoglycosidases and acid phosphatase 
Extraction 
To about 0.5 g lung tissue, 10 vol. of 0.05 M citric acid/Na^HPO« 
buffer (pH 4.2) containing 0.1% Triton X-100 was added Samples were 
mixed with quartz-sand in a chilled mortar and grinded. After 
extraction for 50 min, the material was centnfuged for 30 min at A°C 
at 23000 g. The supernatant (-extract) was used in the enzyme assays. 
It was established that 95% or more of the enzymes was extracted using 
this procedure. Furthermore, the presence of a cocktail of protease 
inhibitors containing 0.1 M 6-amino-n-caproic acid, 5 mM benzamidine 
HCl, 1 mM phenylmethylsulphonyl fluoride, 10 mM disodium EDTA, 1 mM 
lodoacetamide and 10 mM N-ethy1-maleimide was tested. The presence of 
this cocktail during the extraction procedure and the subsequent 
enzyme assays did not influence the results. This indicates that no 
significant degradation of the exoglycosidases or acid phosphatase by 
proteolytic enzymes occurred. 
Enzyme assays 
Optimal substrate concentration and pH were used for the assays of 
exoglycosidases. Incubation conditions for acid phophatase were 
according to Taga & Van Etten (19Θ2). In all cases product formation 
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was proportional with the amount of extract 
B-D-N-acetylglucosaminidase (EC 3.2.1.52) 
25 μΐ extract was mixed with 25 μΐ 0.05 M citric acid/NaaHPCU (pH 4.5) 
and 50 μϊ 14 mM p-nitrophenyl-N-acetyl-B-D-glucosaminide. The final pH 
was 4.5. After incubation (5 mm, 37°С) , 0.6 ml 0.2 M glycine/0.2M 
NaCl (pH 10.7) was added, followed by 2 ml deionized water. The 
liberated p-mtrophenol was spectrophotometrically measered at 400 nm 
using a Zeiss PMQ II spectrophotometer. 
ß-D-N-acetylgalactosaminidase (EC 3.2.1.52) 
25 μϊ extract was mixed with 25 μϊ 0.05 M citric acid/NeuzHPO« (pH 4.2) 
and 50 μϊ 2 mM 4-methylumbelliferyl-N-acetyl-ß-D-galactosaminide. The 
final pH was 4.3. After incubation (5 m m , 37°C) , 0.6 ml 0.2 M 
glycine/0 2 M NaCl (pH 10.7) was added, followed by 2 ml deionized 
water. The liberated 4-methylumbelliferon was detected 
f luorimetncal ly using a excitation wavelength of 363 nm and a 
emission wavelength of 452 nm. A Zeiss PMQ-3 was used. 
B-D-glucuromdase (EC 3.2.1.31) 
25 μϊ extract was mixed with 25 μϊ 0.05 M citric acid/Na=HPCU - 0.Θ M 
NaCl (pH 4.3) and 50 μϊ 2.0 mM 4-methyluinbelliferyl-B-D-glucuronide. 
The final pH was 4.4. Incubation was for 45 m m at 37°C. The liberated 
4-methylumbel1 iferon was measured as described above. 
α-L-iduronidase (EC 3.2.1.76) 
25 μϊ extract was mixed with 25 μϊ 0.05 M citric acid/Na^HPO* - 0.8 M 
NaCl (pH 3.3) and 50 μϊ 0.5 mM 4-methyluinbel lif eryl-oc-L-iduromde. The 
final pH was 4.0. Incubation was for 3 h at 370C. Measurement of the 
liberated 4-methylumbelliferon was as described above. 
α-D-N-acetylglucosaminidase (EC 3.2.1.50) 
25 μϊ extract was mixed with 25 μϊ 0.05 M citric acid/Na^HPO* - 0.Θ M 
NaCl (pH 4.0) and 50 μϊ 0.2 mM 4-methylumbelliferyl-a-D-glucosaminide. 
The final pH was 4.3. Incubation was for 4 h at 37°C. Measurement of 
liberated 4-methylumbelliferon was as described above. 
Acid phosphatase (EC 3.1.3.2) 
25 μϊ extract was mixed with 25 μϊ citric acid/NasHPCU (pH 5.0) and 50 
μϊ 10 mM p-mtrophenylphosphate. The final pH was 5 0. Incubation was 
for 30 m m . at 37°C. The formed p-mtrophenol was determined as 
described above. 
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Determination of specific activity 
Because of the presence of a considerable and varying amount of 
blood in the extracts, it was necessary to make a correction for the 
protein derived from blood. For this purpose, the hemoglobin content 
in the extract was determined according to a slightly modified method 
of Kampen & ZuIstra, 1961. Briefly, 100 μΐ extract was mixed with 900 
ul 0.2 M phosphate buffer (pH 7.2), containing 1.0 mM KCN, 0.6 mM 
ItsFeiCNU, 1.5 mM NaCl and 0.05% Triton X-100. After 3 mm, the 
absorbance at 546 nm was read. When the amount of hemoglobin is known, 
the total amount of blood proteins can be calculated by multiplication 
with a factor of 1.25. The amount of protein derived from the lung 
tissue itself was calculated by subtracting the amount of blood 
protein from the total amount of protein. 
It was established for ß-D-N-acetyl-glucosaminidase, 
ß-D-N-acetyl-galactosaminidase, α-L-iduronidase and (î-D-glucuronidase 
that the activity in blood was negligible compared with the enzyme 
activity from the lung tissue itself. The a-D-N-acetylglucosaminidase 
and the acid phosphatase activity in blood, however, could not be 
neglected and were subtracted from the total activities. 
Electron microscopy 
To investigate proteoglycans at the ultrastructural level, the 
Cuprolinic Blue staining procedure was used as described previously 
(Van Kuppevelt et al., 1985a). Sampling and the use of chondroitinase 
ABC, chondroitinase AC and nitrous acid were also as described. 
Results 
In non-emphysematous human lung parenchyma, the amount of uronic 
acid is 1.26 цд/тд dry defatted tissue (Table II). This corresponds to 
about 3 pg GAG/mg dry defatted tissue. The values were not corrected 
for blood components. Using cellulose acetate electrophoresis and/or 
enzyme digestions, it was found that DS and CS are the major GAGs in 
the peripheral lung tissue, followed by HA. CS is present only in 
small amounts (less than 10%). Heparin could not be detected. When 
comparing non-emphysematous with emphysematous specimens, no 
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T a b l e I I . P r o t e i n and u r o n i c a c i d c o n t e n t and g lyoosaminoglycan c x i i p u s i t i o n of 
n o n - e n p h y s e r a t o u s and e r p h y s e n a t o u s lung t i s s u e . 
C o n s t i t u e n t Non-CTphysenatous 
t i s s u e 
EirphysciTBtous 
t i s s u e 
Protein 
Uroric acid 
Ratio uronic acid/protein 
Hyalurooic acid 
Heparan sulphate 
DexTiatan sulp^te 
(n=n) 
733 + 43 
1.26 + 0.27 
1.72 + 0.37 
(n=10) 
24 + 11 
38 + 7 
38 + 14 
(n=U) 
758 + 36 
1.28 + 0.47 
1.57 + 0.51 
(n-9) 
27 + 10 
35 + 7 
38 + 9 
P r o t e i n and u r o n i c a c i d c o n t e n t a r e e x p r e s s e d a s mg/g d e l i p i d a t e d , d r y lung t i s s u e . 
G l y c o s a r u n o g l y c a n s a r e g iven i n % of t o t a l c o n t e n t ; c h o n d r o i t i n s u l p h a t e , which i s 
below 10% was n o t t a k e n i n t o a c c o u n t . 
F o r s t a t i s t i c a l a n a l y s i s t h e t w o - s i d e d H L l a u m ' s r a n k sum t e s t was used w i t h a 
c o n f i d e n c e l e v e l of a=5%. Values a r e ілеапз + S.D. and a r e n o t s i g n i f i c a n t l y d i f f e r e n t 
f o r b o t h g r o u p s . 
T a b l e I I I . E x o q l y c o s i d a s e and a c i d p h o s p h a t a s e a c t i v i t i e s i n гюп-enphysa ia tous 
and o r p h y s e n a t o u s lung t i s s u e . 
Enzyme Non-e iphysenatous 
t i s s u e 
Drphysematcus 
t i s s u e 
B-D-N-acety I g l u c o s a m i m d a s e 
e-D-N-acety Iga l a c t o s a i a n i d a s e 
Acid p h o s p h a t a s e 
(n=31) 
142 + 77 
17 f 14 
64 + 46 
ίπ=19) 
183 + 89 
18 + 10 
83 + 46 
B-D-glucuronidase 
a - L - i d u r o n i d a s e 
α-D-N-acetylg lucosamin i d a s e 
(n=15) (n=14) 
0.112 + 0.064 0.124 + 0.056 
0.035 + 0.017 0.038 + 0.015 
0.018 + 0.009 0.021 + 0.010 
Enzyme a c t i v i t i e s a r e e x p r e s s e d a s nmoles of s u b s t r a t e hydrolyzed/min p e r mj p r o t e i n . 
For s t a t i s t i c a l a n a l y s i s t h e two-s ided Wilcoxon's rank sim t e s t was used w i t h a 
c o n f i d e n c e l e v e l of a=5%. Values a r e means + S.D. and a r e n o t s i g n i f i c a n t l y d i f f e r e n t 
for b o t h g r o u p s . 
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significant differences could be detected in the content of protein 
and uronic acid and the GAG composition (Table II). 
In alveoli of non-emphysematous lung, PGs are periodically 
associated with collagen fibrils (Fig. la) These PGs were 
chondroitinase AC- and nitrous acid-resistant, but could be degraded 
with chondroitinase ABC; they therefore represent DSPGs, as described 
earlier (Van Kuppevelt et al., 1985a). The PGs present in the alveolar 
and capillary basement membrane (Fig. lb) were sensitive towards 
nitrous acid, but not towards chondroitinase ABC and chondroitinase 
AC, indicating their HSPG-nature. Four emphysematous lungs were 
studied ultrastructurally for the presence of PGs in the alveoli (Fig 
1c). When compared with normal alveoli, no differences could be 
detected in the location of the PGs and their sensitivity towards 
GAG-degrading procedures. However, no morphometric studies were 
performed. 
Finally, the specific activity of a set of exoglycosidases was 
studied (Table III) No significant differences between specimens from 
non-emphysematous and emphysematous lungs could be observed. 
Individual variation, however, is considerable. In an attempt to 
reduce this variation, enzyme activities were related to the activity 
of the universal lysosomal enzyme acid phosphatase. It was reasoned 
that a variation in enzyme activity due to local processes (e.g. 
inflammatory cells) could be met in this way. The specific activity of 
acid phosphatase did not differ significantly between specimens from 
non-emphysematous and emphysematous lungs (Table III). Although in 
some cases the coefficient of variation was substantially reduced by 
relating exoglycosidases to acid phosphatase, this was not a general 
pattern. When specimens of non-emphysematous and emphysematous lungs 
were compared, no significant difference could be detected in enzyme 
activities related to acid phosphatase (data not shown). 
Discussion 
The GAG content found in non-emphysematous human lungs is about 
0.3* of the defatted dry weight, a value corresponding to that found 
by others (Konno et al., 1982; Schmid et al., 1982). The amount of GAG 
derived from blood accounts for only about 0.2% of the lung GAGs 
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Fig. 1. Part of an alveolar wall after the Cuprolinic Blue staining procedure, 
used to detect proteoglycans. Bar: 300 nm. Poststained with uranyl acetate and 
lead citrate. 
a,b: non-emphysematous lung. 
a. Heparan sulphate proteoglycans (HSPC) are located in the alveolar basement 
membrane (abm) as well as in the capillary basement membrane (cbm). 
b. Dermatan sulphate proteoglycans (DSPG) are regularly associated with collagen 
fibrils (c) and are separated from each other according to the main banding 
period of the collagen fibrils (about 60 nm). 
c: emphysematous lung. The form and location of the HSPGs and the DSPGs are 
similar when compared to the non-emphysematous lung. 
a: alveolar airspace; cap.: capillary; ect I: type I epithelial cell; 
en: endothelium. 
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(Schmid et al.. 1982). Of the 5 types of GAGs, HA, CS, DS, and HS 
could be detected in peripheral lung tissue. The two main GAGs, DS and 
HS, are present in the alveoli as PGs and are associated with collagen 
fibrils and basement membranes, respectively (Van Kuppevelt et al., 
1985a; Fig. 1). In an elastase-induced emphysema model, alveolar edema 
coincides with a loss of HSPGs and edema subsides when regeneration 
occurs (Vaccaro et al., 1985). This points to a filter function for 
the HSPGs as suggested (Van Kuppevelt et al., 1984). CS, a minor GAG 
in our preparations, may be present (at least partially) as the large 
CS/DSPG, which are irregularly present in human lung (Van Kuppevelt et 
al., 1985b). Heparin could not be detected in human lung parenchyma, 
in accordance with the results of Schmid and coworkers (1982). 
However, since mast cells are present, small amounts of this GAG are 
likely present. Keratan sulphate is not present in peripheral lung 
tissue: it is restricted to the tracheobronchial cartilage (Mason & 
Wusteman, 1970). 
Several studies have been published dealing with the possible 
involvement of PGs (GAGs) in emphysema. The outcome of these studies 
is often contradictory. For human emphysematous lung a decrease and an 
increase in the percentage HA have been noted (Konno et al., 1982; 
Pecora et al., 1966). An increase in the glucosamine/galactosamine 
ratio was detected for human emphysematous lung by Laros et al., 
(1972), but Saltzman and coworkers (1961) did not demonstrate such an 
increase. In pronase-induced emphysema, an increase in HA and DS was 
noted (Radhakrishnamurthy et al., 1985), while elastase-induced 
emphysema was characterized by an elevated incorporation of 
[1*C]glucosamine into HS and HA (Lafuma et al., 1985). Karlinsky 
(1982), also working with elastase-induced emphysema demonstrated an 
increase in DS, but could not corroborate this result later (Karlinsky 
et al., 1983). In starvation-induced emphysema, no change in the 
amount of GAGs could be detected (Karlinsky et al., 1986). Studies are 
difficult to compare due to different methodologies. Furthermore, the 
type of emphysema seems to be of importance. In rabbits, CdCl3-induced 
centri lobular emphysema was characterized by a decrease in uronic 
acid, while an increase was found in pronase-induced panlobular 
emphysema (Radhakrishnamurthy et al., 1985). 
In this study no significant differences could be observed in the 
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content of protein and uronic acid in specimens from non-emphysematous 
and emphysematous lungs, in accordance with the results of Laros et 
al., (1972). Their suggestion of an internal shift in the composition 
of the GAGs, however, could not be confirmed. Furthermore, the 
activities of exoglycosidases involved in the catabolism of GAGs were 
similar for the emphysematous and the non-emphysematous group. It 
should be noted that there is a large individual variation. A 
considerably larger number of lung specimens should be investigated in 
order to make a more definite statement. In all 4 emphysematous lungs 
examined ultrastructurally, no differences could be detected in the 
location of the PGs nor in their sensitivity towards GAG-degrading 
procedures. 
Another point should be considered here. From studies on 
elastase-induced emphysema, it has become clear that the time of 
tissue sampling is of importance Incorporation of f^Clglucosamine 
into GAGs was initially lower after elastase administration, but then 
increased (together with the total GAG level); at day 21, the 
situation returned to normal and stayed that way over the period 
measured (1 year), although progression of airspace enlargement and 
distortion still continued (Karlinsky et al., 19Θ3). In explant 
cultures of hamster lungs, incorporation of [1'*C]glucosamine into HS 
and HA was less at day 24 after elastase administration than at day 1 
(Lafuma et al., 19Θ5) In a ultrastructural study, it was noted that 
HSPGs in the alveolar basement membrane were degraded 2 h after 
elastase treatment, but that regeneration was well underway at day 4 
and was completed at day 10 (Vaccaro et al., 19Θ5). The severity of 
the emphysema, however, is known to progress for many months after 
induction (Snider et al , 19Θ6). In men, where emphysema is more or 
less an end-stage phenomenon, a similar situation may occur. GAGs may 
be initially affected, but (apparently?) restored at a later time. 
An approach in the study on the possible involvememt of PGs (GAGs) 
in emphysematogenesis, could be trying to provoke emphysema by 
broncho-alveolar lavage with specific GAG-degrading enzyme. 
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Survey and summary 
A main goal of this investigation on proteoglycans and 
glycosaminoglycans was to get a clue as to which role these components 
play in lung parenchyma. Since a combination of diciplines may be 
complementary, both histochemical and biochemical techniques were 
applied 
Cuprolinic staining procedure 
In Chapter 2, a staining procedure is described using the catiomc 
dye Cuprolinic Blue in a critical electrolyte concentration method. 
This procedure detects proteoglycans on basis of their sulphate 
groups. The specificity of this method was demonstrated by use of 
enzymes and chemical treatments (Chapter 3). Proteoglycans appear as 
electron-dense filaments, probably caused by the collapse of the 
glycosaminoglycan side-chain(s) onto the protein core. Comparison with 
other studies, makes it acceptable that each filament represents a 
monomer (i.e. one molecule). X-ray diffraction studies have indicated 
that no dislocation of proteoglycans occurs during dehydration and 
embedding (Meek et al., 1985 and 19Θ6). In Chapter 4, an attempt is 
made to correlate biochemical data from literature with the 
ultrastructural appearance of proteoglycans. Although one has to be 
cautious, the appearance may be indicative for the 
glycosaminoglycan/protein ratio and for the molecular weight of the 
part of the protein core to which glycosaminoglycans are attached. 
In conclusion, the Cuprolinic staining procedure is a suitable 
method for the ultrastructural localization and characterization of 
proteoglycans in tissue. 
Proteoglycans in lung parenchyma 
From electron microscopical investigations of alveoli of mouse 
(Chapter 3), man (Chapter 5) and cattle (Chapter 6), the picture has 
emerged that two types of proteoglycans are permanently present: 
dermatan sulphate proteoglycans, which are associated with collagen 
fibrils and heparan sulphate proteoglycans, which are confined to 
basement membranes. Biochemical analysis of the parenchyma (including 
small bloodvessel and bronchioli) showed that dermatan sulphate and 
heparan sulphate are the predominant glycosaminoglycans and that 
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hyaluronic acid is also present in considerable amounts (Chapter 9). 
Since the latter lacks sulphate groups, its presence c.q. location in 
alveoli can not be demonstrated by the Cuprolinic Blue staining 
procedure. 
A large, irregularly present, chondroitin sulphate/dermatan 
sulphate proteoglycan was detected in human alveoli (Chapter 7). A 
similar proteoglycan was found during a distinct phase of mouse lung 
development (Chapter 8). It was suggested that this proteoglycan plays 
a role in tissue repair and development; more evidence, however, is 
needed to make a more definite statement of its function. 
Dermatan sulphate proteoglycan 
It was demonstrated that an iduronic acid-rich dermatan sulphate 
proteoglycan is regularly associated with collagen fibrils in human 
alveoli, bovine alveoli, small bloodvessels and bronchioli (Chapter 5 
and 6). The isolation of this proteoglycan and its biochemical 
characterization is described in Chapter 6. It is a small proteoglycan 
with 1-3 dermatan sulphate side-chain(s) and a high content (91%) of 
iduronic acid residues. On base of morphological and biochemical data, 
the following model has been proposed for the interaction of the 
dermatan sulphate proteoglycan with the collagen fibrils: the anionic 
protein core is specifically attached to the fibrils, while 
proteoglycans from neighbouring collagen fibrils are attached to each 
other by the dermatan sulphate side-chains. In this way the fibrils 
adhere to each other and provide structural coherence. This may cause 
the collagen fibrils to act together as fibres instead of separate 
fibrils. For a dynamic organ as the lung, this may be of importance. 
Recent information indicates that the protein core is necessary for 
binding of dermatan sulphate proteoglycans to collagen fibrils in 
vitro (Scott et al., 1986). 
The obtained ultrastructural and biochemical data give us a clue to 
the functions of proteoglycans in lung parenchym. More experimental 
evidence may be obtained by specific enzymatic digestions of 
proteoglycans or glycosaminoglycans in vivo and examination of the 
effect of these treatments on lung mechanics. Elastase has been shown 
to reach the alveolar interstitium after intratracheal instillation. 
The transport to the extracellular matrix was predominantly by endo-
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and exocytosis (Snider et al., 1986). Collagen fibrils are affected 
after endotracheal instillation of collagenase (Karlinsky et al., 
1976). Using specific glycosidases in perfusion studies, direct 
evidence was obtained for the role of heparan sulphate proteoglycans 
in establishing the restrictive permeability of the glomerular 
basement membrane (Kanwar et al., 1980; Rosenzweig and Kanwar, 1982). 
In lung, experiments in vivo applying chondroitinase ABC or 
chondroitinase B, which specifically degrades dermatan sulphate, 
should provide more conclusive evidence about the function of the 
dermatan sulphate proteoglycan. 
It has been suggested that lysyl oxidase is a proteoglycan 
conjugate since after chondroitinase ABC treatment 75% of the enzyme 
activity was destroyed. (Tänzer and Housley, 1981) Lysyl oxidase is 
extracellularly involved in the cross-linking of collagen and appears 
to work preferentially on collagen molecules after they have 
aggregated into fibrillar forms. The number of ruthenium red-positive, 
collagen fibri1-associated granules (dermatan sulphate proteoglycans 
?) was reduced in cornea by treatment with beta-aminopropionitrile, an 
inhibitor of lysyl oxidase (Moorhead, 1981). Whether dermatan sulphate 
proteoglycans are involved in the cross-linking process by association 
with lysyl oxidase is intrigueing, but needs further clarification. 
Heparan sulphate proteoglycans. 
Heparan sulphate proteoglycans of human and mouse alveoli are 
present in alveolar and capillary basement membranes (Chapter 2, 3 and 
5) In the alveolar basement membrane they are lying in one plane, 
thus providing the alveolus with an envelope of negatively charged 
molecules. A filter function seems likely for these proteoglycans. 
After intratracheal instillation of elastase in hamsters, a loss of 
heparan sulphate proteoglycans was noticed, coinciding with alveolar 
edema (Vaccaro et al., 1985a). As the proteoglycans were regenerating, 
edema subsided. They therefore may act as a charge barrier and prevent 
leak of proteins from capillaries into the alveolar airspace. One 
should, however, be careful since elastase degrades also other 
molecules such as elastin, collagen and fibronectin. A similar study 
with heparitinase, which digests specifically heparan sulphate, might 
be more conclusive. It has been suggested that basement membrane 
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elasticity contributes to the lung mechanical properties (Vaccaro et 
al., 1985b). By mutual repulsion of the negative charges, the 
proteoglycan envelope may be of importance in this respect. 
There exists a heterogeneity in the appearance of heparan sulphate 
proteoglycans in the basement membranes of lung alveoli. In the 
capillary basement membrane, the proteoglycans are more scattered and 
stain less intense (i.e. contain less sulphate groups) when compared 
to the alveolar basement membrane. This may relate to a greater 
permeability of the capillary basememt membrane, which may be 
necessary in view of the transendothelial transport. In mice, the 
alveolar basement membrane underlying type II epithelial cells, 
contains smaller proteoglycan-filaments than the basement membrane 
underlying type I epithelial cell. 
Proteoglycan-fι laments in the alveolar basement membrane of mice 
are larger compared to those in the human alveolar basement membrane 
(Chapter 2 and 5). The latter sometimes contain a second layer of 
proteoglycans, not observed in alveolar basement membranes of adult 
mouse. The possible fuctional consequences of these differences are 
not clear. 
Emphysema 
When comparing specimens from non-emphysematoua and emphysematous 
lungs, no differences could be determined in the amount of uronic 
acid, the glycosaminoglycan composition and the activity of 
glycosaminoglycan-degrading enzymes (Chapter 9). Ultrastructurally, 
the location of proteoglycans and their sensitivity toward degrading 
procedures is similar in both groups. These results do not exclude the 
involvement of proteoglycans in the pathogenesis of emphysema, since 
only advanced stages were examined. An experiment to test this 
involvement, is to try to provoke emphysema by intratracheal 
instillation of glycosaminoglycan-degrading enzymes. 
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Samenvatting 
In dit proefschrift wordt een electronenmicroscopisch en 
biochemisch onderzoek naar proteoglycanen en glycosaminoglycanen in 
longparenchym beschreven. Proteoglycanen zijn macromoleculen bestaande 
uit een eiwitketen waaraan covalent glycosaminoglycanen en 
Oligosacchariden zijn gebonden. De proteoglycanen zijn als gevolg van 
de talrijke carboxyl- en sulfaat groepen sterk negatief geladen. 
In hoofstuk 1 wordt de structuur van de long beschreven. Tevens 
komen drie belangrijke componenten van de extracellulaire matrix aan 
de orde: collageen, elastine en proteoglycanen. De relatie van 
proteoglycanen met emfyseem wordt kort besproken. 
In hoofstuk 2 wordt een kleuringsmethode besproken voor het 
zichtbaar maken van proteoglycanen op ultrastructureel niveau. Hiertoe 
is de catiomsche kleurstof Cuprolimc Blue gebruikt volgens de 
"critische electrolyt concentratie" methode. 
De specificiteit van de kleuringsmethode is onderzocht in hoofdstuk 
3. Door middel van enzymatische en chemische afbraakprocedures kon 
aangetoond worden dat de na de kleuring zichtbare electronen-dichte 
filamenten proteoglycanen vertegenwoordigen; elk filament is 
waarschijnlijk een molecuul. Met behulp van genoemde procedures kan 
tevens het type proteoglycaan vastgesteld worden. 
In hoofstuk 4 is voor een aantal bindweefsels gepoogd een 
correlatie te leggen tussen het ultrastructure Ie voorkomen van 
proteoglycanen en hun biochemische karakteristieken. Alhoewel grote 
voorzichtigheid geboden is, kan gesteld worden dat uit morfologische 
karakteristieken aanwijzingen verkregen kunnen worden omtrent de 
glycosaminoglycaan/eiwit ratio en het molecuul gewicht van dat deel 
van het eiwit waaraan glycosaminoglycanen gebonden zijn. 
Alveoli van de muis, de mens en het rund zijn ultrastructureel 
onderzocht op hun proteoglycaan samenstelling (hoofdstuk 3, 5 en 6). 
Heparaan sulfaat proteoglycanen zijn aanwezig in de basaal membranen, 
terwijl dermataan sulfaat proteoglycanen geassocieerd zijn met 
collageen fibrillen. Voor humane en runder alveoli en voor kleine 
bloedvaatjes en bronchioli van het rund kon aangetoond worden dat het 
dermataan sulfaat proteoglycaan rijk is aan iduronzuur. De isolatie 
van dit proteoglycaan uit runder longparenchym wordt beschreven in 
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hoofdstuk 6. Het is een klein proteoglycaan met 1-3 dermataan sulfaat 
zijketens met een hoog iduronzuur gehalte {91% van het totale 
uronzuur) . Op grond van ultrastructure Ie en biochemische gegevens is 
een model opgesteld voor de interactie tussen dermataan sulfaat 
proteoglycaan en collageen fibril (hoofdstuk 6). In dit model bindt de 
negatief geladen eiwitketen specifiek aan de collageen fibril, terwijl 
proteoglycanen gebonden aan verschillende fibrillen met elkaar 
verbonden zijn door associatie van dermataan sulfaat ketens. Op deze 
manier worden collageen fibrillen met elkaar verbonden en kunnen ze 
gezamenlijk functioneren als vezels 
Er bestaat een heterogeniteit in de heparaan sulfaat proteoglycanen in 
de basaal membranen (hoofdstuk 3 en 5). De proteoglycanen in de 
capillaire basaal membraan liggen meer verspreid en kleuren minder 
intens (i.e. bevatten minder sulfaat groepen) dan die in de alvéolaire 
basale membraan. Verder zijn er verschillen aanwezig tussen heparaan 
sulfaat proteoglycanen in alveoli van mens en muis. De aaneengesloten 
laag van negatief geladen heparaan sulfaat moleculen in de alvéolaire 
basaal membraan duidt op een f ιIterfunctie. Mogelijkerwijs speelt deze 
laag ook een rol in de longmechamca. 
In humane alveoli werd een groot, onregelmatig aanwezig, 
proteoglycaan aangetoond. Het handelt zich hier om een chondroitine 
sulfaat en/of glucuronzuur-rijk dermataan sulfaat proteoglycaan 
(hoofdstuk 7). Een soortgelijk proteoglycaan is aanwezig tijdens een 
bepaalde fase van de longontwikkeling in de muis (hoofdstuk Θ). 
In hoofdstuk 9 is het onderzoek beschreven naar een mogelijke 
betrokkenheid van proteoglycanen in de longziekte emfyseem. Er kon 
geen verschil aangetoond worden tussen monsters van emfysemateuze en 
niet-emfysemateuze humane long wat betreft het uronzuur gehalte en de 
glycosaminoglycaan samenstelling. De activiteit van een vijftal 
glycosaminoglycaan-afbrekende enzymen en de ultrastructure Ie 
karakteristieken van de proteoglycanen in alveoli vertoonden ook geen 
duidelijke verschillen. 
182 
CURRICULUM VITAE 
Tom van Kuppeveit werd op 8 november 1955 geboren te Grave. 
In 1974 behaalde hij het Gymnasium 8 diploma aan het St. Dominicus 
College te Nijmegen. 
Hij studeerde biologie aan de Katholieke Universiteit te Nijmegen, waar 
hij in 1981 het doctoraal examen deed met als hoofdvak submicroscopische 
morfologie (o.l.v. Prof. Dr. M.M.A. Sassen) en als bijvakken 
chemische cytologie (o.l.v. Prof. Dr. Ch.M.A. Kuyper) en cytologie-
histologie (o.l.v. Dr. W. Eling en Prof. Dr. C. Jerusalem). 
Van 1981 tot 1986 was hij als wetenschappelijk medewerker werkzaam 
op de afdeling Chemische Cytologie van de Faculteit der Wiskunde en 
Natuurwetenschappen van de Universiteit Nijmegen. Gedurende deze tijd 
leverde hij een bijdrage aan het onderwijs van biologie studenten. 
183 

STELLINGEN 
I 
De ultrastructurele locatie van proteoglycanen in situ kan belangrijke 
aanwijzingen geven omtrent de functie van deze macromoleculen. 
Dit proefschrift 
II 
Het fotografisch bewijsmateriaal dat Vaccaro en Brody overleggen om aan 
te tonen dat de basaal-membraan van capillaire endotheelcellen in alveoli 
van de long van de rat niet alleen heparaan sulfaat proteoglycanen bevat, 
maar ook chondroitine sulfaat- en/of dermataan sulfaat proteoglycanen is 
niet overtuigend. 
Vaccaro, C A . en Brody, J.S., 1981. J. Cell Biol. 91^ , 427-437. 
Ill 
De controversiële resultaten van Karlinsky en medewerkers omtrent de 
betrokkenheid van glycosaminoglycanen bij de Pathogenese van emfyseem 
zijn tekenend voor de onduidelijkheid op dit gebied. 
Karlinsky, J.B., 1982. Am. Rev. Hespir. Dis. 125, 85-88. Karlinsky, J.B. 
et al., 1983. J. Lab. Clin. Med. 102, 151-162. Karlinsky, J.B. et al., 
1986. Am. J. Physiol. 251, R282-R288. 
IV 
De aanwijzingen die hebben geleid tot de gepostuleerde partiele transformatie 
van interne matrix fibrillen tot chromosoomscaffolds tijdens de transitie in 
een eukaryotische celcyclus van interfase naar mitose, zijn overtuigend. 
Bekers, A.G.M, et al., 1986. J. Celi Sci. 86, 155-171. 
V 
Bij de isolatie van lymfocyten uit bloed door middel van centrifugatie 
over "lymphocyte separation medium", dient men zich ervan bewust te zijn 
dat dit niet het enige celtype is dat zich na centrifugatie in de interfase 
bevindt. 
Nooij, F.J.M, et al., 1986. Eur. J. Immunol. J16, 981-984. 
VI 
Het verdient aanbeveling de diffusiecoëfficiënten van substraten in poreuze 
gelen te relateren aan de concentratie van het dragermateriaal in de deeltjes 
in plaats van aan de concentratie van het materiaal in de oplossing voor 
gelbereiding. 
Nguyen, A-L. en Luong, J.H.T., 1986. Biotechnol. Bioeng. 28, 1261-1267. 
VII 
Bij een onderzoek naar een ziekte waarbij patientenmateriaal gebruikt wordt, 
verdient het de voorkeur de onderzoeker te stationeren in het ziekenhuis 
waarvan het materiaal betrokken wordt. 
VIII 
In het openbaar rokende anti-kernenergie demonstranten zijn en blijven 
-ook na het kemreactorongeval in Tsjemobyl- hypocriet. 
IX 
Bij sommige bioscoopfilms zou men zich gewenst hebben dat de tekst "In verband 
met de lengte van het programma valt de pauze tijdens de hoofdfilm" was 
vervangen door de tekst "In verband met zijn kwaliteit valt de hoofdfilm 
tijdens de pauze". 
Nijmegen, 9 april 1987 Toin van Kuppevelt 

